Access Medicare (HMO) 2015 Formulary (List of Covered Drugs)
Transcripción
Access Medicare (HMO) 2015 Formulary (List of Covered Drugs)
Access Medicare (HMO) 2015 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN HPMS Approved Formulary File Submission ID 15483.000, Version Number 5 This formulary was updated on 01/01/2015. For more recent information or other questions, please contact Access Medicare Member Services at 1-877-696-1121 or, for TTY users, 1-800-662-1220, 8am to 8pm 7 days a week, or visit www.accessmedicareny.com. Note to existing members: This formulary has changed since last year. Please review this document to make sure that it still contains the drugs you take. When this drug list (formulary) refers to “we,” “us”, or “our,” it means Cuatro, LLC. When it refers to “plan” or “our plan,” it means Access Medicare. This document includes list of the drugs (formulary) for our plan which is current as of 01/01/2015. For an updated formulary, please contact us. Our contact information, along with the date we last updated the formulary, appears on the front and back cover pages. You must generally use network pharmacies to use your prescription drug benefit. Benefits, formulary, pharmacy network, and/or copayments/coinsurance may change on January 1, 2016, and from time to time during the year. H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 What is the Access Medicare Formulary? A formulary is a list of covered drugs selected by in consultation with a team of health care providers, which represents the prescription therapies believed to be a necessary part of a quality treatment program. Access Medicare will generally cover the drugs listed in our formulary as long as the drug is medically necessary, the prescription is filled at a Access Medicare network pharmacy, and other plan rules are followed. For more information on how to fill your prescriptions, please review your Evidence of Coverage. Can the Formulary (drug list) change? Generally, if you are taking a drug on our 2015 formulary that was covered at the beginning of the year, we will not discontinue or reduce coverage of the drug during the 2015 coverage year except when a new, less expensive generic drug becomes available or when new adverse information about the safety or effectiveness of a drug is released. Other types of formulary changes, such as removing a drug from our formulary, will not affect members who are currently taking the drug. It will remain available at the same cost-sharing for those members taking it for the remainder of the coverage year. We feel it is important that you have continued access for the remainder of the coverage year to the formulary drugs that were available when you chose our plan, except for cases in which you can save additional money or we can ensure your safety. If we remove drugs from our formulary, add prior authorization, quantity limits and/or step therapy restrictions on a drug or move a drug to a higher cost-sharing tier, we must notify affected members of the change at least 60 days before the change becomes effective, or at the time the member requests a refill of the drug, at which time the member will receive a 60-day supply of the drug. If the Food and Drug Administration deems a drug on our formulary to be unsafe or the drug’s manufacturer removes the drug from the market, we will immediately remove the drug from our formulary and provide notice to members who take the drug. The enclosed formulary is current as of 01/01/2015. To get updated information about the drugs covered by Access Medicare, please contact us. Our contact information appears on the front and back cover pages. In the event of a mid-year non-maintenance formulary changes, Access Medicare will provide all members notice of those changes in writing. How do I use the Formulary? There are two ways to find your drug within the formulary: Medical Condition The formulary begins on page 1. The drugs in this formulary are grouped into categories depending on the type of medical conditions that they are used to treat. For example, drugs used to treat a heart condition are listed under the category, “Cardiovascular Agents”. If you know what your drug is used for, look for the category name in the list that begins on page number 1. Then look under the category name for your drug. i H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 Alphabetical Listing If you are not sure what category to look under, you should look for your drug in the Index that begins on page I-1. The Index provides an alphabetical list of all of the drugs included in this document. Both brand name drugs and generic drugs are listed in the Index. Look in the Index and find your drug. Next to your drug, you will see the page number where you can find coverage information. Turn to the page listed in the Index and find the name of your drug in the first column of the list. What are generic drugs? Access Medicare covers both brand name drugs and generic drugs. A generic drug is approved by the FDA as having the same active ingredient as the brand name drug. Generally, generic drugs cost less than brand name drugs. Are there any restrictions on my coverage? Some covered drugs may have additional requirements or limits on coverage. These requirements and limits may include: Prior Authorization: Access Medicare requires you or your physician to get prior authorization for certain drugs. This means that you will need to get approval from Access Medicare before you fill your prescriptions. If you don’t get approval, Access Medicare may not cover the drug. Quantity Limits: For certain drugs, Access Medicare limits the amount of the drug that Access Medicare will cover. For example, Access Medicare provides nine (9) 200mg tablets per prescription for XIFAXAN. This may be in addition to a standard one-month or three-month supply. Step Therapy: In some cases, Access Medicare requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition. For example, if Drug A and Drug B both treat your medical condition, Access Medicare may not cover Drug B unless you try Drug A first. If Drug A does not work for you, Access Medicare will then cover Drug B. You can find out if your drug has any additional requirements or limits by looking in the formulary that begins on page 1. You can also get more information about the restrictions applied to specific covered drugs by visiting our Web site. We have posted on line a document that explain our prior authorization and step therapy restrictions. You may also ask us to send you a copy. Our contact information, along with the date we last updated the formulary, appears on the front and back cover pages. You can ask Access Medicare to make an exception to these restrictions or limits or for a list of other, similar drugs that may treat your health condition. See the section, “How do I request an exception to the Access Medicare’s formulary?” on page iii for information about how to request an exception. ii H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 What if my drug is not on the Formulary? If your drug is not included in this formulary (list of covered drugs), you should first contact Member Services and ask if your drug is covered. If you learn that Access Medicare does not cover your drug, you have two options: You can ask Member Services for a list of similar drugs that are covered by Access Medicare. When you receive the list, show it to your doctor and ask him or her to prescribe a similar drug that is covered by Access Medicare. You can ask Access Medicare to make an exception and cover your drug. See below for information about how to request an exception. How do I request an exception to the Access Medicare’s Formulary? You can ask Access Medicare to make an exception to our coverage rules. There are several types of exceptions that you can ask us to make. You can ask us to cover a drug even if it is not on our formulary. If approved, this drug will be covered at a pre-determined cost-sharing level, and you would not be able to ask us to provide the drug at a lower cost-sharing level. You can ask us to cover a formulary drug at a lower cost-sharing level if this drug is not on the specialty tier. If approved this would lower the amount you must pay for your drug. You can ask us to waive coverage restrictions or limits on your drug. For example, for certain drugs, Access Medicare limits the amount of the drug that we will cover. If your drug has a quantity limit, you can ask us to waive the limit and cover a greater amount. Generally, Access Medicare will only approve your request for an exception if the alternative drugs included on the plan’s formulary, the lower cost-sharing drug or additional utilization restrictions would not be as effective in treating your condition and/or would cause you to have adverse medical effects. You should contact us to ask us for an initial coverage decision for a formulary, tiering or utilization restriction exception. When you request a formulary, tiering, or utilization restriction exception you should submit a statement from your prescriber or physician supporting your request. Generally, we must make our decision within 72 hours of getting your prescriber’s supporting statement. You can request an expedited (fast) exception if you or your doctor believe that your health could be seriously harmed by waiting up to 72 hours for a decision. If your request to expedite is granted, we must give you a decision no later than 24 hours after we get a supporting statement from your doctor or other prescriber. iii H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 What do I do before I can talk to my doctor about changing my drugs or requesting an exception? As a new or continuing member in our plan you may be taking drugs that are not on our formulary. Or, you may be taking a drug that is on our formulary but your ability to get it is limited. For example, you may need a prior authorization from us before you can fill your prescription. You should talk to your doctor to decide if you should switch to an appropriate drug that we cover or request a formulary exception so that we will cover the drug you take. While you talk to your doctor to determine the right course of action for you, we may cover your drug in certain cases during the first 90 days you are a member of our plan. For each of your drugs that is not on our formulary or if your ability to get your drugs is limited, we will cover a temporary 30-day supply (unless you have a prescription written for fewer days) when you go to a network pharmacy. After your first 30-day supply, we will not pay for these drugs, even if you have been a member of the plan less than 90 days. If you are a resident of a long-term care facility, we will allow you to refill your prescription until we have provided you with 91-day transition supply, consistent with dispensing increment, (unless you have a prescription written for fewer days). We will cover more than one refill of these drugs for the first 90 days you are a member of our plan. If you need a drug that is not on our formulary or if your ability to get your drugs is limited, but you are past the first 90 days of membership in our plan, we will cover a 31-day emergency supply of that drug (unless you have a prescription for fewer days) while you pursue a formulary exception. For those members who have transitioned from one level of care to another such as a hospital admission to home: We will cover a temporary supply of your drug during the first 90 days of this transition period. The first supply will be for a maximum of a 31-day supply, or less if your prescription is written for fewer days. If needed, we will cover additional refills during your first 90 days in the plan. For more information For more detailed information about your Access Medicare prescription drug coverage, please review your Evidence of Coverage and other plan materials. If you have questions about Access Medicare, please contact us. Our contact information, along with the date we last updated the formulary, appears on the front and back cover pages. If you have general questions about Medicare prescription drug coverage, please call Medicare at 1-800MEDICARE (1-800-633-4227) 24 hours a day/7 days a week. TTY users should call 1-877-486-2048. Or, visit http://www.medicare.gov. iv H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 Access Medicare’s Formulary The formulary that begins on the page 1 provides coverage information about the drugs covered by Access Medicare. If you have trouble finding your drug in the list, turn to the Index that begins on page I-1. The first column of the chart lists the drug name. Brand name drugs are capitalized (BUTRANS) and generic drugs are listed in lower-case italics (e.g., fentanyl citrate). The information in the Requirements/Limits column tells you if Access Medicare has any special requirements for coverage of your drug. The second column indicates the tier level. Tier 1 Preferred Generic Drugs Tier 2 Non-Preferred Generic Drugs Tier 3 Preferred Brand Drugs Tier 4 Non-Preferred Brand Drugs Tier 5 Specialty Drugs Until your Part D total drug cost reaches $2,960 for Platinum, $2,500 for Gold, or $4700 for Pearl, your copayments or coinsurances for formulary drug tiers are noted in the table below in the following format: 30 day Retail / 90 day Retail / Mail Order. Plan Name Tier 1 Tier 2 Tier 3 Tier 4 Access $4/$12/$6 Medicare Gold $8/$24/$12 $35/$105/$52.50 $75/$225/$112.50 33% Access Medicare Platinum 25% 25% 25% 25% 25% Access Medicare Pearl $0/$1.20/$2.65 $0/$1.20/$2.65 $0/$3.60/$6.60 $0/$3.60/$6.60 $0/$3.60/$6.60 Please refer to our Evidence of Coverage for more information about this coverage. v H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 Tier 5 2015 Drug Formulary Formulario de medicamentos 2015 The information in the Requirements/Limits column tells you if Access Medicare has any special requirements for coverage of your drug. The following Utilization Management abbreviations may be found within the body of this document COVERAGE NOTES ABBREVIATIONS ABBREVIATION DESCRIPTION EXPLANATION Utilization Management Restrictions PA You (or your physician) are required to get prior authorization from Access Medicare before you Prior Authorization Restriction fill your prescription for this drug. Without prior approval, Access Medicare may not cover this drug. PA BvD This drug may be eligible for payment under Medicare Part B or Part D. You (or your Prior Authorization Restriction physician) are required to get prior authorization from Access Medicare to determine that this drug for is covered under Medicare Part D before you fill Part B vs Part D your prescription for this drug. Without prior Determination approval, Access Medicare may not cover this drug. PA-HRM This drug has been deemed by CMS to be potentially harmful and therefore, a High Risk Medication for Medicare beneficiaries 65 years or Prior Authorization Restriction older. Members age 65 yrs or older are required for to get prior authorization from Access Medicare High Risk Medications before you fill your prescription for this drug. Without prior approval, Access Medicare may not cover this drug PA NSO If you are a new member, you (or your physician) Prior Authorization Restriction are required to get prior authorization from Access Medicare before you fill your prescription for for this drug. Without prior approval, Access New Starts Only Medicare may not cover this drug. vi H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ABBREVIATION DESCRIPTION QL Quantity Limit Restriction Access Medicare limits the amount of this drug that is covered per prescription, or within a specific time frame. Step Therapy Restriction Before Access Medicare will provide coverage for this drug, you must first try another drug(s) to treat your medical condition. This drug may only be covered if the other drug(s) does not work for you. ST EXPLANATION The following additional coverage note abbreviations may be found within the body of this document OTHER SPECIAL REQUIREMENTS FOR COVERAGE ABBREVIATION DESCRIPTION EXPLANATION EX Excluded Part D Drug This prescription drug is not normally covered in a Medicare Prescription Drug Plan. The amount you pay when you fill a prescription for this drug does not count towards your total drug costs (that is, the amount you pay does not help you qualify for catastrophic coverage). In addition, if you are receiving extra help to pay for your prescriptions, you will not get any extra help to pay for this drug FF Free First Fill (Generic Use Incentive) This prescription drug will be provided at reduced cost-sharing the first time you fill it. Limited Access Drug This prescription may be available only at certain pharmacies. For more information consult your Pharmacy Directory or call Member Services at 1-877-696-1121, 8am to 8pm, 7 days a week. TTY/TDD users should call 1-800-662-1220. Gap Coverage We provide coverage of this prescription drug in the coverage gap. Please refer to our Evidence of Coverage for more information about this coverage. LA GC vii H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ABBREVIATION NM HI DESCRIPTION EXPLANATION Non-Mail Order Drug You may be able to receive greater than a 1month supply of most of the drugs on your formulary via mail order at a reduced cost share. Drugs not available via your mail order benefit are noted with “NM” in the Requirements/Limits column of your formulary. Home Infusion Drug This prescription drug may be covered under our medical benefit. For more information, call Member Services at 1-877-696-1121, 8am to 8pm, 7 days a week. TTY/TDD users should call 1-800-662-1220. vi i i H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 STRENGTH AND DOSAGE FORM ABBREVIATIONS ABBREVIATION adh. patch aer br act aer pow aer pow ba aer refill aer w/adap ampul blkbaginj cap dr mp cap ds pk cap er 12h cap er 24h cap er deg cap er pel cap mphase cap.sa 24h cap.sr 12h cap.sr 24h cap24h pct cap24h pel cap sprink cap sr pel cap w/dev capsule dr capsule er capsule sa cmb cappad cmb ont fm cmb ont lt cmb tabpad combo. pkg cpmp 12hr cpmp 24hr cpmp 30-70 cpmp 50-50 cream(g), cream(gm) cream(ml) cream/appl DESCRIPTION adhesive patch aerosol, breath activated aerosol, powder aerosol powder, breath activated aerosol refill aerosol with adapter ampule bulk bag injection capsule, delayed release multiphasic capsule, dose pack capsule, 12 hour extended release capsule, 24 hour extended release capsule, extended release degradable capsule, extended release pellets capsule, multiphasic capsule, 24 hour sustained action capsule, 12 hour sustained release capsule, 24 hour sustained release capsule, 24 hour controlled-onset pellets capsule, 24 hour sustained release pellets capsule, sprinkle capsule sustained release pellets capsule with device capsule, delayed release capsule, extended release capsule, sustained action combination: capsule, pad combination: ointment, foam combination: ointment, lotion combination: tablet, pad combination package capsule, 12 hour multiphasic capsule, 24 hour multiphasic capsule, multiphasic, 30%-70% capsule, multiphasic, 50%-50% cream (grams) cream (milliliters) cream with applicator ix H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ABBREVIATION cream, er (g) cream pack dehp fr bg dis needle disk w/dev disp syrin drops susp drps hpvis emul adhes emul packt emulsn(g) foam/appl. froz.piggy g gel/pf app gel (gm) gel (ml) gel md pmp gel w/appl gel w/pump gran pack hfa aer ad infus. btl insuln pen ip soln irrig soln iv soln. jel jelly/app jel/pf app kit cl&crm kt crm le kt lotn ce kt oint le lotion, er lozenge hd m.ht patch ma buc tab mcg med. pad DESCRIPTION cream, extended release (grams) cream, package di(2-ethylhexyl)phthalate free bag disposable needle disk with inhalation device disposable syringe drops, suspension drops, hyperviscous emulsion adhesive emulsion packet emulsion (grams) foam with applicator frozen piggyback gram gel with prefilled applicator gel (grams) gel (milliliters) gel in metered dose pump gel with applicator gel with pump granule pack hfa aerosol adapter infusion bottle insulin pen intraperitoneal solution irrigating solution intravenous solution jelly jelly with applicator jelly with pre-filled applicator kit: cleanser and cream kit: cream, lotion emollient kit: lotion, cream emollient kit: ointment, lotion emollient lotion, extended release lozenge handle medicated heated patch mucoadhesive buccal tablet microgram medicated pad x H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ABBREVIATION med. swab med. tape mg ml muc er 12h ndl fr inj nl fm susp oint. (g), oint.(gm) oral conc oral susp paste (g) patch td24 patch td72 patch tdsw patch tdwk pca syring pca vial pellet(ea) pen ij kit pen injctr pggybk btl plast. bag powd pack sol md pmp sol w/appl sol/pf app sol-gel soln recon soln(gram) spray susp spray/pump stick(ea) supp.rect supp.vag suppos. sus er 24h sus er rec sus mc rec suspdr pkt susp recon DESCRIPTION medicated swab medicated tape milligram milliliter mucoadhesive system, 12 hour extended release needle for injection nail film suspension ointment (grams) oral concentrate oral suspension paste (grams) patch, 24 hour transdermal patch, 72 hour transdermal patch, biweekly transdermal patch, weekly transdermal patient-controlled analgesic syringe patient-controlled analgesic vial pellet (each) pen injector kit pen injector piggyback bottle plastic bag powder pack solution with multi-dose pump solution with applicator solution with pre-filled applicator solution, gel-forming solution, reconstituted solution (grams) spray, suspension spray with pump stick (each) suppository, rectal suppository, vaginal suppository suspension, 24 hour extended release suspension, extended release reconstituted suspension, microcapsule reconstituted suspension, delayed release packet suspension, reconstituted xi H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ABBREVIATION syringekit tab chew tab er 12h tab er 24h tab er prt tab er seq tab disper tab ds pk tab er 24 tab mphase tab part tab rap dr tab rapdis tab subl tab.sr 12h tab.sr 24h tabergr24hr tablet dr tablet, er tablet eff tablet sa tablet sol tb er dspk tb mp dspk tb rd dspk tbdspk 3mo tbmp 12hr tbmp 24hr u vag ring DESCRIPTION syringe kit tablet, chewable tablet, 12 hour extended release tablet, 24 hour extended release tablet, extended release particles tablet, extended release sequels tablet, dispersible tablet, dose pack tablet, 24 hour extended release tablet, multiphasic tablet, particles tablet, rapid disintegrating delayed release tablet, rapid disintegrating tablet, sublingual tablet, 12 hour sustained release tablet, 24 hour sustained release tablet, 24 hour gradual extended release tablet, delayed release tablet, extended release tablet, effervescent tablet, sustained action tablet, soluble tablet, extended release dose pack tablet, multiphasic dose pack tablet, rapid disintegrating dose pack tablet, 3-month dose pack tablet, 12 hour multiphasic tablet, 24 hour multiphasic unit vaginal ring Index of Drugs This formulary was updated on 01/01/2015. For more recent information or other questions, please contact Access Medicare Member Services at 1-877-696-1121 or, for TTY users, 1-800-662-1220, 8am to 8pm 7 days a week, or visit www.accessmedicareny.com. Access Medicare is an HMO with a Medicare Contract. Enrollment in Access Medicare depends on contract renewal. xii H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 Nombre del plan de Access Medicare Formulario para 2015 (Lista de medicamentos cubiertos) LEA LO SIGUIENTE: ESTE DOCUMENTO CONTIENE INFORMACIÓN ACERCA DE LOS MEDICAMENTOS QUE CUBRIMOS EN ESTE PLAN HPMS Approved Formulary File Submission ID 15483.000, Version Number 5 Este formulario se actualizó el 01/01/2015. Para obtener información más reciente o si tiene alguna pregunta, póngase en contacto con el Servicio para los miembros de Access Medicare al 1-877-696-1121 (los usuarios de TTY deben llamar al 1-800-662-1220) de 8:00 a. m. a 8:00 p. m., los 7 días de la semana, o visite www.accessmedicareny.com. Nota para los miembros actuales: este Formulario ha cambiado con respecto al año pasado. Revise este documento para asegurarse de que aún contenga los medicamentos que toma. Cuando esta lista de medicamentos (Formulario) menciona “nosotros,” “nos” o “nuestro”, hace referencia a Cuatro, LLC. Cuando menciona “plan” o “nuestro plan,” hace referencia a Access Medicare. Este documento incluye una lista de los medicamentos (formulario) de nuestro plan, la cual estará en vigencia a partir del 01/01/2015. Para obtener un Formulario actualizado, póngase en contacto con nosotros. Nuestra información de contacto, junto con la fecha de la última actualización del Formulario, aparece en las páginas de la portada y la portada posterior. Generalmente, debe concurrir a las farmacias de la red para usar el beneficio de medicamentos con receta. Los beneficios, el formulario, la red de farmacias o los copagos/el coseguro pueden cambiar el 1 de enero de 2016 y periódicamente durante el año. xiii H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ¿En qué consiste el Formulario de Access Medicare? Un Formulario es una lista de medicamentos cubiertos seleccionados con la colaboración de un equipo de proveedores de salud, que representa los tratamientos con receta que se cree que son parte necesaria de un programa de tratamiento de calidad. Por lo general, Access Medicare cubrirá los medicamentos enumerados en nuestro Formulario siempre y cuando el medicamento sea médicamente necesario, se obtenga el medicamento en una farmacia de la red de Access Medicare y se cumpla con otras normas del plan. Para obtener más información sobre cómo obtener sus medicamentos con receta, consulte la Evidencia de cobertura. ¿Puede cambiar el Formulario (lista de medicamentos)? En general, si usted toma un medicamento de nuestro Formulario para 2015 que estaba cubierto al comienzo del año, nosotros no discontinuaremos ni reduciremos la cobertura del medicamento durante el año de cobertura 2015, excepto cuando esté disponible un nuevo medicamento genérico de menor costo o cuando se dé a conocer nueva información adversa acerca de la seguridad o eficacia del medicamento. Otros tipos de cambios en el Formulario, como por ejemplo, la eliminación de un medicamento de nuestro Formulario, no afectarán a los miembros que estén actualmente tomando el medicamento. Continuará disponible al mismo costo compartido para aquellos miembros que estén tomándolo por el resto del año de cobertura. Consideramos que es importante que tenga acceso continuo a los medicamentos del Formulario que estaban disponibles cuando eligió nuestro plan durante el resto del año de cobertura, salvo en los casos en los que usted podría ahorrar más dinero o que nosotros podríamos garantizarle su seguridad. Si retiramos medicamentos de nuestro Formulario, [o] agregamos autorizaciones previas, límites de cantidad o restricciones en el Programa de terapia en etapas en relación con un medicamento, o si pasamos un medicamento a un nivel superior de costo compartido, debemos notificar sobre el cambio a los miembros afectados por el cambio al menos 60 días antes de que entre en vigencia dicho cambio, o cuando el miembro solicite un resurtido del medicamento, momento en el cual el miembro recibirá un suministro del medicamento para 60 días. Si la Administración de Drogas y Alimentos considera que un medicamento de nuestro Formulario es inseguro o el fabricante del medicamento lo retira del mercado, eliminaremos de inmediato dicho medicamento de nuestro Formulario y notificaremos a los miembros que toman el medicamento en cuestión. El formulario adjunto está vigente a partir del 01/01/2015. Para recibir información actualizada sobre los medicamentos cubiertos por Access Medicare, póngase en contacto con nosotros. Nuestra información de contacto aparece en las páginas de la portada y la portada posterior. En caso de que a mitad de año se realicen cambios en el Formulario que no sean de mantenimiento, Access Medicare les proporcionará a todos los miembros un aviso por escrito sobre dichos cambios. xiv H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ¿Cómo utilizo el Formulario? Hay dos formas para encontrar su medicamento dentro del Formulario: Afección médica El Formulario empieza en la página 1. Los medicamentos de este Formulario están agrupados en categorías según el tipo de afección médica para cuyo tratamiento se los emplea. Por ejemplo, los medicamentos utilizados para tratar una afección cardíaca se enumeran dentro de la categoría “Agentes Cardiovasculares”. Si sabe para qué se utiliza su medicamento, busque el nombre de la categoría en la lista que empieza en la página 1. Luego busque su medicamento debajo del nombre de la categoría. Listado alfabético Si no está seguro de qué categoría debe consultar, debe buscar su medicamento en el Índice que comienza en la página I-1. El Índice proporciona una lista alfabética de todos los medicamentos incluidos en este documento. En el Índice, están tanto los medicamentos de marca como los genéricos. Busque en el Índice y encuentre su medicamento. Junto a su medicamento, verá el número de página donde puede encontrar información acerca de la cobertura. Vaya a la página que figura en el Índice y encuentre el nombre de su medicamento en la primera columna de la lista. ¿Qué son los medicamentos genéricos? Access Medicare cubre tanto los medicamentos de marca como los genéricos. La FDA aprueba un medicamento genérico que tiene los mismos principios activos que el medicamento de marca. Normalmente, los medicamentos genéricos cuestan menos que los de marca. ¿Hay alguna restricción en mi cobertura? Algunos medicamentos cubiertos pueden tener requisitos o límites adicionales de cobertura. Estos requisitos y límites pueden incluir: Autorización previa: Access Medicare exige que usted o su médico obtengan una autorización previa para determinados medicamentos. Esto significa que necesitará contar con la aprobación de Access Medicare antes de obtener sus medicamentos con receta. Si no consigue la autorización, es posible que Access Medicare no cubra el medicamento. Límites de cantidad: para ciertos medicamentos, Access Medicare limita la cantidad del medicamento que cubrirá. Por ejemplo, Access Medicare proporciona nueve (9) comprimidos de 200 mg por receta de XIFAXAN. Esto puede ser complementario a un suministro estándar para un mes o tres meses. xv H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 Programa de terapia en etapas: en algunos casos, Access Medicare requiere que usted primero pruebe ciertos medicamentos para tratar su afección médica antes de que cubramos otro medicamento para esa afección médica. Por ejemplo, si el medicamento A y el medicamento B tratan su afección médica, es posible que Access Medicare no cubra el medicamento B a menos que usted pruebe primero el medicamento A. Si el medicamento A no funciona para usted, entonces Access Medicare cubrirá el medicamento B. Puede averiguar si su medicamento tiene requisitos adicionales o límites consultando el Formulario que empieza en la página 1. También puede obtener más información sobre las restricciones que se aplican a medicamentos cubiertos específicos en nuestro sitio web. Hemos publicado en línea un documento que explica nuestras restricciones de autorización previa y de Programa de terapia en etapas. También puede pedirnos que le enviemos una copia. Nuestra información de contacto, junto con la fecha de la última actualización del Formulario, aparece en las páginas de la portada y la portada posterior. Puede pedirle a Access Medicare que haga una excepción a estas restricciones o límites o puede solicitarle una lista de otros medicamentos similares que puedan tratar su afección médica. Consulte la sección “¿Cómo solicito una excepción al Formulario de Access Medicare?” en la página iii para obtener información acerca de cómo solicitar una excepción. ¿Qué pasa si mi medicamento no está en el Formulario? Si el medicamento que toma no está incluido en este Formulario (lista de medicamentos cubiertos), primero debe ponerse en contacto con el Servicio para los miembros y preguntar si su medicamento está cubierto. Si resulta que Access Medicare no cubre el medicamento que toma, tiene dos alternativas: Puede solicitar al Servicio para los miembros una lista de medicamentos similares que Access Medicare cubra. Cuando reciba la lista, muéstresela a su médico y pídale que le recete un medicamento similar que esté cubierto por Access Medicare. Puede solicitarle a Access Medicare que haga una excepción y cubra el medicamento. Consulte más abajo para obtener información sobre cómo solicitar una excepción. ¿Cómo puedo solicitar que se haga una excepción al Formulario de Access Medicare? Puede solicitarle a Access Medicare que haga una excepción a nuestras normas de cobertura. Hay varios tipos de excepciones que puede solicitarnos. xvi H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 Puede pedirnos que cubramos un medicamento, incluso si no está en nuestro Formulario. Si se aprueba, este medicamento estará cubierto a un nivel de costo compartido predeterminado, y usted no podrá pedirnos que proporcionemos el medicamento a un nivel de costo compartido menor. Puede pedirnos que cubramos un medicamento del Formulario a un nivel de costo compartido menor si este medicamento no está incluido en el nivel de medicamentos especializados. Si se aprueba, esto reduciría el monto que usted debe pagar por su medicamento. Puede pedirnos que no apliquemos restricciones o límites de cobertura para su medicamento. Por ejemplo: para ciertos medicamentos, Access Medicare limita la cantidad del medicamento que cubriremos. Si su medicamento tiene un límite de cantidad, puede pedirnos que hagamos una excepción al límite y cubramos una cantidad mayor. Por lo general, Access Medicare solo aprobará su solicitud de excepción si los demás medicamentos incluidos en el Formulario del plan, el medicamento de menor costo compartido o las restricciones de uso adicionales no fueran tan efectivos para tratar su enfermedad o pudieran causarle efectos médicos adversos. Debe ponerse en contacto con nosotros para solicitarnos una decisión inicial de cobertura respecto de una excepción al Formulario, al nivel o a la restricción de uso. Cuando solicita una excepción al Formulario, al nivel o a la restricción de uso, debe presentar una declaración de su médico o de la persona autorizada a dar recetas que respalde su solicitud. Por lo general, debemos tomar una decisión dentro de las 72 horas a partir de la fecha de haber recibido la declaración que respalda su solicitud por parte de la persona autorizada a dar recetas. Puede solicitar una excepción acelerada (rápida) si usted o su médico consideran que esperar 72 horas para la toma de la decisión podría perjudicar gravemente su salud. Si se le concede el trámite rápido de la excepción, debemos comunicarle nuestra decisión a más tardar dentro de las 24 horas después de haber recibido la declaración de respaldo de su médico o de otra persona autorizada a dar recetas. ¿Qué debo hacer antes de hablar con mi médico sobre el cambio de los medicamentos que tomo o la solicitud de una excepción? Como miembro nuevo o permanente de nuestro plan, es posible que esté tomando medicamentos que no están incluidos en el Formulario. También es posible que esté tomando un medicamento incluido en el Formulario pero su capacidad de conseguirlo sea limitada. Por ejemplo, puede necesitar nuestra autorización previa antes de poder obtener su medicamento con receta. Debe consultar con su médico para decidir si debe cambiar su medicamento por uno apropiado que nosotros cubramos o solicitar una excepción al Formulario para que le cubramos el medicamento que toma. Mientras evalúa con su médico el procedimiento adecuado a seguir en su caso, podemos cubrir su medicamento en ciertos casos durante los primeros 90 días en que usted sea miembro de nuestro plan. Para cada uno de los medicamentos que no están incluidos en el Formulario o si su capacidad para conseguir los medicamentos es limitada, cubriremos un suministro temporal para 30 días (a menos que tenga una receta x vi i H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 para menos días) cuando acuda a una farmacia de la red. Después del primer suministro para 30 días, no pagaremos los medicamentos, incluso si ha sido miembro del plan durante menos de 90 días. Si reside en un centro de atención a largo plazo, le permitiremos obtener sus medicamentos con receta hasta que le hayamos provisto un suministro de transición para 91 días, de manera consistente con el incremento de provisión (a menos que tenga una receta para menos días). Cubriremos más de un resurtido de estos medicamentos durante los primeros 90 días en que usted sea miembro del plan. Si necesita un medicamento que no está en el Formulario o si su capacidad para conseguir los medicamentos es limitada, pero ya pasaron los primeros 90 días de membresía en nuestro plan, cubriremos un suministro de emergencia del medicamento para 30 días (a menos que tenga una receta para menos días) mientras solicita la excepción al Formulario. Para aquellos miembros que se han transferido de un nivel de atención a otro, como de una estadía en el hospital al hogar: Cubriremos un suministro temporal del medicamento durante los primeros 90 días de este período de transición. El primer suministro será para un suministro máximo de 31 días, o menos, si su receta está indicada para menos días. Si es necesario, cubriremos resurtidos adicionales durante sus primeros 90 días en el plan. Para obtener más información Para obtener información más detallada sobre la cobertura para medicamentos con receta de Access Medicare, consulte la Evidencia de cobertura y la demás documentación del plan. Si tiene alguna pregunta sobre Access Medicare, póngase en contacto con nosotros. Nuestra información de contacto, junto con la fecha de la última actualización del Formulario, aparece en las páginas de la portada y la portada posterior. Si tiene preguntas generales sobre su cobertura para medicamentos con receta de Medicare, llame a Medicare al 1-800-MEDICARE (1-800-633-4227), durante las 24 horas, los 7 días de la semana. Los usuarios de TTY deben llamar al 1-877-486-2048. O visite http://www.medicare.gov. Formulario de Access Medicare El Formulario que empieza en la página 1 proporciona información de cobertura acerca de los medicamentos cubiertos por Access Medicare. Si tiene alguna dificultad para encontrar en la lista el medicamento que toma, consulte el Índice que comienza en la página I-1. La primera columna de la tabla menciona el nombre del medicamento. Los medicamentos de marca están en letra mayúscula (BUTRANS), y los medicamentos genéricos están en letra minúscula y cursiva (p. ej., citrato de fentanilo). La información incluida en la columna de Requisitos/Límites indica si Access Medicare tiene algún requisito especial para la cobertura del medicamento. xviii H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 La segunda columna indica el nivel del medicamento. Nivel 1: medicamentos genéricos preferidos Nivel 2: medicamentos genéricos no preferidos Nivel 3: medicamentos de marca preferidos Nivel 4: medicamentos de marca no preferidos Nivel 5: medicamentos especializados Hasta que el costo total de su medicamento de la Parte D no alcance $2,960 para Platinum, $2,500 para Gold o $4,700 para Pearl, se describen los copagos o coseguros para los niveles de medicamentos del Formulario en la tabla a continuación en el siguiente formato: 30 días farmacia minorista/90 días farmacia minorista/de pedido por correo. Nombre del plan Nivel 1 Nivel 2 Nivel 3 Nivel 4 Nivel 5 Access $4/$12/$6 Medicare Gold $8/$24/$12 $35/$105/$52.50 $75/$225/$112.50 33 % Access Medicare Platinum 25 % 25 % 25 % 25 % 25 % Access Medicare Pearl $0/$1.20/$2.65 $0/$1.20/$2.65 $0/$3.60/$6.60 $0/$3.60/$6.60 $0/$3.60/$6.60 Consulte la Evidencia de cobertura para obtener más información sobre esta cobertura. xix H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 La información incluida en la columna de Requisitos/Límites indica si Access Medicare tiene algún requisito especial para la cobertura del medicamento. Las siguientes abreviaturas de administración de la utilización se pueden encontrar en el cuerpo de este documento. ABREVIATURAS DE LAS NOTAS DE COBERTURA ABREVIATURA DESCRIPCIÓN EXPLICACIÓN Restricciones de la administración de la utilización Restricción de autorización previa Usted (o su médico) tiene que obtener autorización previa de Access Medicare antes de obtener este medicamento con receta. Sin autorización previa, Access Medicare puede no cubrir este medicamento. Restricción de autorización previa para determinación de la Parte B frente a la Parte D Este medicamento puede ser elegible para pago según la Parte B o la Parte D de Medicare. Usted (o su médico) tiene que obtener autorización previa de Access Medicare para determinar si este medicamento está cubierto por la Parte D de Medicare antes de obtener este medicamento con receta. Sin autorización previa, Access Medicare puede no cubrir este medicamento. PA-HRM Restricción de autorización previa para medicamentos de alto riesgo Según los Centros de Servicios de Medicare y Medicaid (CMS, por sus siglas en inglés), este medicamento se considera potencialmente perjudicial y, por lo tanto, un medicamento de alto riesgo para los beneficiarios de Medicare de 65 años o más. Los miembros de 65 años o más tienen que obtener autorización previa de Access Medicare antes de obtener este medicamento con receta. Sin autorización previa, Access Medicare puede no cubrir este medicamento. PA NSO Restricción de autorización previa solo por primera vez Si usted es un miembro nuevo, usted (o su médico) tiene que obtener autorización previa de Access Medicare antes de obtener este medicamento con receta. Sin autorización previa, PA PA BvD xx H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ABREVIATURA DESCRIPCIÓN EXPLICACIÓN Access Medicare puede no cubrir este medicamento. QL ST Restricciones del límite de cantidad Access Medicare limita la cantidad de este medicamento que se cubre por receta o dentro de un plazo de tiempo específico. Restricción del Programa de terapia en etapas Antes de que Access Medicare brinde cobertura para este medicamento, primero debe probar otro(s) medicamento(s) para el tratamiento de su afección médica. Este medicamento solo podrá cubrirse si el/los otro(s) medicamento(s) no funciona(n) para usted. Las siguientes abreviaturas adicionales de las notas de cobertura se pueden encontrar en el cuerpo de este documento. OTROS REQUISITOS ESPECIALES DE COBERTURA DESCRIPCIÓN EXPLICACIÓN EX Medicamento de la Parte D excluido Este medicamento con receta generalmente no está cubierto en un plan de medicamentos con receta de Medicare. El monto que paga cuando obtiene uno de estos medicamentos con receta no se tiene en cuenta en sus costos totales de medicamentos (es decir, el monto que usted paga no lo ayuda a calificar para la cobertura en situaciones catastróficas). Además, si recibe ayuda adicional para pagar sus medicamentos con receta, no recibirá ninguna ayuda adicional para pagar este medicamento. FF Primer surtido gratis (Incentivo de uso genérico) Este medicamento con receta se ofrecerá a un costo compartido (de) reducido la primera vez que lo obtenga. LA Medicamento de acceso limitado ABREVIATURA Este medicamento con receta puede estar disponible solamente en determinadas farmacias. Para obtener más información, consulte el xxi H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ABREVIATURA DESCRIPCIÓN EXPLICACIÓN Directorio de farmacias o llame al Servicio para los miembros al 1-877-696-1121, de 8:00 a. m. a 8:00 p. m., los 7 días de la semana. Los usuarios de TTY/TDD deben llamar al 1-800-662-1220. GC NM HI Período sin cobertura Proporcionamos cobertura para este medicamento con receta durante el período sin cobertura. Consulte la Evidencia de cobertura para obtener más información sobre esta cobertura. Medicamento no disponible para pedido por correo Podrá recibir un suministro para más de 1 mes de la mayoría de los medicamentos incluidos en el Formulario por correo a un costo compartido reducido. Los medicamentos no disponibles a través de su beneficio de pedido por correo se indican con “NM” en la columna de Requisitos/Límites de su Formulario. Este medicamento con receta puede ser cubierto por nuestro beneficio médico. Para obtener más Medicamento de infusión en el información, llame al Servicio para los miembros al 1-877-696-1121, de 8:00 a. m. a 8:00 p. m., los hogar 7 días de la semana. Los usuarios de TTY/TDD deben llamar al 1-800-662-1220. xxii H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ABREVIATURAS DE FORMA DE DOSIFICACIÓN Y CONCENTRACIÓN ABREVIATURA adh. patch aer br act aer pow aer pow ba aer refill aer w/adap ampul blkbaginj cap dr mp cap ds pk cap er 12h cap er 24h cap er deg cap er pel cap mphase cap.sa 24h cap.sr 12h cap.sr 24h cap24h pct cap24h pel cap sprink cap sr pel cap w/dev capsule dr capsule er capsule sa cmb cappad cmb ont fm cmb ont lt cmb tabpad combo. pkg cpmp 12hr cpmp 24hr cpmp 30-70 cpmp 50-50 cream(g), cream(gm) cream(ml) cream/appl DESCRIPCIÓN parche adhesivo aerosol activado por respiración aerosol en polvo aerosol en polvo activado por respiración aerosol recarga aerosol con adaptador ampolla inyección en bolsa a granel cápsula multifásica de liberación retardada cápsula en paquete de dosis cápsula de liberación prolongada de 12 horas cápsula de liberación prolongada de 24 horas cápsula de liberación prolongada degradable cápsula en gránulos de liberación prolongada cápsula multifásica cápsula de acción sostenida de 24 horas cápsula de liberación sostenida de 12 horas cápsula de liberación sostenida de 24 horas cápsula en gránulos de inicio controlado de 24 horas cápsula en gránulos de liberación sostenida de 24 horas cápsula granulada cápsula en gránulos de liberación sostenida cápsula con dispositivo cápsula de liberación retardada cápsula de liberación prolongada cápsula de acción sostenida combinación: cápsula y almohadilla combinación: ungüento y espuma combinación: ungüento y loción combinación: comprimido y almohadilla paquete combinado cápsula multifásica de 12 horas cápsula multifásica de 24 horas cápsula multifásica, 30 %-70 % cápsula multifásica, 50 %-50 % crema (gramos) crema (mililitros) crema con aplicador xxiii H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ABREVIATURA cream, er (g) cream pack dehp fr bg dis needle disk w/dev disp syrin drops susp drps hpvis emul adhes emul packt emulsn(g) foam/appl. froz.piggy g gel/pf app gel (gm) gel (ml) gel md pmp gel w/appl gel w/pump gran pack hfa aer ad infus. btl insuln pen ip soln irrig soln iv soln. jel jelly/app jel/pf app kit cl&crm kt crm le kt lotn ce kt oint le lotion, er lozenge hd m.ht patch ma buc tab mcg med. pad DESCRIPCIÓN crema de liberación prolongada (gramos) crema en paquete bolsa libre de di(2-etilhexil) ftalato aguja descartable disco con dispositivo de inhalación jeringa descartable gotas en suspensión gotas hiperviscosas emulsión adhesiva paquete de emulsión emulsión (gramos) espuma con aplicador infusión intravenosa congelada gramo gel con aplicador prellenado gel (gramos) gel (mililitros) gel en bomba de dosis medida gel con aplicador gel con bomba paquete de gránulos adaptador de aerosol con inhalador de HFA infusión en botella pluma de insulina solución intraperitoneal solución de irrigación solución intravenosa jalea jalea con aplicador jalea con aplicador prellenado kit de limpiador y crema kit de crema y loción emoliente kit de loción y crema emoliente kit de ungüento y loción emoliente loción de liberación prolongada comprimido para chupar con aplicador bucal parche caliente medicinal comprimido bucal mucoadhesivo microgramo almohadilla medicinal xxiv H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ABREVIATURA med. swab med. tape mg ml muc er 12h ndl fr inj nl fm susp oint. (g), oint.(gm) oral conc oral susp paste (g) patch td24 patch td72 patch tdsw patch tdwk pca syring pca vial pellet(ea) pen ij kit pen injctr pggybk btl plast. bag powd pack sol md pmp sol w/appl sol/pf app sol-gel soln recon soln(gram) spray susp spray/pump stick(ea) supp.rect supp.vag suppos. sus er 24h sus er rec sus mc rec suspdr pkt susp recon DESCRIPCIÓN hisopo medicinal cinta medicinal miligramo mililitro sistema mucoadhesivo de liberación prolongada de 12 horas aguja para inyección suspensión en película para uñas ungüento (gramos) concentrado oral suspensión oral pasta (gramos) parche transdérmico de 24 horas parche transdérmico de 72 horas parche transdérmico quincenal parche transdérmico semanal jeringa con analgésico controlada por el paciente frasco con analgésico controlado por el paciente gránulo (cada uno) kit de pluma de inyección pluma de inyección frasco de infusión intravenosa bolsa de plástico polvo en paquete solución con bomba de dosis múltiples solución con aplicador solución con aplicador prellenado solución formadora de gel solución reconstituida solución (gramos) suspensión en aerosol aerosol con bomba varilla (cada una) supositorio rectal supositorio vaginal supositorio suspensión de liberación prolongada de 24 horas suspensión de liberación prolongada reconstituida suspensión con microcápsulas reconstituida suspensión con paquete de liberación retardada suspensión reconstituida xxv H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 2015 Drug Formulary Formulario de medicamentos 2015 ABREVIATURA syringekit tab chew tab er 12h tab er 24h tab er prt tab er seq tab disper tab ds pk tab er 24 tab mphase tab part tab rap dr tab rapdis tab subl tab.sr 12h tab.sr 24h tabergr24hr tablet dr tablet, er tablet eff tablet sa tablet sol tb er dspk tb mp dspk tb rd dspk tbdspk 3mo tbmp 12hr tbmp 24hr u vag ring DESCRIPCIÓN kit de jeringas comprimido masticable comprimido de liberación prolongada de 12 horas comprimido de liberación prolongada de 24 horas comprimido con partículas de liberación prolongada comprimido Sequels de liberación prolongada comprimido de disolución comprimido en paquete de dosis comprimido de liberación prolongada de 24 horas comprimido multifásico comprimido con partículas comprimido de desintegración rápida de liberación retardada comprimido de desintegración rápida comprimido sublingual comprimido de liberación sostenida de 12 horas comprimido de liberación sostenida de 24 horas comprimido de liberación prolongada gradual de 24 horas comprimido de liberación retardada comprimido de liberación prolongada comprimido efervescente comprimido de acción sostenida comprimido soluble comprimido en paquete de dosis de liberación prolongada comprimido multifásico en paquete de dosis comprimido en paquete de dosis de desintegración rápida comprimido en paquete de dosis de 3 meses comprimido multifásico de 12 horas comprimido multifásico de 24 horas unidad anillo vaginal Índice de medicamentos Este Formulario se actualizó el 01/01/2015. Para obtener información más reciente o si tiene otras preguntas, póngase en contacto con el Servicio para los miembros de Access Medicare llamando al 1-877-696-1121 (los usuarios de TTY deben llamar al 1-800-662-1220) de 8:00 a. m. a 8:00 p. m., los 7 días de la semana, o visite www.accessmedicareny.com. Access Medicare es una Organización para el mantenimiento de la salud (HMO, por sus siglas en inglés) que tiene un contrato con Medicare. La inscripción en Access Medicare depende de la renovación del contrato. x x vi H4866_AM4011 Accepted 09132014 H4866_AM4011_SP Accepted 09132014 Drug Name Drug Tier Requirements/Limits Analgesics Analgesics, Miscellaneous acetaminophen-codeine oral solution (Acetaminophen with Codeine) acetaminophen-codeine oral tablet 300-15 (Tylenol-Codeine No.3) mg, 300-30 mg acetaminophen-codeine oral tablet 300-60 (Tylenol-Codeine No.3) mg buprenorphine hcl injection (Buprenorphine HCl) butalb-acetaminophen-caffeine oral (Esgic) capsule 50-325-40 mg butalb-acetaminophen-caffeine oral (Butalb/Acetaminophen/ solution 50-325-40 mg/15 ml Caffeine) butalbital-acetaminop-caf-cod (Fioricet with Codeine) 1 QL (2700 per 30 days) 1 QL (360 per 30 days) 1 QL (180 per 30 days) butalbital-acetaminophen (Tencon) 1 butalbital-acetaminophen-caff oral tablet 50-325-40 mg butalbital-aspirin-caffeine oral capsule (Esgic) 1 (Fiorinal) 1 butorphanol tartrate nasal BUTRANS codeine sulfate oral tablet codeine-butalbital-asa-caffein oral capsule 30-50-325-40 mg DURAMORPH (PF) EMBEDA ORAL CAPSULE,ORAL ONLY,EXT.REL PELL 100-4 MG, 803.2 MG EMBEDA ORAL CAPSULE,ORAL ONLY,EXT.REL PELL 20-0.8 MG, 301.2 MG, 50-2 MG, 60-2.4 MG fentanyl citrate (Butorphanol Tartrate) 2 3 1 1 fentanyl transdermal patch 72 hour 100 mcg/hr (Codeine Sulfate) (Fiorinal with Codeine #3) 2 1 1 1 PA-HRM; QL (180 per 30 days) PA-HRM; QL (2700 per 30 days) PA-HRM; QL (180 per 30 days) PA-HRM; QL (180 per 30 days) PA-HRM; QL (180 per 30 days) PA-HRM; QL (180 per 30 days) QL (5 per 28 days) QL (4 per 28 days) QL (180 per 30 days) PA-HRM; QL (180 per 30 days) 4 4 QL (120 per 30 days) 4 QL (60 per 30 days) (Actiq) 5 (Duragesic) 2 PA; QL (120 per 30 days) PA; QL (20 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 1 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits fentanyl transdermal patch 72 hour 12 (Duragesic) mcg/hr, 25 mcg/hr, 37.5 mcg/hour, 50 mcg/hr, 62.5 mcg/hour, 75 mcg/hr, 87.5 mcg/hour hydrocodone-acetaminophen oral solution (Hycet) hydrocodone-acetaminophen oral tablet (Norco) 10-300 mg, 5-300 mg, 7.5-300 mg 2 PA; QL (10 per 30 days) 1 1 hydrocodone-acetaminophen oral tablet 10-325 mg, 2.5-325 mg, 5-325 mg, 7.5-325 mg hydrocodone-ibuprofen hydromorphone (pf) injection solution 10 mg/ml hydromorphone (pf) injection solution 4 mg/ml hydromorphone injection solution hydromorphone injection syringe 2 mg/ml hydromorphone oral liquid hydromorphone oral tablet 2 mg, 4 mg hydromorphone oral tablet 8 mg LAZANDA levorphanol tartrate methadone hcl oral tablet,soluble 40 mg methadone injection methadone oral methadone oral morphine concentrate oral solution morphine concentrate oral syringe morphine injection solution 15 mg/ml, 8 mg/ml morphine injection syringe 10 mg/ml, 2 mg/ml morphine intramuscular morphine intravenous morphine intravenous solution 25 mg/ml, 50 mg/ml (Norco) 1 QL (2700 per 30 days) (includes Vicodin, Vicodin ES and Vicodin HP); QL (390 per 30 days) QL (360 per 30 days) (Ibudone) (Hydromorphone HCl/PF) (Dilaudid) 1 2 (Hydromorphone HCl) (Hydromorphone HCl) (Dilaudid) (Dilaudid) (Dilaudid) (Levorphanol Tartrate) (Diskets) (Methadone HCl) (Methadone HCl) (Diskets) (Msir) (Morphine Sulfate) (Morphine Sulfate) 2 2 1 1 1 5 2 1 1 1 1 1 1 1 (Morphine Sulfate) 1 (Morphine Sulfate) (Morphine Sulfate) (Morphine Sulfate) 1 1 1 QL (150 per 30 days) 2 QL (1200 per 30 days) QL (180 per 30 days) QL (240 per 30 days) PA; QL (30 per 30 days) QL (180 per 30 days) QL (90 per 30 days) QL (1800 per 30 days) QL (360 per 30 days) QL (200 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 2 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name morphine intravenous morphine oral solution 10 mg/5 ml morphine oral solution 20 mg/5 ml MORPHINE ORAL TABLET morphine oral tablet extended release 100 mg, 30 mg, 60 mg morphine oral tablet extended release 15 mg, 200 mg morphine rectal NUCYNTA NUCYNTA ER oxycodone hcl-acetaminophen oral solution 5-325 mg/5 ml oxycodone hcl-acetaminophen oral tablet 10-325 mg, 2.5-325 mg, 5-325 mg, 7.5-325 mg oxycodone hcl-aspirin oxycodone oral capsule oxycodone oral concentrate oxycodone oral solution oxycodone oral tablet oxycodone-acetaminophen oral tablet 10325 mg, 2.5-325 mg, 5-325 mg, 7.5-325 mg oxycodone-acetaminophen oral tablet 10650 mg oxycodone-acetaminophen oral tablet 7.5500 mg oxycodone-aspirin OXYCONTIN ORAL TABLET,ORAL ONLY,EXT.REL.12 HR 10 MG, 15 MG, 20 MG, 30 MG, 40 MG, 60 MG OXYCONTIN ORAL TABLET,ORAL ONLY,EXT.REL.12 HR 80 MG oxymorphone oral tablet oxymorphone oral tablet extended release 12 hr 10 mg, 15 mg, 20 mg, 5 mg, 7.5 mg Drug Tier (Morphine Sulfate) (Msir) (Msir) Requirements/Limits (MS Contin) 1 1 1 1 1 QL (700 per 30 days) QL (300 per 30 days) QL (180 per 30 days) QL (120 per 30 days) (MS Contin) 1 QL (180 per 30 days) (Morphine Sulfate) 2 3 3 1 QL (181 per 30 days) QL (60 per 30 days) QL (1800 per 30 days) 1 QL (360 per 30 days) (Percodan) (Oxycodone HCl) (Oxycodone HCl) (Oxycodone HCl) (Percolone) (Xolox) 2 2 1 1 1 1 QL (360 per 30 days) QL (180 per 30 days) QL (180 per 30 days) QL (1300 per 30 days) QL (180 per 30 days) QL (360 per 30 days) (Xolox) 1 QL (180 per 30 days) (Xolox) 1 QL (240 per 30 days) (Percodan) 2 3 QL (360 per 30 days) QL (60 per 30 days) 3 QL (120 per 30 days) 2 2 QL (180 per 30 days) QL (60 per 30 days) (Oxycodone HCl/Acetaminophen) (Xolox) (Opana) (Opana ER) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 3 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits oxymorphone oral tablet extended release (Opana ER) 12 hr 30 mg, 40 mg tramadol oral tablet (Ultram) tramadol-acetaminophen (Ultracet) XARTEMIS XR xylon 10 (Ibudone) Nonsteroidal Anti-Inflammatory Agents CALDOLOR INTRAVENOUS RECON SOLN celecoxib (Celebrex) choline,magnesium salicylate (Choline Sal/Mag Salicylate) COMFORT PAC-IBUPROFEN COMFORT PAC-MELOXICAM COMFORT PAC-NAPROXEN diclofenac potassium (Cataflam) diclofenac sodium oral tablet extended (Voltaren-XR) release 24 hr diclofenac sodium oral tablet,delayed (Diclofenac Sodium) release (dr/ec) diclofenac sodium topical gel (Solaraze) diclofenac-misoprostol (Arthrotec 50) diflunisal (Diflunisal) etodolac oral capsule (Etodolac) etodolac oral tablet (Etodolac) etodolac oral tablet extended release 24 hr (Etodolac) fenoprofen oral tablet (Fenoprofen Calcium) FLECTOR flurbiprofen (Ansaid) ibuprofen oral (Ibuprofen) ibuprofen oral tablet 400 mg, 600 mg, 800 (Ibuprofen) mg indomethacin oral capsule 25 mg (Indomethacin) 2 QL (120 per 30 days) 1 1 3 1 QL (240 per 30 days) QL (240 per 30 days) QL (360 per 30 days) QL (150 per 30 days) indomethacin oral capsule 50 mg (Indomethacin) 1 indomethacin oral capsule, extended release (Indomethacin) 2 4 2 1 QL (60 per 30 days) 1 1 1 1 1 1 5 2 2 1 1 2 2 3 1 1 1 1 PA PA-HRM; QL (240 per 30 days) PA-HRM; QL (120 per 30 days) PA-HRM; QL (60 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 4 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name indomethacin sodium ketoprofen oral capsule ketoprofen oral capsule,ext rel. pellets 24 hr 200 mg ketorolac injection cartridge 15 mg/ml ketorolac injection cartridge 30 mg/ml ketorolac injection solution 15 mg/ml ketorolac injection solution 30 mg/ml (1 ml) ketorolac intramuscular solution ketorolac oral mefenamic acid meloxicam oral suspension meloxicam oral tablet nabumetone naproxen oral suspension naproxen oral tablet naproxen oral tablet,delayed release (dr/ec) naproxen sodium oral tablet 275 mg, 550 mg piroxicam salsalate sulindac oral tolmetin VOLTAREN TOPICAL Drug Tier Requirements/Limits (Indocin I.V.) (Ketoprofen) (Ketoprofen) 1 1 2 PA-HRM (Toradol) (Toradol) (Ketorolac Tromethamine) (Ketorolac Tromethamine) (Ketorolac Tromethamine) (Ketorolac Tromethamine) (Ponstel) (Mobic) (Mobic) (Nabumetone) (Naprosyn) (Naprosyn) (Ec-Naprosyn) 1 1 1 QL (40 per 30 days) QL (20 per 30 days) QL (40 per 30 days) 1 QL (20 per 30 days) 1 QL (20 per 30 days) 1 QL (20 per 30 days) (Anaprox) 1 (Feldene) (Salsalate) (Sulindac) (Tolmetin Sodium) 2 2 1 2 3 (Lidocaine HCl) (Xylocaine-MPF) 1 1 (Lidocaine HCl/PF) 1 (Xylocaine) 1 2 2 1 1 1 1 1 Anesthetics Local Anesthetics glydo lidocaine (pf) injection solution lidocaine (pf) intravenous syringe 100 mg/5 ml (2 %) lidocaine hcl injection solution PA BvD; (PA for ESRD Only) PA BvD; (PA for ESRD Only) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 5 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits lidocaine hcl laryngotracheal lidocaine hcl mucous membrane gel lidocaine hcl mucous membrane jelly in applicator lidocaine hcl mucous membrane solution lidocaine hcl urethral lidocaine topical adhesive patch,medicated lidocaine topical ointment (Xylocaine) (Lidocaine HCl) (Lidocaine HCl) 1 1 1 (Xylocaine) (Lidocaine HCl) (Lidoderm) 1 1 2 (Lidocaine) 2 lidocaine-prilocaine topical (EMLA) 1 lidocaine-prilocaine topical kit RELADOR PAK (Relador Pak) 1 1 PA BvD; (PA for ESRD Only) PA BvD; (PA for ESRD Only) PA BvD PA BvD 2 2 2 PA; QL (90 per 30 days) PA; QL (90 per 30 days) 2 3 3 QL (168 per 84 days) QL (56 per 28 days) PA Anti-Addiction/Substance Abuse Treatment Agents Anti-Addiction/Substance Abuse Treatment Agents acamprosate (Campral) buprenorphine hcl sublingual (Subutex) buprenorphine-naloxone (Buprenorphine HCl/Naloxone HCl) bupropion hcl sr 150 mg tablet f/c (Zyban) CHANTIX CHANTIX CONTINUING MONTH BOX CHANTIX CONTINUING MONTH PAK CHANTIX STARTING MONTH BOX disulfiram (Antabuse) naloxone (Naloxone HCl) naltrexone hcl (Revia) naltrexone (Revia) NICOTROL ZUBSOLV SUBLINGUAL TABLET 1.40.36 MG ZUBSOLV SUBLINGUAL TABLET 11.4-2.9 MG ZUBSOLV SUBLINGUAL TABLET 2.90.71 MG, 8.6-2.1 MG 3 3 2 1 2 2 4 3 QL (56 per 28 days) QL (53 per 28 days) 3 PA; QL (120 per 30 days) PA; QL (30 per 30 days) 3 PA; QL (60 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 6 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits 3 PA; QL (90 per 30 days) (Xanax) (Xanax XR) 1 1 QL (90 per 30 days) QL (90 per 30 days) (Xanax XR) 1 QL (60 per 30 days) (Alprazolam) (Chlordiazepoxide HCl) (Klonopin) (Klonopin) (Clonazepam) 2 1 1 1 1 QL (90 per 30 days) QL (120 per 30 days) QL (90 per 30 days) QL (300 per 30 days) QL (90 per 30 days) (Clonazepam) 1 QL (300 per 30 days) (Tranxene T-Tab) (Tranxene T-Tab) 1 1 QL (120 per 30 days) QL (60 per 30 days) ZUBSOLV SUBLINGUAL TABLET 5.71.4 MG Antianxiety Agents Benzodiazepines alprazolam oral tablet alprazolam oral tablet extended release 24 hr 0.5 mg alprazolam oral tablet extended release 24 hr 1 mg, 2 mg, 3 mg alprazolam oral tablet,disintegrating chlordiazepoxide hcl clonazepam oral tablet 0.5 mg, 1 mg clonazepam oral tablet 2 mg clonazepam oral tablet,disintegrating 0.125 mg, 0.25 mg, 0.5 mg, 1 mg clonazepam oral tablet,disintegrating 2 mg clorazepate dipotassium oral tablet 15 mg clorazepate dipotassium oral tablet 3.75 mg, 7.5 mg DIASTAT ACUDIAL RECTAL KIT 12.5-15-17.5-20 MG diazepam injection diazepam intensol diazepam oral solution diazepam oral tablet diazepam rectal estazolam oral tablet 1 mg 4 (Diazepam) (Diazepam) (Diazepam) (Valium) (Diastat Acudial) (Estazolam) 1 1 1 1 2 1 QL (10 per 28 days) QL (1200 per 30 days) QL (1200 per 30 days) QL (120 per 30 days) PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use with any non-benzodiazepine hypnotic drug); QL (60 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 7 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use with any non-benzodiazepine hypnotic drug); QL (30 per 30 days) PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use with any non-benzodiazepine hypnotic drug); QL (60 per 30 days) PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use with any non-benzodiazepine hypnotic drug); QL (30 per 30 days) QL (150 per 30 days) QL (2 per 30 days) QL (2 per 30 days) QL (90 per 30 days) QL (2 per 30 days) QL (2 per 30 days) estazolam oral tablet 2 mg (Estazolam) 1 flurazepam oral capsule 15 mg (Flurazepam HCl) 1 flurazepam oral capsule 30 mg (Flurazepam HCl) 1 lorazepam oral solution lorazepam injection solution lorazepam injection syringe lorazepam oral tablet midazolam (pf) injection midazolam (pf) injection syringe 2 mg/2 ml (1 mg/ml) midazolam oral syrup 2 mg/ml ONFI ORAL SUSPENSION (Ativan) (Ativan) (Ativan) (Ativan) (Midazolam HCl/PF) (Midazolam HCl/PF) 1 1 1 1 1 1 (Midazolam HCl) 1 4 ONFI ORAL TABLET 10 MG, 20 MG 4 QL (10 per 30 days) PA NSO; QL (480 per 30 days) PA NSO; QL (60 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 8 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use with any non-benzodiazepine hypnotic drug); QL (30 per 30 days) PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use with any non-benzodiazepine hypnotic drug); QL (120 per 30 days) PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use with any non-benzodiazepine hypnotic drug); QL (120 per 30 days) PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use with any non-benzodiazepine hypnotic drug); QL (60 per 30 days) temazepam oral capsule 15 mg, 22.5 mg, 30 mg (Restoril) 1 temazepam oral capsule 7.5 mg (Restoril) 1 triazolam oral tablet 0.125 mg (Halcion) 1 triazolam oral tablet 0.25 mg (Halcion) 1 Antibacterials Aminoglycosides BETHKIS 5 PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 9 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name gentamicin in nacl (iso-osm) intravenous piggyback gentamicin injection solution gentamicin sulfate (ped) (pf) gentamicin sulfate (pf) intravenous solution neomycin streptomycin intramuscular TOBI PODHALER INHALATION tobramycin in 0.225 % nacl tobramycin in 0.9 % nacl tobramycin sulfate injection solution 10 mg/ml tobramycin sulfate injection solution 40 mg/ml Antibacterials, Miscellaneous bacitracin intramuscular chloramphenicol sod succinate clindamycin hcl clindamycin in 5 % dextrose clindamycin palmitate hcl clindamycin phosphate injection clindamycin phosphate intravenous solution colistin (colistimethate na) CUBICIN linezolid methenamine hippurate methenamine mandelate oral tablet 1 gram nitrofurantoin macrocrystal oral capsule 100 mg Drug Tier (Gentamicin In Nacl, Iso-Osm) (Garamycin) (Gentamicin Sulfate/PF) (Gentamicin Sulfate/PF) 1 (Neomycin Sulfate) (Streptomycin Sulfate) 1 2 5 5 1 (Tobi) (Tobramycin/Sodium Chloride) (Nebcin) 1 1 1 QL (224 per 28 days) PA BvD 1 (Nebcin) 2 (Bacitracin) (Chloramphenicol Sod Succ) (Cleocin HCl) (Cleocin Phosphate In D5w) (Cleocin Palmitate) (Cleocin Phosphate) (Cleocin Phosphate) 2 1 (Coly-Mycin M Parenteral) 2 (Zyvox) (Hiprex) (Methenamine Mandelate) (Macrodantin/Macrobid) Requirements/Limits 1 1 2 1 1 5 5 2 2 2 PA-HRM; QL (120 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 10 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use of nitrofurantoin drugs); QL (120 per 30 days) PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use of nitrofurantoin drugs); QL (120 per 30 days) PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use of nitrofurantoin drugs); QL (2400 per 30 days) nitrofurantoin macrocrystal oral capsule (Macrodantin/Macrobid) 2 nitrofurantoin monohyd/m-cryst (Macrobid) 2 nitrofurantoin oral (Furadantin) 2 polymyxin b sulfate (Polymyxin B Sulfate) SYNERCID trimethoprim (Trimethoprim) vancomycin in d5w intravenous piggyback (Vancomycin HCl/D5W) vancomycin intravenous recon soln 1,000 (Vancomycin HCl) mg, 10 gram, 750 mg vancomycin intravenous recon soln 500 (Vancomycin mg HCl/D5W) vancomycin oral capsule (Vancocin HCl) XIFAXAN ORAL TABLET 200 MG XIFAXAN ORAL TABLET 550 MG ZYVOX ORAL Cephalosporins 1 5 1 2 2 2 5 5 5 5 PA; QL (9 per 30 days) ST; QL (60 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 11 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name CEDAX ORAL SUSPENSION FOR RECONSTITUTION 90 MG/5 ML cefaclor oral capsule cefaclor oral suspension for reconstitution 125 mg/5 ml, 250 mg/5 ml, 375 mg/5 ml cefaclor oral tablet extended release 12 hr cefadroxil oral capsule cefadroxil oral suspension for reconstitution 250 mg/5 ml, 500 mg/5 ml cefadroxil oral tablet cefazolin in dextrose (iso-os) intravenous piggyback 1 gram/50 ml cefazolin in dextrose (iso-os) intravenous piggyback 2 gram/50 ml cefazolin injection recon soln cefazolin injection recon soln 100 gram, 300 g cefazolin intravenous cefdinir cefditoren pivoxil cefepime CEFEPIME IN DEXTROSE 5 % CEFEPIME IN DEXTROSE,ISO-OSM INTRAVENOUS PIGGYBACK cefixime cefotaxime cefoxitin cefoxitin in dextrose, iso-osm intravenous piggyback 2 gram/50 ml cefpodoxime oral suspension for reconstitution 100 mg/5 ml cefpodoxime oral suspension for reconstitution 50 mg/5 ml cefpodoxime oral tablet cefprozil ceftazidime ceftazidime injection recon soln 2 gram, 6 gram Drug Tier Requirements/Limits 4 (Cefaclor) (Cefaclor) 2 1 (Cefaclor) (Cefadroxil) (Cefadroxil) 2 1 1 (Cefadroxil) (Cefazolin Sodium) 1 2 (Cefazolin Sodium/Dextrose, Iso) (Ancef) (Cefazolin Sodium) 2 (Cefazolin Sodium) (Cefdinir) (Spectracef) (Maxipime) 2 2 2 2 4 4 (Suprax) (Claforan) (Mefoxin) (Cefoxitin Sodium/Dextrose, Iso) (Cefpodoxime Proxetil) 2 1 2 2 (Cefpodoxime Proxetil) 1 (Cefpodoxime Proxetil) (Cefprozil) (Fortaz) (Fortaz) 2 2 2 2 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 12 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name ceftibuten ceftriaxone in dextrose,iso-os intravenous piggyback 1 gram/50 ml CEFTRIAXONE IN DEXTROSE,ISO-OS INTRAVENOUS PIGGYBACK 2 GRAM/50 ML ceftriaxone injection recon soln ceftriaxone intravenous recon soln 1 gram CEFTRIAXONE INTRAVENOUS RECON SOLN 2 GRAM cefuroxime axetil oral tablet cefuroxime sodium injection recon soln 1.5 gram, 750 mg cefuroxime sodium intravenous cefuroxime-dextrose (iso-osm) cephalexin oral capsule cephalexin oral suspension for reconstitution cephalexin oral tablet MEFOXIN IN DEXTROSE (ISO-OSM) SUPRAX ORAL SUSPENSION FOR RECONSTITUTION SUPRAX ORAL TABLET SUPRAX ORAL TABLET,CHEWABLE TEFLARO Macrolides azithromycin clarithromycin oral suspension for reconstitution clarithromycin oral tablet clarithromycin oral tablet extended release 24 hr DIFICID ERYTHROCIN erythromycin base oral tablet,delayed release (dr/ec) 250 mg, 500 mg Drug Tier (Cedax) (Ceftriaxone Na/Dextrose, Iso) Requirements/Limits 2 2 2 (Rocephin) (Ceftriaxone Na/Dextrose, Iso) 2 2 2 (Ceftin) (Zinacef) 1 2 (Zinacef) (Cefuroxime Sodium/Dextrose, Iso) (Keflex) (Cephalexin) 1 1 (Cephalexin) 1 4 4 1 1 4 4 4 (Zithromax) (Biaxin) 1 2 (Biaxin) (Biaxin XL) 2 2 (Erythromycin Base) 5 4 1 QL (20 per 10 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 13 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier ERYTHROMYCIN BASE ORAL TABLET,DELAYED RELEASE (DR/EC) 333 MG erythromycin ethylsuccinate oral (Eryped 200) suspension for reconstitution 200 mg/5 ml erythromycin ethylsuccinate oral tablet (Erythromycin 400 mg Ethylsuccinate) erythromycin oral capsule,delayed (Erythromycin Base) release(dr/ec) erythromycin oral tablet (Erythromycin Base) erythromycin stearate oral tablet 250 mg (Erythromycin Stearate) Miscellaneous B-Lactam Antibiotics aztreonam (Azactam) CAYSTON imipenem-cilastatin (Primaxin) INVANZ meropenem (Merrem) Penicillins amoxicillin oral capsule (Amoxicillin) amoxicillin oral suspension for (Amoxil) reconstitution amoxicillin oral tablet (Amoxicillin) amoxicillin oral tablet,chewable 125 mg, (Amoxicillin) 250 mg amoxicillin-pot clavulanate oral (Augmentin) suspension for reconstitution amoxicillin-pot clavulanate oral tablet (Augmentin) amoxicillin-pot clavulanate oral tablet (Augmentin XR) extended release 12 hr amoxicillin-pot clavulanate oral (Amoxicillin/Potassium tablet,chewable Clav) ampicillin (Ampicillin Trihydrate) ampicillin sodium injection recon soln (Totacillin-N) ampicillin sodium intravenous recon soln (Totacillin-N) ampicillin-sulbactam injection recon soln (Unasyn) 1.5 gram, 3 gram ampicillin-sulbactam injection recon soln (Unasyn) 15 gram 2 Requirements/Limits 1 2 1 1 2 2 5 2 4 2 LA 1 1 1 1 1 1 1 1 1 2 2 2 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 14 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name ampicillin-sulbactam intravenous recon soln BICILLIN C-R BICILLIN L-A dicloxacillin nafcillin in dextrose iso-osm nafcillin injection nafcillin intravenous recon soln oxacillin in dextrose(iso-osm) oxacillin injection recon soln oxacillin intravenous recon soln penicillin g pot in dextrose penicillin g potassium penicillin g procaine penicillin v potassium piperacillin-tazobactam Quinolones ciprofloxacin ciprofloxacin (mixture) ciprofloxacin hcl oral ciprofloxacin in 5 % dextrose ciprofloxacin lactate intravenous solution 400 mg/40 ml levofloxacin in d5w intravenous piggyback levofloxacin intravenous levofloxacin oral solution levofloxacin oral tablet moxifloxacin ofloxacin oral Sulfonamides sulfadiazine oral sulfamethoxazole-trimethoprim intravenous sulfamethoxazole-trimethoprim oral suspension Drug Tier (Unasyn) (Dicloxacillin Sodium) (Nafcillin In Dextrose,Iso-Osm) (Unipen) (Nallpen) (Oxacillin Sodium/Dextrose, Iso) (Oxacillin Sodium) (Oxacillin Sodium) (Pen G Pot/DextroseWater) (Penicillin G Potassium) (Penicillin G Procaine) (Penicillin V Potassium) (Zosyn) Requirements/Limits 2 4 4 1 4 2 2 2 2 2 2 2 2 1 2 (Cipro) (Cipro XR) (Cipro) (Cipro I.V.) (Cipro I.V.) 2 2 1 1 1 (Levaquin) (Levofloxacin) (Levaquin) (Levaquin) (Avelox) (Ofloxacin) 1 1 2 1 2 2 (Sulfadiazine) (Sulfamethoxazole/Trim ethoprim) (Sulfamethoxazole/Trim ethoprim) 2 1 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 15 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier sulfamethoxazole-trimethoprim oral tablet (Bactrim) sulfasalazine (Azulfidine) sulfatrim (Sulfamethoxazole/Trim ethoprim) sulfazine (Azulfidine) sulfazine ec (Azulfidine) Tetracyclines demeclocycline oral (Demeclocycline HCl) doxycycline hyclate oral capsule 100 mg (Morgidox) doxycycline hyclate 100 mg tab f/c (Doryx) doxycycline hyclate intravenous (Doxycycline Hyclate) doxycycline hyclate oral capsule 100 mg (Adoxa) doxycycline hyclate oral capsule 50 mg (Morgidox) doxycycline hyclate oral tablet 100 mg, 50 (Adoxa) mg doxycycline hyclate oral tablet 20 mg (Doryx) doxycycline hyclate oral tablet,delayed (Doryx) release (dr/ec) doxycycline mono 100 mg cap (Adoxa) doxycycline mono 100 mg tablet (Adoxa) doxycycline monohydrate oral capsule 150 (Adoxa) mg, 75 mg doxycycline monohydrate oral capsule 50 (Adoxa) mg doxycycline monohydrate oral suspension (Vibramycin) for reconstitution doxycycline monohydrate oral tablet 150 (Adoxa) mg, 75 mg doxycycline monohydrate oral tablet 50 (Adoxa) mg MINOCIN INTRAVENOUS minocycline oral capsule (Minocin) minocycline oral tablet (Minocycline HCl) minocycline oral tablet extended release (Minocycline HCl) 24 hr tetracycline (Ala-Tet) TYGACIL 1 1 1 Requirements/Limits 1 1 2 1 1 2 1 1 1 2 2 1 1 2 1 2 2 1 5 1 2 2 1 5 Anticancer Agents You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 16 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Anticancer Agents ABRAXANE ADCETRIS 5 5 AFINITOR DISPERZ 5 AFINITOR ORAL TABLET 10 MG 5 AFINITOR ORAL TABLET 2.5 MG, 5 MG, 7.5 MG ALIMTA INTRAVENOUS RECON SOLN anastrozole ARRANON ARZERRA AVASTIN azacitidine BELEODAQ bexarotene 5 bicalutamide bleomycin BLINCYTO Requirements/Limits PA NSO; QL (4 per 21 days) PA NSO; QL (112 per 28 days) PA NSO; QL (56 per 28 days) PA NSO; QL (28 per 28 days) 5 (Arimidex) (Vidaza) (Targretin) (Casodex) (Bleomycin Sulfate) 1 5 5 5 5 5 5 2 1 5 BOSULIF ORAL TABLET 100 MG 5 BOSULIF ORAL TABLET 500 MG 5 CAPRELSA ORAL TABLET 100 MG 5 CAPRELSA ORAL TABLET 300 MG 5 carboplatin intravenous solution cisplatin cladribine COMETRIQ (Carboplatin) (Cisplatin) (Cladribine) 2 1 2 5 cyclophosphamide intravenous recon soln (Cyclophosphamide) 2 PA NSO PA NSO PA NSO PA NSO; QL (420 per 30 days) PA BvD PA NSO; QL (140 per 365 days) PA NSO; QL (120 per 30 days) PA NSO; QL (30 per 30 days) PA NSO; QL (60 per 30 days) PA NSO; QL (30 per 30 days) PA BvD PA NSO; QL (112 per 28 days) PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 17 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name CYCLOPHOSPHAMIDE ORAL CAPSULE cyclophosphamide oral tablet CYRAMZA cytarabine cytarabine (pf) injection recon soln cytarabine (pf) injection solution dacarbazine intravenous recon soln dactinomycin daunorubicin intravenous DAUNOXOME decitabine docetaxel intravenous solution doxorubicin hcl intravenous recon soln 10 mg doxorubicin hcl peg-liposomal intravenous suspension 2 mg/ml doxorubicin, peg-liposomal DROXIA ELIGARD SUBCUTANEOUS SYRINGE 22.5 MG (3 MONTH) ELIGARD SUBCUTANEOUS SYRINGE 30 MG (4 MONTH) ELIGARD SUBCUTANEOUS SYRINGE 45 MG (6 MONTH) ELIGARD SUBCUTANEOUS SYRINGE 7.5 MG (1 MONTH) EMCYT epirubicin intravenous solution 50 mg/25 ml ERBITUX ERIVEDGE ETOPOPHOS etoposide intravenous exemestane FARESTON Drug Tier Requirements/Limits 4 PA BvD; ST PA BvD; ST PA NSO PA BvD PA BvD PA BvD (Dacogen) (Taxotere) (Doxorubicin HCl) 2 5 1 1 1 1 1 2 3 5 5 2 (Doxil) 5 PA BvD (Doxil) 5 3 4 PA BvD 4 QL (1 per 112 days) 5 QL (1 per 168 days) 4 QL (1 per 28 days) (Cyclophosphamide) (Cytarabine) (Cytarabine/PF) (Cytarabine/PF) (Dtic-Dome IV) (Dactinomycin) (Cerubidine) (Ellence) QL (1 per 84 days) 3 1 5 5 (Etoposide) (Aromasin) PA BvD PA NSO PA NSO; QL (30 per 30 days) 4 2 2 5 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 18 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier FARYDAK 5 FASLODEX FIRMAGON KIT W DILUENT SYRINGE floxuridine fludarabine fluorouracil intravenous solution 2.5 gram/50 ml, 5 gram/100 ml, 500 mg/10 ml flutamide GAZYVA 5 4 gemcitabine intravenous recon soln 1 gram GILOTRIF (FUDR) (Fludara) (Fluorouracil) 1 2 2 (Flutamide) 2 5 (Gemzar) GLEEVEC ORAL TABLET 100 MG 5 GLEEVEC ORAL TABLET 400 MG 5 HALAVEN 5 HERCEPTIN HEXALEN hydroxyurea IBRANCE 5 5 1 5 ICLUSIG ORAL TABLET 15 MG 5 ICLUSIG ORAL TABLET 45 MG 5 idarubicin ifosfamide intravenous recon soln ifosfamide intravenous solution ifosfamide-mesna IMBRUVICA (Idamycin Pfs) (Ifex) (Ifex) (Ifosfamide/Mesna) PA NSO; QL (6 per 21 days) PA BvD PA BvD PA NSO; QL (40 per 28 days) 5 5 (Hydrea) Requirements/Limits 2 2 2 5 5 PA NSO; QL (30 per 30 days) PA NSO; QL (90 per 30 days) PA NSO; QL (60 per 30 days) PA NSO; QL (24 per 28 days) PA NSO PA NSO; QL (21 per 28 days) PA NSO; QL (60 per 30 days) PA NSO; QL (30 per 30 days) PA BvD PA BvD PA BvD PA NSO; QL (120 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 19 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits INLYTA ORAL TABLET 1 MG 5 INLYTA ORAL TABLET 5 MG 5 IRESSA 5 PA NSO; QL (180 per 30 days) PA NSO; QL (60 per 30 days) PA NSO; QL (60 per 30 days) irinotecan intravenous solution ISTODAX IXEMPRA JAKAFI (Camptosar) 5 5 5 5 JEVTANA KADCYLA KEYTRUDA KYPROLIS 5 5 5 5 LENVIMA letrozole LEUKERAN leuprolide lomustine LUPRON DEPOT LUPRON DEPOT (3 MONTH) LUPRON DEPOT (4 MONTH) LUPRON DEPOT (6 MONTH) LUPRON DEPOT-PED LUPRON DEPOT-PED (3 MONTH) INTRAMUSCULAR SYRINGE KIT LYNPARZA 5 1 4 2 2 5 5 5 5 5 5 (Femara) (Leuprolide Acetate) (Gleostine) 5 LYSODREN MARQIBO 3 5 MATULANE MEGACE ES megestrol oral suspension megestrol oral suspension 625 mg/5 ml megestrol oral tablet 5 5 1 5 1 (Megace Es) (Megace Es) (Megestrol Acetate) PA NSO PA NSO; QL (60 per 30 days) PA NSO PA NSO PA NSO; QL (6 per 28 days) PA NSO QL (1 per 28 days) QL (1 per 84 days) QL (1 per 84 days) QL (1 per 168 days) QL (1 per 28 days) QL (1 per 84 days) PA NSO; QL (480 per 30 days) PA NSO; QL (4 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 20 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits MEKINIST ORAL TABLET 0.5 MG 5 MEKINIST ORAL TABLET 2 MG 5 PA NSO; QL (90 per 30 days) PA NSO; QL (30 per 30 days) melphalan hcl intravenous mercaptopurine methotrexate sodium (pf) injection recon soln methotrexate sodium (pf) injection solution methotrexate sodium injection methotrexate sodium oral mitomycin intravenous recon soln mitoxantrone MUSTARGEN NEXAVAR NILANDRON ONCASPAR OPDIVO INTRAVENOUS SOLUTION 40 MG/4 ML oxaliplatin intravenous solution 100 mg/20 ml paclitaxel PERJETA POMALYST (Alkeran) (Purinethol) (Methotrexate Sodium/PF) (Methotrexate Sodium) 5 2 1 PA BvD 1 PA BvD (Methotrexate Sodium) (Methotrexate Sodium) (Mitomycin) (Mitoxantrone HCl) 1 1 1 1 3 5 PA BvD PA BvD; ST PA BvD 3 5 5 (Eloxatin) 5 (Paclitaxel) 2 5 5 PROLEUKIN PURIXAN REVLIMID 5 5 5 RITUXAN SOLTAMOX SPRYCEL ORAL TABLET 100 MG, 140 MG, 50 MG, 70 MG, 80 MG SPRYCEL ORAL TABLET 20 MG 5 4 5 5 PA NSO; QL (120 per 30 days) PA NSO PA NSO PA NSO PA NSO; QL (21 per 28 days) PA NSO; LA; QL (21 per 28 days) PA NSO PA NSO; QL (30 per 30 days) PA NSO; QL (60 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 21 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits STIVARGA 5 SUTENT 5 SYLVANT SYNRIBO 5 5 PA NSO; QL (84 per 28 days) PA NSO; QL (30 per 30 days) PA NSO PA NSO; QL (28 per 28 days) TABLOID TAFINLAR 3 5 tamoxifen TARCEVA ORAL TABLET 100 MG, 25 MG TARCEVA ORAL TABLET 150 MG (Tamoxifen Citrate) 1 5 5 TARGRETIN TOPICAL 5 TASIGNA 5 TEMODAR INTRAVENOUS teniposide toposar intravenous topotecan intravenous TORISEL 5 5 2 5 5 (Teniposide) (Etoposide) (Hycamtin) TREANDA INTRAVENOUS RECON SOLN TREANDA INTRAVENOUS SOLUTION TRELSTAR INTRAMUSCULAR SUSPENSION FOR RECONSTITUTION TRELSTAR INTRAMUSCULAR SYRINGE 11.25 MG/2 ML TRELSTAR INTRAMUSCULAR SYRINGE 22.5 MG/2 ML TRELSTAR INTRAMUSCULAR SYRINGE 3.75 MG/2 ML tretinoin (chemotherapy) (Tretinoin) TREXALL PA NSO; QL (120 per 30 days) PA NSO; QL (60 per 30 days) PA NSO; QL (90 per 30 days) PA NSO; QL (60 per 28 days) PA NSO; QL (112 per 28 days) PA NSO; (vial only) PA BvD; QL (4 per 28 days) 5 5 5 QL (1 per 168 days) 5 QL (1 per 84 days) 5 QL (1 per 168 days) 5 QL (1 per 28 days) 5 4 (capsule: 10mg) PA BvD; ST You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 22 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name TYKERB UNITUXIN VALSTAR VECTIBIX VELCADE vinblastine intravenous vincristine vincristine sulfate intravenous solution 1 mg/ml vinorelbine intravenous solution VOTRIENT Drug Tier (Vinblastine Sulfate) (Vincristine Sulfate) (Vincristine Sulfate) (Navelbine) 5 5 5 5 5 2 1 1 1 5 Requirements/Limits PA NSO PA NSO PA NSO PA BvD PA BvD PA BvD XALKORI 5 XTANDI 5 YERVOY ZALTRAP INTRAVENOUS SOLUTION ZELBORAF 5 5 5 ZOLADEX SUBCUTANEOUS IMPLANT 10.8 MG ZOLADEX SUBCUTANEOUS IMPLANT 3.6 MG ZOLINZA ZYDELIG 4 PA NSO; QL (120 per 30 days) PA NSO; QL (60 per 30 days) PA NSO; QL (120 per 30 days) PA NSO PA NSO PA NSO; QL (240 per 30 days) QL (1 per 84 days) 4 QL (1 per 28 days) ZYKADIA 5 ZYTIGA 5 5 5 PA NSO; QL (60 per 30 days) PA NSO; QL (140 per 28 days) PA NSO; QL (120 per 30 days) Anticholinergic Agents Antimuscarinics/Antispasmodics atropine 0.1 mg/ml syringe luer-jet syr atropine injection solution atropine injection syringe 0.05 mg/ml, 0.1 mg/ml propantheline (Atropine Sulfate) (Atropine Sulfate) (Atropine Sulfate) 1 1 1 (Propantheline Bromide) 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 23 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits Anticonvulsants Anticonvulsants APTIOM BANZEL carbamazepine carbamazepine oral capsule, er multiphase 12 hr carbamazepine oral suspension carbamazepine oral tablet extended release 12 hr carbamazepine oral tablet,chewable CELONTIN ORAL CAPSULE 300 MG DILANTIN divalproex oral capsule, sprinkle divalproex oral tablet extended release 24 hr divalproex oral tablet,delayed release (dr/ec) ethosuximide oral capsule ethosuximide oral solution felbamate fosphenytoin FYCOMPA ORAL TABLET gabapentin oral capsule gabapentin oral solution gabapentin oral tablet 600 mg, 800 mg GABITRIL ORAL TABLET 12 MG, 16 MG GRALISE GRALISE 30-DAY STARTER PACK LAMICTAL ODT STARTER (BLUE) LAMICTAL ODT STARTER (GREEN) LAMICTAL ODT STARTER (ORANGE) LAMICTAL ORAL TABLET, CHEWABLE DISPERSIBLE 2 MG lamotrigine oral tablet lamotrigine oral tablet extended release 24hr (Tegretol) (Carbatrol) 4 4 1 2 (Tegretol) (Tegretol XR) 2 2 (Carbamazepine) (Depakote Sprinkle) (Depakote ER) 1 3 3 2 2 (Depakote) 1 (Zarontin) (Zarontin) (Felbatol) (Cerebyx) 2 1 2 1 4 1 2 2 3 (Neurontin) (Neurontin) (Neurontin) 4 4 4 4 4 4 (Lamictal) (Lamictal XR) ST; QL (90 per 30 days) ST; QL (78 per 30 days) 1 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 24 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name lamotrigine oral tablet, chewable dispersible lamotrigine oral tablet,disintegrating lamotrigine oral tablets,dose pack 25 mg (35) levetiracetam in nacl (iso-os) levetiracetam intravenous levetiracetam oral solution levetiracetam oral tablet levetiracetam oral tablet extended release 24 hr LYRICA ORAL CAPSULE LYRICA ORAL SOLUTION oxcarbazepine oral suspension oxcarbazepine oral tablet OXTELLAR XR PEGANONE phenobarbital oral elixir phenobarbital oral tablet 100 mg, 15 mg, 16.2 mg, 32.4 mg, 60 mg, 64.8 mg, 97.2 mg phenobarbital oral tablet 30 mg phenobarbital sodium injection solution PHENYTEK phenytoin oral suspension 125 mg/5 ml phenytoin oral phenytoin sodium phenytoin sodium extended POTIGA ORAL TABLET 200 MG, 300 MG, 400 MG POTIGA ORAL TABLET 50 MG primidone QUDEXY XR SABRIL TEGRETOL XR ORAL TABLET EXTENDED RELEASE 12 HR 100 MG tiagabine Drug Tier (Lamictal) 1 (Lamictal Odt) (Lamictal (Blue)) 2 2 (Levetiracetam In Nacl (Iso-Os)) (Keppra) (Keppra) (Keppra) (Keppra XR) 1 (Trileptal) (Trileptal) (Phenobarbital) (Phenobarbital) (Phenobarbital) (Phenobarbital Sodium) (Dilantin-125) (Dilantin) (Phenytoin Sodium) (Phenytek) (Mysoline) (Gabitril) Requirements/Limits 1 2 2 2 3 3 2 1 4 3 1 1 QL (90 per 30 days) QL (900 per 30 days) 1 1 3 1 1 1 1 4 QL (200 per 30 days) QL (2 per 30 days) 4 1 4 5 3 QL (270 per 30 days) QL (1500 per 30 days) QL (90 per 30 days) QL (90 per 30 days) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 25 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name topiramate topiramate oral capsule, sprinkle topiramate oral capsule,sprinkle,er 24hr TRILEPTAL ORAL SUSPENSION TROKENDI XR valproate sodium valproic acid valproic acid (as sodium salt) oral solution 250 mg/5 ml VIMPAT INTRAVENOUS VIMPAT ORAL SOLUTION VIMPAT ORAL TABLET zonisamide Drug Tier (Topamax) (Topamax) (Qudexy XR) Requirements/Limits (Depacon) (Depakene) (Depakene) 1 2 2 4 4 1 1 1 QL (200 per 5 days) QL (1200 per 30 days) QL (60 per 30 days) (Zonegran) 4 4 4 1 1 2 1 2 2 QL (30 per 30 days) QL (30 per 30 days) QL (30 per 30 days) QL (30 per 30 days) QL (30 per 30 days) 2 2 2 2 3 3 3 3 QL (200 per 30 days) QL (60 per 30 days) QL (60 per 30 days) QL (49 per 28 days) QL (360 per 30 days) QL (60 per 30 days) QL (49 per 28 days) QL (28 per 28 days) 3 QL (30 per 30 days) (Exelon) 3 2 QL (60 per 30 days) (Amitriptyline HCl) 1 PA NSO-HRM Antidementia Agents Antidementia Agents donepezil oral tablet 10 mg, 5 mg donepezil oral tablet 23 mg donepezil oral tablet,disintegrating EXELON TRANSDERMAL galantamine oral capsule,ext rel. pellets 24 hr galantamine oral solution galantamine oral tablet memantine oral tablet memantine oral tablets,dose pack NAMENDA ORAL SOLUTION NAMENDA ORAL TABLET NAMENDA TITRATION PAK NAMENDA XR ORAL CAP,SPRINKLE,ER 24HR DOSE PACK NAMENDA XR ORAL CAPSULE,SPRINKLE,ER 24HR NAMZARIC rivastigmine tartrate (Aricept) (Aricept) (Aricept Odt) (Razadyne ER) (Razadyne) (Razadyne) (Namenda) (Namenda) Antidepressants Antidepressants amitriptyline You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 26 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name amoxapine BRINTELLIX bupropion hcl oral tablet bupropion hcl oral tablet extended release , 150 mg bupropion hcl oral tablet extended release 24 hr citalopram oral solution citalopram oral tablet clomipramine desipramine oral DESVENLAFAXINE FUMARATE DESVENLAFAXINE ORAL doxepin oral duloxetine oral capsule,delayed release(dr/ec) 20 mg, 60 mg duloxetine oral capsule,delayed release(dr/ec) 30 mg duloxetine oral capsule,delayed release(dr/ec) 40 mg EMSAM escitalopram oxalate FETZIMA fluoxetine oral capsule fluoxetine oral capsule,delayed release(dr/ec) fluoxetine oral solution fluoxetine oral tablet 10 mg, 20 mg FLUOXETINE ORAL TABLET 60 MG fluvoxamine oral capsule,extended release 24hr fluvoxamine oral tablet imipramine hcl imipramine pamoate IRENKA KHEDEZLA maprotiline Drug Tier (Amoxapine) (Wellbutrin) (Wellbutrin SR) 2 4 1 2 (Wellbutrin XL) 2 (Citalopram Hydrobromide) (Celexa) (Anafranil) (Norpramin) 2 Requirements/Limits QL (30 per 30 days) PA NSO-HRM (Doxepin HCl) (Irenka) 1 2 2 3 3 1 2 (Irenka) 2 QL (30 per 30 days) (Irenka) 4 QL (30 per 30 days) 4 2 4 1 2 QL (30 per 30 days) (Lexapro) (Prozac) (Prozac Weekly) (Fluoxetine HCl) (Fluoxetine HCl) (Luvox CR) (Fluvoxamine Maleate) (Tofranil) (Tofranil-Pm) (Maprotiline HCl) QL (30 per 30 days) QL (30 per 30 days) PA NSO-HRM QL (60 per 30 days) 1 1 2 2 1 1 2 4 4 2 PA NSO-HRM PA NSO-HRM QL (30 per 30 days) QL (30 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 27 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name MARPLAN mirtazapine nefazodone nortriptyline oral capsule nortriptyline oral solution olanzapine-fluoxetine paroxetine hcl oral tablet paroxetine hcl oral tablet extended release 24 hr PAXIL ORAL SUSPENSION perphenazine-amitriptyline phenelzine PRISTIQ protriptyline sertraline oral concentrate sertraline oral tablet SILENOR SURMONTIL tranylcypromine trazodone venlafaxine oral capsule,extended release 24hr venlafaxine oral tablet venlafaxine oral tablet extended release 24hr 150 mg, 37.5 mg, 75 mg venlafaxine oral tablet extended release 24hr 225 mg VIIBRYD Drug Tier (Remeron) (Nefazodone HCl) (Pamelor) (Nortriptyline HCl) (Symbyax) (Paxil) (Paxil CR) (Perphenazine/Amitripty line HCl) (Nardil) 4 1 2 1 1 2 1 2 4 1 (Parnate) (Trazodone HCl) (Effexor XR) 2 4 2 2 1 3 4 2 1 1 (Venlafaxine HCl) (Venlafaxine HCl) 1 2 (Venlafaxine HCl) 3 (Vivactil) (Zoloft) (Zoloft) Requirements/Limits PA NSO-HRM QL (30 per 30 days) QL (30 per 30 days) PA NSO-HRM 4 Antidiabetic Agents Antidiabetic Agents, Miscellaneous acarbose (Precose) ACTOPLUS MET XR BYDUREON BYETTA SUBCUTANEOUS PEN INJECTOR 10 MCG/DOSE(250 MCG/ML) 2.4 ML 2 3 3 3 QL (90 per 30 days) QL (60 per 30 days) QL (4 per 28 days) QL (2.4 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 28 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier BYETTA SUBCUTANEOUS PEN INJECTOR 5 MCG/DOSE (250 MCG/ML) 1.2 ML CYCLOSET GLYSET GLYXAMBI INVOKAMET ORAL TABLET 1501,000 MG, 150-500 MG, 50-1,000 MG INVOKAMET ORAL TABLET 50-500 MG INVOKANA ORAL TABLET 100 MG INVOKANA ORAL TABLET 300 MG JANUMET JANUMET XR ORAL TABLET, ER MULTIPHASE 24 HR 100-1,000 MG, 50500 MG JANUMET XR ORAL TABLET, ER MULTIPHASE 24 HR 50-1,000 MG JANUVIA JARDIANCE JENTADUETO KAZANO KORLYM metformin oral tablet 1,000 mg metformin oral tablet 500 mg metformin oral tablet 850 mg metformin oral tablet extended release 24 hr 500 mg metformin oral tablet extended release 24 hr 750 mg metformin oral tablet extended release 24hr nateglinide NESINA OSENI pioglitazone pioglitazone-glimepiride Requirements/Limits 3 QL (1.2 per 28 days) 4 3 3 3 QL (180 per 30 days) QL (90 per 30 days) QL (30 per 30 days) ST; QL (60 per 30 days) 3 3 3 3 3 ST; QL (120 per 30 days) ST; QL (60 per 30 days) ST; QL (30 per 30 days) QL (60 per 30 days) QL (30 per 30 days) 3 QL (60 per 30 days) 3 3 3 4 5 (Glucophage) (Glucophage) (Glucophage) (Glucophage XR) 1 1 1 1 QL (30 per 30 days) ST; QL (30 per 30 days) QL (60 per 30 days) QL (60 per 30 days) PA; QL (112 per 28 days) QL (60 per 30 days) QL (120 per 30 days) QL (90 per 30 days) QL (120 per 30 days) (Glucophage XR) 1 QL (90 per 30 days) (Fortamet) 1 QL (60 per 30 days) (Starlix) 2 4 4 2 2 QL (90 per 30 days) QL (30 per 30 days) QL (30 per 30 days) QL (30 per 30 days) QL (30 per 30 days) (Actos) (Duetact) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 29 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name pioglitazone-metformin PRANDIMET repaglinide SYMLINPEN 120 SYMLINPEN 60 TRADJENTA TRULICITY VICTOZA Insulins HUMALOG KWIKPEN SUBCUTANEOUS INSULIN PEN 100 UNIT/ML HUMALOG KWIKPEN SUBCUTANEOUS INSULIN PEN 200 UNIT/ML (3 ML) HUMALOG MIX 50-50 HUMALOG MIX 50-50 KWIKPEN HUMALOG MIX 75-25 HUMALOG MIX 75-25 KWIKPEN HUMALOG SUBCUTANEOUS CARTRIDGE HUMALOG SUBCUTANEOUS HUMULIN 70/30 HUMULIN 70/30 KWIKPEN HUMULIN N HUMULIN N KWIKPEN HUMULIN R HUMULIN R U-500 (CONCENTRATED) LANTUS LANTUS SOLOSTAR NOVOLIN 70/30 NOVOLIN N NOVOLIN R NOVOLOG NOVOLOG FLEXPEN NOVOLOG MIX 70-30 NOVOLOG MIX 70-30 FLEXPEN Drug Tier (Actoplus Met) (Prandin) Requirements/Limits 2 3 2 4 4 3 3 4 QL (90 per 30 days) QL (150 per 30 days) QL (240 per 30 days) QL (10.8 per 28 days) QL (6 per 28 days) QL (30 per 30 days) QL (4 per 28 days) PA; QL (9 per 28 days) 3 QL (30 per 28 days) 3 QL (12 per 28 days) 3 3 3 3 3 QL (40 per 28 days) QL (30 per 28 days) QL (40 per 28 days) QL (30 per 28 days) QL (30 per 28 days) 3 3 3 3 3 3 3 QL (40 per 28 days) QL (40 per 28 days) QL (30 per 28 days) QL (40 per 28 days) QL (30 per 28 days) QL (40 per 28 days) QL (40 per 28 days) 3 3 3 3 3 3 3 3 3 QL (40 per 28 days) QL (30 per 28 days) QL (40 per 28 days) QL (40 per 28 days) QL (40 per 28 days) QL (40 per 28 days) QL (30 per 28 days) QL (40 per 28 days) QL (30 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 30 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name NOVOLOG PENFILL TOUJEO SOLOSTAR Sulfonylureas glimepiride oral tablet 1 mg, 2 mg glimepiride oral tablet 4 mg glipizide oral tablet 10 mg glipizide oral tablet 5 mg glipizide oral tablet extended release 24hr 10 mg glipizide oral tablet extended release 24hr 2.5 mg, 5 mg glipizide-metformin oral tablet 2.5-250 mg Drug Tier Requirements/Limits 3 3 QL (30 per 28 days) QL (7.5 per 28 days) (Amaryl) (Amaryl) (Glucotrol) (Glucotrol) (Glucotrol XL) 1 1 1 1 1 QL (30 per 30 days) QL (60 per 30 days) QL (120 per 30 days) QL (60 per 30 days) QL (60 per 30 days) (Glucotrol XL) 1 QL (30 per 30 days) 2 QL (60 per 30 days) glipizide-metformin oral tablet 2.5-500 mg, 5-500 mg glyburide micronized oral tablet 1.5 mg (Glipizide/Metformin HCl) (Glipizide/Metformin HCl) (Glynase) 2 QL (120 per 30 days) 1 glyburide micronized oral tablet 3 mg (Glynase) 1 glyburide micronized oral tablet 6 mg (Glynase) 1 glyburide oral tablet 1.25 mg (Glyburide) 1 glyburide oral tablet 2.5 mg (Glyburide) 1 glyburide oral tablet 5 mg (Glyburide) 1 glyburide-metformin oral tablet 1.25-250 mg glyburide-metformin oral tablet 2.5-500 mg, 5-500 mg tolazamide oral tablet 250 mg tolazamide oral tablet 500 mg tolbutamide (Glucovance) 1 (Glucovance) 1 (Tolazamide) (Tolazamide) (Tolbutamide) 1 1 1 PA-HRM; QL (400 per 30 days) PA-HRM; QL (180 per 30 days) PA-HRM; QL (120 per 30 days) PA-HRM; QL (280 per 30 days) PA-HRM; QL (240 per 30 days) PA-HRM; QL (120 per 30 days) PA-HRM; QL (240 per 30 days) PA-HRM; QL (120 per 30 days) QL (120 per 30 days) QL (60 per 30 days) QL (180 per 30 days) 5 5 PA BvD PA BvD Antifungals Antifungals ABELCET AMBISOME You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 31 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name amphotericin b CANCIDAS ciclopirox topical cream ciclopirox topical gel ciclopirox topical shampoo ciclopirox topical solution ciclopirox topical suspension ciclopirox-ure-camph-menth-euc clotrimazole mucous membrane clotrimazole topical cream clotrimazole topical solution clotrimazole-betamethasone topical cream clotrimazole-betamethasone topical lotion econazole topical EXELDERM fluconazole fluconazole in dextrose(iso-o) intravenous piggyback fluconazole in nacl (iso-osm) intravenous piggyback flucytosine griseofulvin microsize oral suspension griseofulvin microsize oral tablet griseofulvin ultramicrosize itraconazole ketoconazole oral ketoconazole topical cream ketoconazole topical shampoo miconazole nitrate vaginal suppository 200 mg NOXAFIL NYSTATIN (BULK) POWDER 1 BILLION UNIT nystatin oral nystatin oral nystatin topical Drug Tier (Amphotericin B) (Ciclodan) (Loprox) (Loprox) (Penlac) (Ciclopirox Olamine) (Ciclodan) (Clotrimazole) (Clotrimazole) (Lotrimin) (Lotrisone) (Clotrimazole/Betameth asone Dip) (Econazole Nitrate) (Diflucan) (Fluconazole In Nacl,Iso-Osm) (Fluconazole In Nacl,Iso-Osm) (Ancobon) (Griseofulvin, Microsize) (Grifulvin V) (Gris-Peg) (Sporanox) (Ketoconazole) (Ketoconazole) (Nizoral) (Monistat 3) 2 5 2 2 2 2 1 2 1 1 1 2 2 Requirements/Limits PA BvD 1 4 1 1 1 5 2 2 2 2 1 1 1 1 5 1 (Nystatin) (Nystatin) (Nystatin) 1 1 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 32 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name nystatin-triamcinolone SPORANOX ORAL SOLUTION terbinafine hcl oral voriconazole intravenous voriconazole oral Drug Tier (Nystatin/Triamcin) (Lamisil) (Vfend IV) (Vfend) Requirements/Limits 2 4 1 2 5 Antihistamines Antihistamines carbinoxamine maleate oral liquid 4 mg/5 ml carbinoxamine maleate oral tablet clemastine oral syrup clemastine oral tablet 2.68 mg cyproheptadine diphenhydramine hcl injection solution 50 mg/ml diphenhydramine hcl injection syringe levocetirizine oral solution levocetirizine oral tablet promethazine oral syrup (Carbinoxamine Maleate) (Palgic) (Clemastine Fumarate) (Clemastine Fumarate) (Cyproheptadine HCl) (Diphenhydramine HCl) 1 PA-HRM 1 1 1 2 1 PA-HRM PA-HRM PA-HRM PA-HRM (Diphenhydramine HCl) (Xyzal) (Xyzal) (Promethazine HCl) 1 2 1 1 PA-HRM Anti-Infectives (Skin And Mucous Membrane) Anti-Infectives (Skin And Mucous Membrane) AVC VAGINAL clindamycin phosphate vaginal (Cleocin) metronidazole vaginal (Metrogel-Vaginal) terconazole vaginal cream (Terazol 7) terconazole vaginal suppository (Terconazole) 3 1 1 1 1 Antimigraine Agents Antimigraine Agents dihydroergotamine injection dihydroergotamine nasal ERGOMAR naratriptan rizatriptan oral tablet rizatriptan oral tablet,disintegrating sumatriptan nasal spray sumatriptan oral tablet (D.H.E.45) (Migranal) (Amerge) (Maxalt) (Maxalt Mlt) (Imitrex) (Imitrex) 2 2 4 2 2 2 2 1 QL (30 per 28 days) QL (4 per 28 days) QL (40 per 28 days) QL (18 per 28 days) QL (18 per 28 days) QL (18 per 28 days) QL (12 per 28 days) QL (18 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 33 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name sumatriptan succinate subcutaneous cartridge sumatriptan succinate subcutaneous pen injector sumatriptan succinate subcutaneous solution zolmitriptan oral tablet zolmitriptan oral tablet,disintegrating Drug Tier Requirements/Limits (Imitrex) 2 QL (4 per 28 days) (Imitrex) 2 QL (4 per 28 days) (Imitrex) 2 QL (4 per 28 days) (Zomig) (Zomig Zmt) 2 2 QL (12 per 28 days) QL (12 per 28 days) Antimycobacterials Antimycobacterials CAPASTAT dapsone ethambutol isoniazid oral PASER PRIFTIN pyrazinamide rifabutin rifampin rifampin RIFATER SIRTURO (Dapsone) (Myambutol) (Isoniazid) (Pyrazinamide) (Mycobutin) (Rifadin) (Rifadin) TRECATOR 4 1 2 1 4 4 2 2 2 2 4 5 PA; QL (188 per 168 days) 4 Antinausea Agents Antinausea Agents dimenhydrinate injection solution dronabinol EMEND INTRAVENOUS EMEND ORAL CAPSULE 125 MG (Dimenhydrinate) (Marinol) 1 2 4 4 EMEND ORAL CAPSULE 40 MG EMEND ORAL CAPSULE 80 MG 4 4 EMEND ORAL CAPSULE,DOSE PACK 4 granisetron (pf) intravenous solution (Granisetron HCl/PF) QL (2 per 28 days) PA BvD; QL (1 per 1 day) QL (1 per 1 day) PA BvD; QL (2 per 1 day) PA BvD; QL (3 per 1 day) 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 34 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name granisetron hcl intravenous solution 1 mg/ml (1 ml) granisetron hcl oral meclizine oral tablet 12.5 mg, 25 mg ondansetron ondansetron hcl (pf) ondansetron hcl oral solution ondansetron hcl oral tablet prochlorperazine prochlorperazine edisylate injection solution prochlorperazine maleate prochlorperazine maleate oral promethazine hcl promethazine oral tablet promethazine rectal TRANSDERM-SCOP Drug Tier (Kytril) 2 (Granisetron HCl) (Antivert) (Zofran Odt) (Ondansetron HCl/PF) (Zofran) (Zofran) (Compazine) (Compazine) 2 1 1 1 2 1 1 1 (Compazine) (Compazine) (Phenergan) (Promethazine HCl) (Phenergan) 1 1 2 1 2 4 Requirements/Limits PA BvD PA BvD PA BvD PA BvD PA-HRM PA-HRM PA-HRM QL (10 per 30 days) Antiparasite Agents Antiparasite Agents ALBENZA ALINIA atovaquone atovaquone-proguanil BILTRICIDE chloroquine phosphate oral COARTEM DARAPRIM hydroxychloroquine oral ivermectin oral mefloquine metronidazole in nacl (iso-os) metronidazole oral capsule metronidazole oral tablet NEBUPENT paromomycin PENTAM (Mepron) (Malarone) (Aralen Phosphate) (Plaquenil) (Stromectol) (Mefloquine HCl) (Metronidazole/Sodium Chloride) (Flagyl) (Flagyl) (Paromomycin Sulfate) 4 4 5 2 4 2 4 4 1 2 2 1 2 1 4 2 4 PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 35 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name PRIMAQUINE quinine sulfate tinidazole Drug Tier (Qualaquin) (Tindamax) 4 2 2 Requirements/Limits QL (90 per 30 days) PA; QL (42 per 7 days) Antiparkinsonian Agents Antiparkinsonian Agents amantadine hcl APOKYN AZILECT benztropine injection benztropine oral bromocriptine cabergoline carbidopa carbidopa-levodopa oral tablet carbidopa-levodopa oral tablet extended release carbidopa-levodopa oral tablet,disintegrating carbidopa-levodopa-entacapone entacapone NEUPRO pramipexole oral tablet ropinirole oral tablet ropinirole oral tablet extended release 24 hr selegiline hcl oral capsule selegiline hcl oral tablet trihexyphenidyl (Amantadine HCl) (Cogentin) (Benztropine Mesylate) (Parlodel) (Cabergoline) (Lodosyn) (Sinemet CR) (Sinemet CR) 2 5 3 2 1 2 2 2 1 2 (Carbidopa/Levodopa) 2 (Stalevo 50) (Comtan) (Mirapex) (Requip) (Requip XL) 2 2 3 2 1 2 (Eldepryl) (Selegiline HCl) (Trihexyphenidyl HCl) 2 2 1 PA-HRM 3 QL (90 per 30 days) 3 QL (60 per 30 days) 3 5 3 QL (161.2 per 28 days) QL (1 per 28 days) QL (900 per 30 days) QL (60 per 30 days) PA-HRM PA-HRM ST; QL (30 per 30 days) Antipsychotic Agents Antipsychotic Agents ABILIFY DISCMELT ORAL TABLET,DISINTEGRATING 10 MG ABILIFY DISCMELT ORAL TABLET,DISINTEGRATING 15 MG ABILIFY INTRAMUSCULAR ABILIFY MAINTENA ABILIFY ORAL SOLUTION You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 36 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name aripiprazole oral solution aripiprazole oral tablet 10 mg, 15 mg, 20 mg, 30 mg, 5 mg aripiprazole oral tablet 2 mg chlorpromazine injection chlorpromazine oral clozapine oral tablet 100 mg clozapine oral tablet 200 mg clozapine oral tablet 25 mg, 50 mg clozapine oral tablet,disintegrating 100 mg, 12.5 mg, 25 mg clozapine oral tablet,disintegrating 150 mg clozapine oral tablet,disintegrating 200 mg FANAPT ORAL TABLET FANAPT ORAL TABLETS,DOSE PACK fluphenazine decanoate fluphenazine hcl GEODON INTRAMUSCULAR haloperidol haloperidol decanoate intramuscular solution 100 mg/ml haloperidol decanoate intramuscular solution 50 mg/ml haloperidol lactate INVEGA ORAL TABLET EXTENDED RELEASE 24HR 1.5 MG, 3 MG, 9 MG INVEGA ORAL TABLET EXTENDED RELEASE 24HR 6 MG INVEGA SUSTENNA INTRAMUSCULAR SYRINGE 117 MG/0.75 ML INVEGA SUSTENNA INTRAMUSCULAR SYRINGE 156 MG/ML Drug Tier Requirements/Limits (Abilify) (Abilify) 2 2 QL (900 per 30 days) QL (30 per 30 days) (Abilify) (Chlorpromazine HCl) (Chlorpromazine HCl) (Clozaril) (Clozaril) (Clozaril) (Fazaclo) 2 1 2 2 2 2 2 QL (60 per 30 days) (Fazaclo) 2 (Fazaclo) 2 ST; QL (180 per 30 days) ST; QL (120 per 30 days) ST; QL (60 per 30 days) ST; QL (8 per 28 days) 4 4 (Fluphenazine Decanoate) (Fluphenazine HCl) QL (270 per 30 days) QL (135 per 30 days) QL (90 per 30 days) ST; QL (90 per 30 days) 2 (Haloperidol) (Haloperidol Decanoate) 1 4 1 1 (Haldol Decanoate 50) 1 (Haloperidol Lactate) 1 4 ST; QL (30 per 30 days) 4 ST; QL (60 per 30 days) 5 QL (0.75 per 28 days) 5 QL (1 per 28 days) QL (6 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 37 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name INVEGA SUSTENNA INTRAMUSCULAR SYRINGE 234 MG/1.5 ML INVEGA SUSTENNA INTRAMUSCULAR SYRINGE 39 MG/0.25 ML INVEGA SUSTENNA INTRAMUSCULAR SYRINGE 78 MG/0.5 ML INVEGA TRINZA INTRAMUSCULAR SYRINGE 273 MG/0.875 ML INVEGA TRINZA INTRAMUSCULAR SYRINGE 410 MG/1.315 ML INVEGA TRINZA INTRAMUSCULAR SYRINGE 546 MG/1.75 ML INVEGA TRINZA INTRAMUSCULAR SYRINGE 819 MG/2.625 ML LATUDA ORAL TABLET 120 MG, 20 MG, 40 MG, 60 MG LATUDA ORAL TABLET 80 MG loxapine succinate olanzapine intramuscular olanzapine oral tablet olanzapine oral tablet,disintegrating 10 mg, 15 mg, 5 mg olanzapine oral tablet,disintegrating 20 mg ORAP paliperidone oral tablet extended release 24hr 1.5 mg, 3 mg, 9 mg paliperidone oral tablet extended release 24hr 6 mg perphenazine quetiapine REXULTI ORAL TABLET 0.25 MG REXULTI ORAL TABLET 0.5 MG REXULTI ORAL TABLET 1 MG, 2 MG, 3 MG, 4 MG Drug Tier Requirements/Limits 5 QL (1.5 per 28 days) 3 QL (0.25 per 28 days) 3 QL (0.5 per 28 days) 5 QL (0.875 per 84 days) 5 QL (1.315 per 84 days) 5 QL (1.75 per 84 days) 5 QL (2.625 per 84 days) 4 ST; QL (30 per 30 days) ST; QL (60 per 30 days) (Loxitane) (Zyprexa) (Zyprexa) (Zyprexa Zydis) 4 1 2 2 2 (Zyprexa Zydis) 2 QL (31 per 30 days) (Invega) 4 2 QL (30 per 30 days) (Invega) 2 QL (60 per 30 days) (Perphenazine) (Seroquel) 2 1 5 5 5 QL (30 per 30 days) QL (30 per 30 days) QL (30 per 30 days) QL (90 per 30 days) ST; QL (120 per 30 days) ST; QL (60 per 30 days) ST; QL (30 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 38 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name RISPERDAL CONSTA risperidone oral solution risperidone oral tablet risperidone oral tablet,disintegrating 0.25 mg, 0.5 mg, 1 mg, 2 mg risperidone oral tablet,disintegrating 3 mg, 4 mg SAPHRIS (BLACK CHERRY) SEROQUEL XR ORAL TABLET EXTENDED RELEASE 24 HR 150 MG, 300 MG, 400 MG, 50 MG SEROQUEL XR ORAL TABLET EXTENDED RELEASE 24 HR 200 MG thioridazine thiothixene trifluoperazine VERSACLOZ Drug Tier Requirements/Limits (Risperdal) (Risperdal) (Risperdal M-Tab) 4 1 1 2 QL (4 per 28 days) QL (480 per 30 days) QL (60 per 30 days) QL (60 per 30 days) (Risperdal M-Tab) 2 QL (120 per 30 days) 4 4 ST; QL (60 per 30 days) ST; QL (60 per 30 days) 4 ST; QL (30 per 30 days) 1 1 1 5 PA NSO-HRM (Thioridazine HCl) (Thiothixene) (Trifluoperazine HCl) ziprasidone hcl (Geodon) ZYPREXA RELPREVV INTRAMUSCULAR SUSPENSION FOR RECONSTITUTION 210 MG, 405 MG 2 5 ST; QL (540 per 30 days) QL (60 per 30 days) QL (2 per 28 days) Antivirals (Systemic) Antiretrovirals abacavir abacavir-lamivudine-zidovudine APTIVUS ORAL CAPSULE APTIVUS ORAL SOLUTION ATRIPLA COMPLERA CRIXIVAN ORAL CAPSULE 200 MG, 400 MG didanosine EDURANT EMTRIVA EPIVIR HBV ORAL SOLUTION EPZICOM EVOTAZ (Ziagen) (Trizivir) 2 5 5 4 5 5 4 (Videx EC) 2 5 3 4 5 5 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 39 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name FUZEON SUBCUTANEOUS INTELENCE ORAL TABLET 100 MG, 200 MG INTELENCE ORAL TABLET 25 MG INVIRASE ISENTRESS ORAL POWDER IN PACKET ISENTRESS ORAL TABLET ISENTRESS ORAL TABLET,CHEWABLE KALETRA ORAL SOLUTION KALETRA ORAL TABLET 100-25 MG KALETRA ORAL TABLET 200-50 MG lamivudine lamivudine-zidovudine LEXIVA ORAL SUSPENSION LEXIVA ORAL TABLET nevirapine oral suspension nevirapine oral tablet nevirapine oral tablet extended release 24 hr NORVIR PREZCOBIX PREZISTA ORAL SUSPENSION PREZISTA ORAL TABLET 150 MG, 75 MG PREZISTA ORAL TABLET 400 MG, 600 MG, 800 MG RESCRIPTOR RETROVIR INTRAVENOUS REYATAZ ORAL CAPSULE 150 MG, 200 MG, 300 MG REYATAZ ORAL POWDER IN PACKET SELZENTRY stavudine STRIBILD SUSTIVA Drug Tier Requirements/Limits 5 5 3 5 3 5 3 (Epivir) (Combivir) (Viramune) (Viramune) (Viramune XR) 5 3 5 2 5 3 5 2 2 2 4 5 4 3 5 4 3 5 5 (Zerit) 5 2 5 4 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 40 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name TIVICAY TRIUMEQ TRUVADA VIDEX 2 GRAM PEDIATRIC VIDEX 4 GRAM PEDIATRIC VIRACEPT ORAL TABLET VIRAMUNE XR ORAL TABLET EXTENDED RELEASE 24 HR 100 MG VIREAD VITEKTA ZIAGEN ORAL SOLUTION zidovudine oral capsule zidovudine oral syrup zidovudine oral tablet Antivirals, Miscellaneous foscarnet RELENZA DISKHALER rimantadine SYNAGIS TAMIFLU Hcv Antivirals DAKLINZA HARVONI OLYSIO SOVALDI TECHNIVIE VIEKIRA PAK Interferons INTRON A INJECTION PEGASYS PEGASYS PROCLICK PEGINTRON PEGINTRON REDIPEN SYLATRON Drug Tier Requirements/Limits 5 5 5 3 3 4 3 (Retrovir) (Retrovir) (Zidovudine) (Foscavir) (Flumadine) 5 5 4 2 1 1 1 4 1 5 3 PA BvD 5 5 5 5 5 5 PA; QL (28 per 28 days) PA; QL (30 per 30 days) PA; QL (28 per 28 days) PA; QL (28 per 28 days) PA; QL (56 per 28 days) PA; QL (112 per 28 days) 4 5 5 5 5 5 PA NSO PA PA PA PA PA NSO; QL (4 per 28 days) Nucleosides And Nucleotides You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 41 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name acyclovir oral capsule acyclovir oral suspension 200 mg/5 ml acyclovir oral tablet acyclovir sodium intravenous recon soln acyclovir sodium intravenous solution adefovir BARACLUDE ORAL SOLUTION cidofovir entecavir famciclovir ganciclovir sodium ribavirin oral capsule 200 mg ribavirin oral tablet 200 mg, 400 mg, 600 mg ribavirin oral tablets,dose pack 200 mg (28)- 400 mg (28), 400-400 mg (28)-mg (28), 600-400 mg (28)-mg (28) TYZEKA valacyclovir VALCYTE ORAL RECON SOLN valganciclovir VIRAZOLE Drug Tier (Zovirax) (Zovirax) (Zovirax) (Acyclovir Sodium) (Acyclovir Sodium) (Hepsera) (Vistide) (Baraclude) (Famvir) (Cytovene) (Rebetol) (Copegus) 1 2 1 1 1 5 4 5 5 2 1 2 2 (Ribatab) 5 Requirements/Limits PA BvD PA BvD PA BvD 5 2 4 5 5 PA BvD (Lovenox) (Lovenox) 5 3 2 5 QL (36 per 30 days) QL (36 per 30 days) (Lovenox) 5 QL (27.2 per 30 days) (Lovenox) 5 QL (34 per 30 days) (Lovenox) 2 QL (18 per 30 days) (Lovenox) 2 QL (13.6 per 30 days) (Valtrex) (Valcyte) Blood Products/Modifiers/Volume Expanders Anticoagulants CEPROTIN (BLUE BAR) ELIQUIS enoxaparin subcutaneous solution enoxaparin subcutaneous syringe 100 mg/ml enoxaparin subcutaneous syringe 120 mg/0.8 ml enoxaparin subcutaneous syringe 150 mg/ml enoxaparin subcutaneous syringe 30 mg/0.3 ml enoxaparin subcutaneous syringe 40 mg/0.4 ml You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 42 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name enoxaparin subcutaneous syringe 60 mg/0.6 ml enoxaparin subcutaneous syringe 80 mg/0.8 ml fondaparinux subcutaneous syringe 10 mg/0.8 ml fondaparinux subcutaneous syringe 2.5 mg/0.5 ml fondaparinux subcutaneous syringe 5 mg/0.4 ml fondaparinux subcutaneous syringe 7.5 mg/0.6 ml heparin (porcine) in 5 % dex intravenous parenteral solution 12,500 unit/250 ml, 20,000 unit/500 ml (40 unit/ml) HEPARIN (PORCINE) IN 5 % DEX INTRAVENOUS PARENTERAL SOLUTION 25,000 UNIT/250 ML(100 UNIT/ML), 25,000 UNIT/500 ML (50 UNIT/ML) heparin (porcine) in nacl (pf) intravenous parenteral solution 1,000 unit/500 ml heparin (porcine) injection solution 1,000 unit/ml heparin (porcine) injection solution 10,000 unit/ml, 20,000 unit/ml, 5,000 unit/ml heparin, porcine (pf) injection solution 5,000 unit/0.5 ml heparin, porcine (pf) injection heparin, porcine (pf) intravenous syringe 100 unit/ml HEPARIN-0.45% NACL 25,000 UNITS/250 ML (100 UNITS/ML) BAG LATEX-FREE, OUTER HEPARIN-0.45% NACL 25,000 UNITS/500 ML (50 UNITS/ML) BAG LATEX-FREE, OUTER Drug Tier Requirements/Limits (Lovenox) 2 QL (20.4 per 30 days) (Lovenox) 2 QL (27.2 per 30 days) (Arixtra) 2 QL (24 per 30 days) (Arixtra) 2 QL (15 per 30 days) (Arixtra) 2 QL (12 per 30 days) (Arixtra) 2 QL (18 per 30 days) (Heparin Sodium in 5% Dextrose) 1 1 (Heparin Sodium,Porcine/Ns/PF) (Heparin Sodium,Porcine) (Heparin Sodium,Porcine) 1 (Heparin Sodium,Porcine/PF) (Monoject Prefill Advanced) (Monoject Prefill Advanced) 2 PA BvD 1 PA BvD; (PA for ESRD Only) 1 2 PA BvD; (PA for ESRD Only) PA BvD; (PA for ESRD Only) 1 1 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 43 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier heparin-d5w 25,000 units/250 ml (100 (Heparin Sodium in 5% units/ml) bag excel container Dextrose) heparin-d5w 25,000 units/500 ml (50 (Heparin Sodium in 5% units/ml) bag excel container Dextrose) IPRIVASK jantoven (Coumadin) PRADAXA SAVAYSA warfarin (Coumadin) XARELTO Blood Formation Modifiers EPOGEN INJECTION SOLUTION 10,000 UNIT/ML, 2,000 UNIT/ML, 20,000 UNIT/2 ML, 20,000 UNIT/ML, 3,000 UNIT/ML, 4,000 UNIT/ML GRANIX LEUKINE INJECTION RECON SOLN MIRCERA MOZOBIL NEULASTA SUBCUTANEOUS SYRINGE NEUMEGA NEUPOGEN PROCRIT INJECTION SOLUTION 10,000 UNIT/ML, 2,000 UNIT/ML, 20,000 UNIT/2 ML, 3,000 UNIT/ML, 4,000 UNIT/ML PROCRIT INJECTION SOLUTION 20,000 UNIT/ML PROCRIT INJECTION SOLUTION 40,000 UNIT/ML PROMACTA ZARXIO Hematologic Agents, Miscellaneous aminocaproic acid oral solution (Aminocaproic Acid) aminocaproic acid oral tablet (Amicar) anagrelide (Agrylin) 1 Requirements/Limits 1 5 1 4 4 1 3 PA; QL (24 per 28 days) 3 PA; QL (12 per 28 days) 5 5 4 5 5 PA; QL (0.6 per 28 days) QL (60 per 30 days) QL (30 per 30 days) 5 5 3 PA; QL (12 per 28 days) 5 PA; QL (12 per 28 days) 5 PA; QL (6 per 28 days) 5 5 PA; QL (30 per 30 days) ST 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 44 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits PA BvD; (PA for ESRD Only) protamine (Protamine Sulfate) 1 tranexamic acid intravenous tranexamic acid oral Platelet-Aggregation Inhibitors AGGRENOX aspirin-dipyridamole BRILINTA cilostazol clopidogrel EFFIENT pentoxifylline Volume Expanders ALBUKED-25 ALBUKED-5 ALBUMIN, HUMAN 25 % ALBUMIN, HUMAN 5 % ALBUMINAR 25 % ALBUMINAR 5 % ALBURX (HUMAN) 5 % ALBUTEIN 25 % ALBUTEIN 5 % BUMINATE 25 % BUMINATE 5 % FLEXBUMIN 25 % FLEXBUMIN 5 % KEDBUMIN PLASBUMIN 25 % PLASBUMIN 5 % (Tranexamic Acid) (Lysteda) 2 2 (Aggrenox) (Pletal) (Plavix) (Pentoxifylline) 4 2 3 1 1 3 2 QL (30 per 30 days) QL (60 per 30 days) QL (30 per 30 days) 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 Caloric Agents Caloric Agents AMINO ACIDS 15 % AMINOSYN 10 % AMINOSYN 3.5 % AMINOSYN 7 % AMINOSYN 7 % WITH ELECTROLYTES 4 4 4 4 4 PA BvD PA BvD PA BvD PA BvD PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 45 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name AMINOSYN 8.5 % AMINOSYN 8.5 %-ELECTROLYTES AMINOSYN II 10 % AMINOSYN II 15 % AMINOSYN II 7 % AMINOSYN II 8.5 % AMINOSYN II 8.5 %-ELECTROLYTES AMINOSYN M 3.5 % AMINOSYN-HBC 7% AMINOSYN-PF 10 % AMINOSYN-PF 7 % (SULFITE-FREE) AMINOSYN-RF 5.2 % CLINIMIX 5%/D15W SULFITE FREE CLINIMIX 5%/D25W SULFITE-FREE CLINIMIX 2.75%/D5W SULFIT FREE CLINIMIX 4.25%/D10W SULF FREE CLINIMIX 4.25%/D5W SULFIT FREE CLINIMIX 4.25%-D20W SULF-FREE CLINIMIX 4.25%-D25W SULF-FREE CLINIMIX 5%-D20W(SULFITE-FREE) CLINIMIX E 2.75%/D10W SUL FREE CLINIMIX E 2.75%/D5W SULF FREE CLINIMIX E 4.25%/D10W SUL FREE CLINIMIX E 4.25%/D25W SUL FREE CLINIMIX E 4.25%/D5W SULF FREE CLINIMIX E 5%/D15W SULFIT FREE CLINIMIX E 5%/D20W SULFIT FREE CLINIMIX E 5%/D25W SULFIT FREE CLINISOL SF 15 % cysteine (l-cysteine) intravenous solution d10 % & 0.45 % sodium chloride d10 %-0.9 % sodium chloride d2.5 %-0.45 % sodium chloride Drug Tier (Cysteine HCl) (Dextrose 10 % and 0.45 % NaCl) (Dextrose 10 % and 0.9 % NaCl) (Dextrose 2.5 % and 0.45 % NaCl) 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 1 1 Requirements/Limits PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD 1 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 46 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name d5 % and 0.9 % sodium chloride d5 %-0.45 % sodium chloride dextrose 10 % and 0.2 % nacl dextrose 10 % in water (d10w) intravenous dextrose 2.5 % in water(d2.5w) dextrose 20 % in water (d20w) dextrose 25 % in water (d25w) dextrose 40 % in water (d40w) dextrose 5 % in ringers dextrose 5 % in water (d5w) intravenous dextrose 5 %-lactated ringers dextrose 5%-0.2 % sod chloride dextrose 5%-0.3 % sod.chloride dextrose 50 % in water (d50w) dextrose 70 % in water (d70w) dextrose with sodium chloride FREAMINE HBC 6.9 % FREAMINE III 10 % glucose oral tablet,chewable HEPATAMINE 8% HEPATASOL 8 % INTRALIPID INTRAVENOUS EMULSION 20 %, 30 % KABIVEN Drug Tier (Dextrose 5 % and 0.9 % NaCl) (Dextrose 5 %-0.45 % NaCl) (Dextrose 10 % and 0.2 % NaCl) (Dextrose 10 % in Water) (Dextrose 2.5 % in Water) (Dextrose 20 % in Water) (Dextrose 25 % in Water) (Dextrose 40 % in Water) (Dextrose 5% In Ringers) (Dextrose 5 % in Water) (Dextrose 5%-Lactated Ringers) (Dextrose 5 %-0.2 % NaCl) (Dextrose 5 % and 0.3 % NaCl) (Dextrose 50 % in Water) (Dextrose 70 % in Water) (Dextrose 5 %-0.2 % NaCl) (Dextrose) Requirements/Limits 1 1 1 1 PA BvD 1 PA BvD 1 PA BvD 1 PA BvD 1 PA BvD 1 1 1 1 1 1 PA BvD 1 PA BvD 1 4 4 1 4 4 4 PA BvD PA BvD 4 PA BvD PA BvD PA BvD PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 47 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name LIPOSYN II LIPOSYN III NEPHRAMINE 5.4 % NUTRILIPID PERIKABIVEN potassium chloride in lr-d5 intravenous parenteral solution PREMASOL 10 % PREMASOL 6 % PROCALAMINE 3% PROSOL 20 % TRAVASOL 10 % TROPHAMINE 10 % TROPHAMINE 6% Drug Tier (Potassium Chloride In Lr-D5) Requirements/Limits 4 4 4 4 4 1 PA BvD PA BvD PA BvD PA BvD PA BvD 4 4 4 4 4 4 4 PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD PA BvD Cardiovascular Agents Alpha-Adrenergic Agents clonidine hcl oral tablet clonidine hcl-chlorthalidone clonidine transdermal patch weekly 0.1 mg/24 hr, 0.2 mg/24 hr clonidine transdermal patch weekly 0.3 mg/24 hr doxazosin guanfacine oral tablet midodrine NORTHERA (Catapres) (Clonidine HCl/Chlorthalidone) (Catapres-Tts 1) 1 2 2 QL (4 per 28 days) (Catapres-Tts 1) 2 QL (8 per 28 days) (Cardura) (Tenex) (Midodrine HCl) 1 1 2 5 phenylephrine hcl injection (Vazculep) prazosin oral (Minipress) Angiotensin Ii Receptor Antagonists BENICAR BENICAR HCT candesartan (Atacand) candesartan-hydrochlorothiazid (Atacand HCT) EDARBI EDARBYCLOR PA-HRM PA; QL (180 per 30 days) 1 1 3 3 2 2 4 4 ST ST ST ST You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 48 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits ENTRESTO eprosartan (Teveten) irbesartan (Avapro) irbesartan-hydrochlorothiazide (Avalide) losartan (Cozaar) losartan-hydrochlorothiazide (Hyzaar) telmisartan (Micardis) telmisartan-hydrochlorothiazid (Micardis HCT) TEVETEN HCT TRIBENZOR valsartan (Diovan) valsartan-hydrochlorothiazide (Diovan HCT) Angiotensin-Converting Enzyme Inhibitors benazepril (Lotensin) benazepril-hydrochlorothiazide (Lotensin HCT) captopril (Captopril) captopril-hydrochlorothiazide (Captopril/Hydrochlorot hiazide) enalapril maleate (Vasotec) enalaprilat intravenous injectable (Enalaprilat Dihydrate) enalapril-hydrochlorothiazide (Vaseretic) fosinopril (Fosinopril Sodium) fosinopril-hydrochlorothiazide (Fosinopril/Hydrochloro thiazide) lisinopril (Zestril) lisinopril-hydrochlorothiazide (Zestoretic) moexipril (Univasc) moexipril-hydrochlorothiazide (Uniretic) perindopril erbumine (Aceon) quinapril (Accupril) quinapril-hydrochlorothiazide (Accuretic) ramipril (Altace) trandolapril (Mavik) Antiarrhythmic Agents amiodarone hcl oral tablet 100 mg, 200 (Cordarone) mg, 400 mg amiodarone intravenous (Amiodarone HCl) 3 2 2 2 1 1 2 2 3 3 2 2 PA; QL (60 per 30 days) ST ST 1 1 2 2 1 2 1 1 2 1 1 1 1 1 1 1 1 1 1 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 49 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name amiodarone oral disopyramide phosphate oral capsule flecainide lidocaine (pf) intravenous syringe 50 mg/5 ml (1 %) lidocaine in 5 % dextrose (pf) intravenous parenteral solution 8 mg/ml (0.8 %) mexiletine MULTAQ procainamide injection propafenone oral capsule,extended release 12 hr propafenone oral tablet quinidine gluconate oral quinidine sulfate TIKOSYN Beta-Adrenergic Blocking Agents acebutolol atenolol atenolol-chlorthalidone betaxolol oral bisoprolol fumarate bisoprolol-hydrochlorothiazide BYSTOLIC carvedilol COREG CR esmolol intravenous labetalol intravenous solution labetalol oral metoprolol succinate metoprolol ta-hydrochlorothiaz metoprolol tartrate intravenous metoprolol tartrate oral nadolol pindolol propranolol intravenous Drug Tier (Cordarone) (Norpace) (Flecainide Acetate) (Lidocaine HCl/PF) 1 2 1 1 (Lidocaine HCl/D5w/PF) (Mexiletine HCl) 1 (Procainamide HCl) (Rythmol SR) 1 3 1 2 (Rythmol) (Quinidine Gluconate) (Quinidine Sulfate) 2 2 1 3 (Sectral) (Tenormin) (Tenoretic 50) (Kerlone) (Zebeta) (Ziac) 1 1 1 2 1 1 3 1 3 1 1 1 1 2 1 1 1 2 1 (Coreg) (Esmolol HCl) (Trandate) (Trandate) (Toprol XL) (Lopressor HCT) (Metoprolol Tartrate) (Lopressor) (Corgard) (Pindolol) (Propranolol HCl) Requirements/Limits PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 50 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name propranolol oral capsule,extended release 24 hr propranolol oral solution propranolol oral tablet propranolol-hydrochlorothiazid Drug Tier (Inderal LA) 1 (Propranolol HCl) (Propranolol HCl) (Propranolol/Hydrochlor othiazid) (Betapace) 1 1 1 sotalol hcl oral tablet 120 mg, 160 mg, 240 mg, 80 mg sotalol oral (Betapace) timolol maleate oral (Timolol Maleate) Calcium-Channel Blocking Agents cartia xt (Cardizem CD) diltiazem hcl intravenous (Cardizem CD) diltiazem hcl oral capsule, extended (Cardizem CD) release 180 mg, 360 mg, 420 mg diltiazem hcl oral capsule,extended (Cardizem CD) release 12 hr diltiazem hcl oral capsule,extended (Cardizem CD) release 24hr diltiazem hcl oral tablet (Cardizem CD) diltiazem hcl oral tablet extended release (Cardizem LA) 24 hr dilt-xr (Cardizem CD) matzim la (Cardizem CD) taztia xt (Cardizem CD) verapamil intravenous syringe (Verapamil HCl) verapamil oral capsule, 24 hr er pellet ct (Verelan Pm) verapamil oral capsule,ext rel. pellets 24 (Verelan) hr verapamil oral tablet (Calan) verapamil oral tablet extended release (Calan SR) Cardiovascular Agents, Miscellaneous ADRENALIN 1 MG/ML VIAL SUV ADRENALIN INJECTION SOLUTION 1 MG/ML (1:1,000) adrenalin injection solution 1 mg/ml (Epinephrine) (1:1,000) (1ml) CORLANOR Requirements/Limits 1 1 1 2 1 2 2 2 1 2 2 2 2 1 1 1 1 1 1 1 1 3 ST You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 51 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits DEMSER digitek oral tablet 125 mcg (Lanoxin) 4 1 digitek oral tablet 250 mcg (Lanoxin) 1 digoxin injection DIGOXIN ORAL SOLUTION (Digoxin) 1 3 digoxin oral tablet (Lanoxin) 1 dobutamine in d5w intravenous parenteral solution 1,000 mg/250 ml (4,000 mcg/ml), 250 mg/250 ml (1 mg/ml), 500 mg/250 ml (2,000 mcg/ml) dobutamine intravenous solution dopamine in 5 % dextrose intravenous solution dopamine intravenous solution ephedrine sulfate injection solution epinephrine 1 mg/ml ampul latex-free epinephrine hcl (pf) intravenous epinephrine injection auto-injector 0.15 mg/0.15 ml (1:1,000) epinephrine injection auto-injector 0.3 mg/0.3 ml (1:1,000) epinephrine injection syringe 0.1 mg/ml (1:10,000) EPIPEN 2-PAK EPIPEN JR 2-PAK ethamolin FIRAZYR (Dobutamine HCl/D5W) 1 PA-HRM; (High Risk Med for Ages 65 and Older and Dose is Greater Than 125mcg Per Day); QL (30 per 30 days) PA-HRM; QL (30 per 30 days) PA-HRM PA-HRM; QL (300 per 30 days) PA-HRM; (High Risk Med for Ages 65 and Older and Dose is Greater Than 125mcg Per Day); QL (30 per 30 days) PA BvD (Dobutamine HCl) (Dopamine HCl/D5W) 2 1 PA BvD PA BvD (Dopamine HCl) (Ephedrine Sulfate) (Epinephrine) (Epinephrine HCl/PF) (Adrenaclick) 1 1 1 1 2 PA BvD (Adrenaclick) 1 (Epinephrine) 1 (Ethanolamine Oleate) 3 3 1 5 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 52 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier hydralazine LANOXIN ORAL TABLET 187.5 MCG, 62.5 MCG (Hydralazine HCl) milrinone milrinone in 5 % dextrose intravenous piggyback 40 mg/200 ml (200 mcg/ml) norepinephrine bitartrate papaverine injection solution papaverine oral RANEXA Dihydropyridines amlodipine amlodipine-benazepril amlodipine-valsartan amlodipine-valsartan-hcthiazid AZOR CLEVIPREX INTRAVENOUS EMULSION felodipine isradipine nicardipine oral nifedipine oral tablet extended release 24hr 30 mg, 60 mg, 90 mg nifedipine oral tablet extended release 30 mg, 60 mg Diuretics amiloride oral amiloride-hydrochlorothiazide (Milrinone Lactate) (Milrinone Lactate/D5W) (Levophed Bitartrate) (Papaverine HCl) (Papaverine HCl) 5 5 (Norvasc) (Lotrel) (Exforge) (Exforge HCT) 1 2 2 2 3 4 bumetanide chlorothiazide chlorothiazide sodium chlorthalidone oral tablet 25 mg, 50 mg DYRENIUM 1 4 1 1 1 3 (Felodipine) (Isradipine) (Nicardipine HCl) (Procardia XL) 2 2 2 1 (Adalat CC) 1 (Midamor) (Amiloride/Hydrochloro thiazide) (Bumetanide) (Chlorothiazide) (Sodium Diuril) (Chlorthalidone) 2 1 Requirements/Limits PA-HRM; (High Risk Med for Ages 65 and Older and Dose is Greater Than 125mcg Per Day); QL (30 per 30 days) PA BvD PA BvD PA BvD PA PA ST 1 1 1 1 4 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 53 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name furosemide injection furosemide oral solution furosemide oral tablet hydrochlorothiazide oral capsule hydrochlorothiazide oral tablet indapamide methyclothiazide metolazone torsemide oral triamterene-hydrochlorothiazid oral capsule triamterene-hydrochlorothiazid oral tablet Dyslipidemics ALTOPREV amlodipine-atorvastatin atorvastatin cholestyramine (with sugar) oral cholestyramine-aspartame oral powder 4 gram cholestyramine-aspartame oral powder in packet 4 gram colestipol CRESTOR fenofibrate micronized fenofibrate nanocrystallized fenofibrate oral tablet fenofibric acid fenofibric acid (choline) fluvastatin oral capsule gemfibrozil oral lovastatin niacin niacin oral tablet extended release 24 hr omega-3 acid ethyl esters PRALUENT PEN PRALUENT SYRINGE pravastatin Drug Tier (Furosemide) (Furosemide) (Lasix) (Microzide) (Hydrochlorothiazide) (Indapamide) (Methyclothiazide) (Zaroxolyn) (Demadex) (Dyazide) 1 1 1 1 1 1 2 1 1 1 (Maxzide) 1 (Caduet) (Lipitor) (Questran) (Cholestyramine/Asparta me) (Cholestyramine/Asparta me) (Colestid) (Antara) (Tricor) (Lofibra) (Fibricor) (Trilipix) (Lescol) (Lopid) (Mevacor) (Niacin) (Niaspan) (Lovaza) (Pravachol) Requirements/Limits 4 2 1 2 2 2 2 3 2 2 2 2 2 2 1 1 1 2 2 5 5 1 PA; QL (2 per 28 days) PA; QL (2 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 54 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier REPATHA SURECLICK REPATHA SYRINGE simvastatin (Zocor) VASCEPA VYTORIN 10-10 VYTORIN 10-20 VYTORIN 10-40 VYTORIN 10-80 WELCHOL ZETIA Renin-Angiotensin-Aldosterone System Inhibitors eplerenone (Inspra) spironolactone (Aldactone) spironolacton-hydrochlorothiaz (Aldactazide) Vasodilators BIDIL isosorbide dinitrate oral (Isochron) isosorbide dinitrate sublingual (Isosorbide Dinitrate) isosorbide mononitrate oral tablet (Isosorbide Mononitrate) isosorbide mononitrate oral tablet (Imdur) extended release 24 hr minitran transdermal patch 24 hour 0.1 (Nitro-Dur) mg/hr, 0.2 mg/hr, 0.6 mg/hr minitran transdermal patch 24 hour 0.4 (Nitro-Dur) mg/hr minoxidil oral (Minoxidil) NITRO-BID nitroglycerin in 5 % dextrose intravenous (Nitroglycerin/D5W) solution nitroglycerin intravenous (Nitroglycerin) nitroglycerin transdermal patch 24 hour (Nitro-Dur) 0.1 mg/hr, 0.2 mg/hr, 0.6 mg/hr nitroglycerin transdermal patch 24 hour (Nitro-Dur) 0.4 mg/hr NITROSTAT PROGLYCEM 5 5 1 3 4 4 4 4 3 3 Requirements/Limits PA; QL (3 per 28 days) PA; QL (3 per 28 days) QL (30 per 30 days) 2 1 1 3 2 1 1 1 1 QL (30 per 30 days) 1 QL (60 per 30 days) 1 3 1 1 1 QL (30 per 30 days) 1 QL (60 per 30 days) 3 4 Central Nervous System Agents You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 55 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Central Nervous System Agents amphetamine salt combo AMPYRA caffeine citrated intravenous caffeine citrated oral caffeine-sodium benzoate clonidine hcl oral tablet extended release 12 hr dexmethylphenidate oral tablet dextroamphetamine oral capsule, extended release dextroamphetamine oral tablet dextroamphetamine-amphetamine oral capsule,extended release 24hr 10 mg, 15 mg, 5 mg dextroamphetamine-amphetamine oral capsule,extended release 24hr 20 mg, 25 mg, 30 mg flumazenil guanfacine oral tablet extended release 24 hr lithium carbonate oral capsule lithium carbonate oral tablet lithium carbonate oral tablet extended release lithium citrate oral solution methylphenidate oral capsule, er biphasic 30-70 10 mg, 20 mg, 50 mg, 60 mg methylphenidate oral capsule, er biphasic 30-70 30 mg methylphenidate oral capsule,er biphasic 50-50 20 mg methylphenidate oral capsule,er biphasic 50-50 30 mg methylphenidate oral capsule,er biphasic 50-50 40 mg methylphenidate oral solution (Adderall) (Cafcit) (Cafcit) (Caffeine/Sodium Benzoate) (Kapvay) Drug Tier Requirements/Limits 1 5 1 1 1 QL (60 per 30 days) PA; QL (60 per 30 days) 2 (Focalin) (Dexedrine) 2 2 QL (60 per 30 days) QL (120 per 30 days) (Dexedrine) (Adderall XR) 1 2 QL (180 per 30 days) QL (30 per 30 days) (Adderall XR) 2 QL (60 per 30 days) (Romazicon) (Intuniv) 1 2 (Eskalith) (Lithobid) (Lithobid) 1 1 1 (Lithium Citrate) (Metadate Cd) 1 2 QL (30 per 30 days) (Metadate Cd) 2 QL (60 per 30 days) (Metadate Cd) 2 QL (30 per 30 days) (Metadate Cd) 2 QL (60 per 30 days) (Ritalin LA) 2 QL (30 per 30 days) (Methylin) 1 QL (900 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 56 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name methylphenidate oral tablet methylphenidate oral tablet extended release methylphenidate oral tablet extended release 24hr 18 mg, 27 mg, 54 mg methylphenidate oral tablet extended release 24hr 36 mg NUEDEXTA QUILLIVANT XR riluzole SAVELLA STRATTERA tetrabenazine Drug Tier Requirements/Limits (Ritalin) (Ritalin-SR) 1 1 QL (90 per 30 days) QL (90 per 30 days) (Concerta) 2 QL (30 per 30 days) (Concerta) 2 QL (60 per 30 days) 3 3 2 3 3 5 QL (60 per 30 days) (Rilutek) (Xenazine) XENAZINE 5 QL (60 per 30 days) PA; QL (112 per 28 days) PA; QL (112 per 28 days) Contraceptives Contraceptives ashlyna cyred deblitane desog-e.estradiol/e.estradiol desogestrel-ethinyl estradiol oral tablet 0.1/.125/.15-25 mg-mcg, 0.15-0.03 mg drospirenone-ethinyl estradiol ELLA ethinyl estradiol/drospirenone ethynodiol d-ethinyl estradiol gildess 24 fe junel fe 24 kimidess (28) l norgest/e.estradiol-e.estrad larin 24 fe levonorgestrel levonorgestrel oral tablet 1.5 mg (Seasonique) (Desogen) (Nor-Q-D) (Mircette) (Desogen) 2 1 1 1 1 (Yaz) 2 3 2 1 (Yaz) (Ethynodiol D-Ethinyl Estradiol) (Loestrin Fe) (Loestrin Fe) (Mircette) (Seasonique) (Loestrin Fe) (Plan B One-Step) (Plan B One-Step) 1 1 1 2 1 1 1 QL (91 per 84 days) QL (91 per 84 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 57 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name levonorgestrel-ethin estradiol oral tablet 0.1-20 mg-mcg, 0.15-0.03 mg, 50-30 (6)/75-40 (5)/125-30(10) levonorgestrel-ethin estradiol oral tablets,dose pack,3 month 0.15-30 mg-mcg levonorgestrel-ethinyl estrad oral tablet 0.1-20 mg-mcg, 90-20 mcg levonorgestrel-ethinyl estrad oral tablets,dose pack,3 month l-norgest-eth estr/ethin estra norelgestromin/ethin.estradiol noreth-ethinyl estradiol/iron norethindrone norethindrone (contraceptive) norethindrone ac-eth estradiol oral tablet 1-20 mg-mcg, 1.5-30 mg-mcg norethindrone-e.estradiol-iron norethindrone-e.estradiol-iron oral tablet 1-20(5)/1-30(7) /1mg-35mcg (9), 1.5 mg30 mcg (21)/75 mg (7) norethindrone-ethinyl estrad oral tablet 0.4-35 mg-mcg, 0.5-35 mg-mcg, 0.5-35/135 mg-mcg/mg-mcg, 0.5/0.75/1 mg- 35 mcg, 0.5/1/0.5-35 mg-mcg, 1-35 mg-mcg norethindrone-mestranol norgestimate-ethinyl estradiol norgestrel-ethinyl estradiol NUVARING setlakin tarina fe Drug Tier Requirements/Limits (Amethyst) 1 (Levonorgestrel-Ethin Estradiol) (Amethyst) 1 (Levonorgestrel-Ethin Estradiol) (Seasonique) (Ortho Evra) (Femcon Fe) (Nor-Q-D) (Nor-Q-D) (Loestrin) 1 QL (91 per 84 days) 2 2 2 1 1 1 QL (91 per 84 days) QL (3 per 28 days) (Loestrin Fe) (Loestrin Fe) 1 1 (Modicon) 1 (Norinyl 1+50) (Ortho-Cyclen) (Norgestrel-Ethinyl Estradiol) 1 1 1 (Levonorgestrel-Ethin Estradiol) (Loestrin Fe) QL (91 per 84 days) 1 3 1 QL (1 per 28 days) QL (91 per 84 days) 1 Dental And Oral Agents Dental And Oral Agents cevimeline chlorhexidine gluconate mucous membrane pilocarpine hcl oral (Evoxac) (Peridex) 2 1 (Salagen) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 58 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name triamcinolone acetonide dental Drug Tier (Triamcinolone Acetonide) Requirements/Limits 1 Dermatological Agents Dermatological Agents, Other 8-MOP acitretin acyclovir topical ALCOHOL PADS ALCOHOL PREP PADS ALCOH-WIPE aluminum chloride ammonium lactate ANACAINE calcipotriene topical cream calcipotriene topical ointment calcipotriene topical solution calcitriol topical CONDYLOX TOPICAL GEL COSENTYX (2 SYRINGES) COSENTYX PEN COSENTYX PEN (2 PENS) DENAVIR DRYSOL DAB-O-MATIC FLUOROPLEX fluorouracil topical cream fluorouracil topical solution imiquimod isotretinoin oral capsule 10 mg, 20 mg, 30 mg, 40 mg mafenide acetate methoxsalen rapid PANRETIN PICATO TOPICAL GEL 0.015 % PICATO TOPICAL GEL 0.05 % podofilox podophyllum resin (Carac) (Fluorouracil) (Aldara) 4 5 2 1 1 1 1 1 4 2 2 2 2 4 5 5 5 4 4 4 2 2 2 (Isotretinoin) 2 (Mafenide Acetate) (Oxsoralen-Ultra) 2 5 5 3 3 2 2 (Soriatane) (Zovirax) (Aluminum Chloride) (Lac-Hydrin) (Dovonex) (Calcipotriene) (Calcipotriene) (Vectical) (Condylox) (Podophyllum Resin) QL (30 per 30 days) PA NSO PA NSO PA NSO PA NSO; QL (24 per 30 days) QL (3 per 56 days) QL (2 per 56 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 59 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name potassium hydroxide REGRANEX SANTYL silver nitrate applicators VALCHLOR VEREGEN ZOVIRAX TOPICAL CREAM Dermatological Antibacterials clindamycin phos-benzoyl perox clindamycin phosphate topical foam clindamycin phosphate topical gel clindamycin phosphate topical lotion clindamycin phosphate topical solution clindamycin phosphate topical swab clindamycin-benzoyl peroxide erythromycin base-ethanol Drug Tier (Potassium Hydroxide) (Silver Nitrate Applicator) (Duac) (Evoclin) (Cleocin T) (Cleocin T) (Cleocin T) (Cleocin T) (Duac) (Erythromycin Base/Ethanol) erythromycin with ethanol topical gel (Emgel) erythromycin with ethanol topical solution (Erythromycin Base/Ethanol) erythromycin with ethanol topical swab (Erythromycin Base/Ethanol) erythromycin-benzoyl peroxide (Benzamycin) gentamicin topical (Gentamicin Sulfate) metronidazole topical (Metrocream) metronidazole topical (Nydamax) metronidazole topical (Metrolotion) mupirocin (Centany) mupirocin calcium (Bactroban) neomycin-polymyxin b gu (Neosporin G.U. Irrigant) selenium sulfide (Selenium Sulfide) silver nitrate topical (Silver Nitrate) silver sulfadiazine topical cream 1 % (Silvadene) sulfacetamide sodium (acne) (Klaron) Dermatological Anti-Inflammatory Agents alclometasone topical cream (Aclovate) 1 4 4 1 5 4 3 Requirements/Limits PA; QL (30 per 30 days) QL (15 per 30 days) 2 2 1 1 1 1 2 1 1 1 1 1 1 2 2 2 1 1 1 1 1 1 2 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 60 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name alclometasone topical ointment (Alclometasone Dipropionate) betamethasone dipropionate topical cream (Diprosone) betamethasone dipropionate topical lotion (Betamethasone Dipropionate) betamethasone dipropionate topical (Betamethasone ointment Dipropionate) betamethasone valerate topical cream (Betamethasone Valerate) betamethasone valerate topical foam (Luxiq) betamethasone valerate topical lotion (Betamethasone Valerate) betamethasone valerate topical ointment (Betamethasone Valerate) betamethasone, augmented topical cream (Diprolene AF) betamethasone, augmented topical gel (Betamethasone Dipropionate) betamethasone, augmented topical lotion (Diprolene) betamethasone, augmented topical (Diprolene) ointment clobetasol propionate topical solution 0.05 (Clobetasol Propionate) % clobetasol topical cream (Temovate) clobetasol topical foam (Olux) clobetasol topical gel (Temovate) clobetasol topical lotion (Clobex) clobetasol topical ointment (Temovate) clobetasol topical shampoo (Clobex) clobetasol topical solution (Clobetasol Propionate) clobetasol-emollient topical (Temovate) clocortolone pivalate (Cloderm) CORDRAN TAPE LARGE ROLL CORDRAN TOPICAL CREAM CORDRAN TOPICAL LOTION CORDRAN TOPICAL OINTMENT desonide topical cream (Desowen) desonide topical lotion (Desowen) desonide topical ointment (Tridesilon) Drug Tier Requirements/Limits 1 2 2 2 1 2 1 1 2 2 2 2 2 1 2 1 2 1 2 1 1 2 4 4 4 4 1 2 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 61 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name desoximetasone diflorasone topical cream diflorasone topical ointment ELIDEL fluocinonide topical cream 0.05 % fluocinonide topical gel fluocinonide topical ointment fluocinonide topical solution fluocinonide-emollient base fluticasone topical cream fluticasone topical ointment halobetasol propionate hydrocortisone 1% ointment carton (otc) hydrocortisone acet-aloe vera topical gel Drug Tier (Topicort) (Psorcon) (Apexicon) (Vanos) (Fluocinonide) (Fluocinonide) (Fluocinonide) (Vanos) (Cutivate) (Fluticasone Propionate) (Ultravate) (Hydrocortisone) (Hydrocortisone Acetate/Aloe V) hydrocortisone acetate-urea (Hydrocortisone Acetate/Urea) hydrocortisone butyrate (Locoid) hydrocortisone butyr-emollient (Locoid) hydrocortisone rectal cream 1 % (Anusol-HC) hydrocortisone rectal cream 2.5 % (Hydrocortisone) hydrocortisone rectal enema 100 mg/60 ml (Cortenema) hydrocortisone topical cream 1 %, 2.5 % (Anusol-HC) hydrocortisone topical lotion 2 %, 2.5 % (Rederm) hydrocortisone topical ointment 1 %, 2.5 (Hydrocortisone) % hydrocortisone valerate topical cream (Hydrocortisone Valerate) hydrocortisone valerate topical ointment (Westcort) mometasone (Elocon) prednicarbate (Dermatop) tacrolimus topical (Protopic) triamcinolone acetonide topical cream (Triamcinolone Acetonide) triamcinolone acetonide topical lotion (Kenalog) triamcinolone acetonide topical ointment (Triderm) 0.025 %, 0.05 %, 0.1 %, 0.5 % 2 2 2 3 1 1 1 1 1 1 1 2 1 1 Requirements/Limits PA; AGE (Min 2 Years) 2 1 1 1 1 2 1 1 1 2 2 1 1 2 1 1 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 62 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name triderm topical cream Dermatological Retinoids adapalene topical cream adapalene topical gel 0.1 % TAZORAC TOPICAL CREAM tretinoin microspheres tretinoin topical cream tretinoin topical gel 0.01 %, 0.025 % Scabicides And Pediculicides EURAX malathion permethrin topical cream spinosad Drug Tier (Triamcinolone Acetonide) 1 (Differin) (Differin) (Retin-A Micro) (Retin-A) (Retin-A) 2 2 4 2 1 1 (Ovide) (Elimite) (Natroba) 3 2 2 2 Requirements/Limits PA PA PA Devices Devices ASSURE ID INSULIN SAFETY SYRINGE BD INSULIN PEN NEEDLE UF SHORT BD INSULIN SYRINGE ULTRA-FINE SYRINGE 0.3 ML 31 X 5/16", 1 ML 31 X 5/16", 1/2 ML 31 X 5/16" BD LUER-LOK SYRINGE SYRINGE 1 ML 20 X 1" INSULIN SYRINGE NEEDLELESS INSULIN SYRINGE SYRINGE INSULIN SYRINGE-NEEDLE U-100 SYRINGE PEN NEEDLE, DIABETIC NEEDLE 31 SURE COMFORT INS. SYR. U-100 1 1 1 1 1 1 1 1 1 Enzyme Replacement/Modifiers Enzyme Replacement/Modifiers ADAGEN ALDURAZYME CEREZYME INTRAVENOUS RECON SOLN 400 UNIT CIMZIA 5 5 5 5 PA You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 63 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name CIMZIA POWDER FOR RECONST CREON ELAPRASE ELITEK INTRAVENOUS RECON SOLN FABRAZYME INTRAVENOUS RECON SOLN KRYSTEXXA KUVAN LINZESS lipase-protease-amylase (Zenpep) LOTRONEX LUMIZYME MYOZYME NAGLAZYME ORFADIN PERTZYE PULMOZYME VIMIZIM VPRIV ZAVESCA ZENPEP Drug Tier 5 3 5 5 Requirements/Limits PA 5 5 5 3 2 5 5 5 5 5 4 5 5 5 5 3 QL (30 per 30 days) PA BvD PA QL (90 per 30 days) Eye, Ear, Nose, Throat Agents Eye, Ear, Nose, Throat Agents, Miscellaneous AKTEN (PF) altacaine (Tetcaine) apraclonidine (Iopidine) atropine ophthalmic drops (Isopto Atropine) atropine ophthalmic ointment (Atropine Sulfate) azelastine nasal (Astepro) azelastine ophthalmic (Optivar) BEPREVE carteolol (Carteolol HCl) cromolyn ophthalmic (Cromolyn Sodium) CYCLOGYL OPHTHALMIC DROPS 0.5 % cyclopentolate (Cyclogyl) 4 1 2 1 1 2 2 4 1 1 3 QL (30 per 25 days) ST 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 64 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name CYSTARAN epinastine homatropine hbr ipratropium bromide nasal spray,nonaerosol 0.03 % ipratropium bromide nasal spray,nonaerosol 0.06 % LACRISERT naphazoline olopatadine PATADAY PATANOL phenylephrine hcl ophthalmic proparacaine proparacaine hcl ophthalmic drops 0.5 % proparacaine-fluorescein sod Drug Tier Requirements/Limits (Elestat) (Isopto Homatropine) (Atrovent) 5 2 1 1 QL (30 per 28 days) (Atrovent) 1 QL (15 per 10 days) (Naphazoline HCl) (Patanase) (Mydfrin) (Proparacaine HCl) (Proparacaine HCl) (Proparacaine/Fluorescei n Sod) (Tetcaine) tetracaine hcl TYZINE NASAL DROPS 0.1 % TYZINE NASAL SPRAY,NONAEROSOL Eye, Ear, Nose, Throat Anti-Infectives Agents acetic acid otic (Acetic Acid) acetic acid-hydrocortisone (Vosol HC) bacitracin ophthalmic (Bacitracin) bacitracin-polymyxin b ophthalmic (Bacitracin/Polymyxin B Sulfate) BLEPHAMIDE BLEPHAMIDE S.O.P. CILOXAN OPHTHALMIC OINTMENT CIPRODEX ciprofloxacin hcl ophthalmic (Ciloxan) ciprofloxacin hcl otic (Cetraxal) COLY-MYCIN S CORTISPORIN-TC erythromycin ophthalmic (Ilotycin) gatifloxacin (Zymaxid) gentamicin ophthalmic (Garamycin) 3 1 2 3 3 1 1 1 1 QL (30.5 per 30 days) ST ST 1 4 4 1 2 2 1 3 3 4 3 1 2 4 3 1 2 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 65 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name gentamicin sulfate ophthalmic ointment 0.3 % (3 mg/gram) hydrocortisone-acetic acid levofloxacin ophthalmic MOXEZA NATACYN neomy sulf-bacitrac zn-poly-hc Drug Tier (Garamycin) 1 (Vosol HC) (Quixin) 2 2 3 3 1 (Neomycin Su/Baci Zn/Poly/HC) neomycin-bacitracin-poly-hc (Neomycin Su/Baci Zn/Poly/HC) neomycin-bacitracin-polymyxin (Neomycin Su/Bacitra/Polymyxin) neomycin-polymyxin b-dexameth (Maxitrol) neomycin-polymyxin-gramicidin (Neosporin) neomycin-polymyxin-hc (Oticin HC) ofloxacin ophthalmic (Ocuflox) ofloxacin otic (Ocuflox) polymyxin b sulf-trimethoprim (Polytrim) sulfacetamide sodium (Sulfacetamide Sodium) sulfacetamide sodium ophthalmic drops 10 (Sulfacetamide Sodium) % sulfacetamide-prednisolone (Sulfacetamide/Predniso lone Sp) TOBRADEX OPHTHALMIC OINTMENT TOBRADEX ST tobramycin (Tobrex) trifluridine (Viroptic) VIGAMOX ZIRGAN ZYLET Eye, Ear, Nose, Throat Anti-Inflammatory Agents ALREX bromfenac (Bromfenac Sodium) dexamethasone sodium phosphate (Dexasol) ophthalmic diclofenac sodium ophthalmic (Diclofenac Sodium) DUREZOL Requirements/Limits 1 1 1 1 1 1 1 1 1 1 1 4 3 1 2 3 4 3 3 2 1 1 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 66 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name fluorometholone flurbiprofen sodium fluticasone nasal ILEVRO ketorolac ophthalmic LOTEMAX NASONEX NEVANAC prednisolone acetate prednisolone sodium phosphate ophthalmic PROLENSA QNASL NASAL HFA AEROSOL INHALER 40 MCG/ACTUATION QNASL NASAL HFA AEROSOL INHALER 80 MCG/ACTUATION RESTASIS triamcinolone acetonide nasal Drug Tier (FML) (Ocufen) (Flonase) (Acular) (Omnipred) (Prednisolone Sod Phosphate) (Nasacort Aq) 1 1 1 3 1 3 4 3 2 1 Requirements/Limits QL (16 per 30 days) QL (34 per 28 days) 3 3 QL (9.8 per 28 days) 3 QL (8.7 per 28 days) 3 2 QL (60 per 30 days) QL (16.5 per 30 days) Gastrointestinal Agents Antiulcer Agents And Acid Suppressants amoxicil-clarithromy-lansopraz (Prevpac) CARAFATE ORAL SUSPENSION cimetidine (Tagamet) cimetidine hcl oral (Cimetidine HCl) DEXILANT esomeprazole sodium (Nexium I.V.) famotidine (pf) (Famotidine/PF) famotidine (pf)-nacl (iso-os) (Famotidine In Nacl,IsoOsm/PF) famotidine oral suspension (Pepcid) famotidine oral tablet 20 mg, 40 mg (Pepcid) lansoprazole oral capsule,delayed (Prevacid) release(dr/ec) misoprostol (Cytotec) nizatidine oral capsule (Axid) nizatidine oral solution (Nizatidine) 2 3 1 1 3 1 1 1 2 1 2 (Rx Product Only) ST (Rx Product Only) (Rx Product Only) (Rx Product Only) 2 1 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 67 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name omeprazole oral capsule,delayed release(dr/ec) pantoprazole intravenous pantoprazole oral ranitidine hcl injection ranitidine hcl oral capsule ranitidine hcl oral syrup ranitidine hcl oral tablet 150 mg, 300 mg sucralfate oral suspension sucralfate oral tablet Gastrointestinal Agents, Other AMITIZA BUPHENYL ORAL TABLET CHOLBAM cromolyn oral dicyclomine oral capsule dicyclomine oral solution dicyclomine oral tablet diphenoxylate-atropine oral liquid diphenoxylate-atropine oral tablet glycopyrrolate glycopyrrolate lactulose oral solution loperamide oral methscopolamine oral metoclopramide hcl injection metoclopramide hcl oral metoclopramide hcl oral MOVANTIK NUTRESTORE RELISTOR SUBCUTANEOUS RELISTOR SUBCUTANEOUS ursodiol oral capsule ursodiol oral tablet Laxatives MOVIPREP Drug Tier (Prilosec) 1 (Pantoprazole Sodium) (Protonix) (Zantac) (Ranitidine HCl) (Ranitidine HCl) (Zantac) (Sucralfate) (Carafate) 1 1 1 1 1 1 2 1 (Gastrocrom) (Bentyl) (Dicyclomine HCl) (Bentyl) (Diphenoxylate HCl/Atropine) (Lomotil) (Robinul) (Robinul) (Lactulose) (Loperamide HCl) (Pamine) (Reglan) (Metoclopramide HCl) (Reglan) (Actigall) (Urso) 3 5 5 5 1 1 1 1 1 1 2 1 1 1 1 1 1 3 4 4 4 2 2 Requirements/Limits (Rx Product Only) (Rx Product Only) (Rx Product Only) (Rx Product Only) QL (60 per 30 days) QL (30 per 30 days) PA; QL (28 per 28 days) PA; QL (28 per 28 days) 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 68 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name peg 3350-electrolytes PEG 3350-GRX peg 3350-na sulf,bicarb,cl-kcl peg-electrolyte soln polyethylene glycol 3350 oral PREPOPIK sodium chloride-nahco3-kcl-peg oral recon soln 420 gram Phosphate Binders AURYXIA calcium acetate oral capsule calcium acetate oral tablet 667 mg calcium carbonate-mag carb-fa Drug Tier (Golytely) (Golytely) (Nulytely with Flavor Packs) (Gavilyte-N) (Nulytely with Flavor Packs) (Phoslo) (Calcium Acetate) (Calcium Carbonate/Mag Carb/Fa) FOSRENOL PHOSLYRA RENAGEL RENVELA sodium polystyrene sulfonate oral powder (Sodium Polystyrene Sulfonate) sodium polystyrene sulfonate oral (Sodium Polystyrene suspension 15 gram/60 ml Sulfonate) sodium polystyrene sulfonate rectal enema (Sodium Polystyrene 30 gram/120 ml Sulfonate) VELPHORO Requirements/Limits 1 1 1 1 1 4 1 4 2 2 1 4 4 3 3 1 1 1 4 Genitourinary Agents Antispasmodics, Urinary flavoxate MYRBETRIQ oxybutynin chloride oral tablet oxybutynin chloride oral tablet extended release 24hr tolterodine oral capsule,extended release 24hr tolterodine oral tablet TOVIAZ (Flavoxate HCl) (Oxybutynin Chloride) (Ditropan XL) 2 3 1 2 (Detrol LA) 2 (Detrol) 2 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 69 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name trospium oral capsule,extended release (Sanctura XR) 24hr trospium oral tablet (Sanctura) VESICARE Genitourinary Agents, Miscellaneous alfuzosin (Uroxatral) tamsulosin (Flomax) terazosin (Terazosin HCl) Drug Tier Requirements/Limits 2 2 3 2 1 1 Heavy Metal Antagonists Heavy Metal Antagonists deferoxamine injection recon soln (Desferal) DEPEN TITRATABS EXJADE ORAL TABLET, DISPERSIBLE 125 MG EXJADE ORAL TABLET, DISPERSIBLE 250 MG, 500 MG FERRIPROX JADENU sodium thiosulfate intravenous solution 1 (Sodium Thiosulfate) gram/10 ml (100 mg/ml), 12.5 gram/50 ml (250 mg/ml) SYPRINE 1 4 4 PA BvD 5 5 5 2 5 Hormonal Agents, Stimulant/Replacement/Modifying Androgens ANADROL-50 ANDRODERM ANDROGEL TRANSDERMAL GEL IN METERED-DOSE PUMP 1.25 GRAM/ ACTUATION (1 %) ANDROGEL TRANSDERMAL GEL IN METERED-DOSE PUMP 20.25 MG/1.25 GRAM (1.62 %) ANDROGEL TRANSDERMAL GEL IN PACKET 1 % (25 MG/2.5GRAM), 1 % (50 MG/5 GRAM) ANDROGEL TRANSDERMAL GEL IN PACKET 1.62 % (20.25 MG/1.25 GRAM), 1.62 % (40.5 MG/2.5 GRAM) 5 3 3 PA; QL (30 per 30 days) PA; QL (300 per 30 days) 3 PA; QL (150 per 30 days) 3 PA; QL (300 per 30 days) 3 PA; QL (150 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 70 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier AXIRON danazol oral fluoxymesterone oxandrolone testosterone cypionate testosterone enanthate testosterone transdermal gel in packet 1 % (25 mg/2.5gram) Estrogens And Antiestrogens COMBIPATCH 3 (Danazol) (Fluoxymesterone) (Oxandrin) (Depo-Testosterone) (Delatestryl) (Androgel) 2 2 2 2 2 2 3 DUAVEE ESTRACE VAGINAL estradiol oral estradiol transdermal patch semiweekly (Estrace) (Vivelle-Dot) 3 3 1 2 estradiol transdermal patch weekly (Climara) 2 estradiol valerate estradiol/norethindrone acet estradiol-norethindrone acet ESTRASORB (Delestrogen) (Activella) (Activella) 2 2 2 4 ESTRING estropipate (Ogen) FEMRING MENEST norethindrone ac-eth estradiol oral tablet (Femhrt) 1-5 mg-mcg PREMARIN INJECTION PREMARIN ORAL PREMARIN VAGINAL PREMPHASE PREMPRO raloxifene (Evista) VAGIFEM Glucocorticoids/Mineralocorticoids 4 1 4 4 2 3 3 3 3 3 2 3 Requirements/Limits PA; QL (180 per 28 days) PA PA; QL (5 per 28 days) PA; QL (150 per 30 days) PA-HRM; QL (8 per 28 days) PA-HRM PA-HRM PA-HRM; QL (8 per 28 days) PA-HRM; QL (4 per 28 days) PA-HRM PA-HRM PA-HRM; QL (97.44 per 28 days) QL (1 per 84 days) PA-HRM QL (1 per 84 days) PA-HRM PA-HRM PA-HRM PA-HRM PA-HRM QL (18 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 71 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name betamethasone acet,sod phos cortisone dexamethasone oral dexamethasone oral dexamethasone sodium phosphate injection fludrocortisone hydrocortisone oral hydrocortisone sod succinate methylprednisolone methylprednisolone acetate methylprednisolone sodium succ injection recon soln 125 mg, 40 mg methylprednisolone sodium succ intravenous prednisolone sodium phosphate oral solution PREDNISONE INTENSOL prednisone SOLU-CORTEF (PF) INJECTION RECON SOLN triamcinolone acetonide injection Pituitary desmopressin injection desmopressin nasal desmopressin nasal desmopressin oral GENOTROPIN GENOTROPIN MINIQUICK SUBCUTANEOUS SYRINGE 0.2 MG/0.25 ML Drug Tier (Celestone) (Cortisone Acetate) (Dexamethasone) (Dexamethasone) (Dexamethasone Sod Phosphate) (Fludrocortisone Acetate) (Cortef) (Hydrocortisone Sod Succinate) (Medrol) (Depo-Medrol) (A-Methapred) 1 1 1 1 1 Requirements/Limits PA BvD PA BvD PA BvD PA BvD PA BvD 1 1 1 PA BvD PA BvD 1 1 1 PA BvD PA BvD PA BvD (A-Methapred) 1 PA BvD (Orapred) 1 PA BvD (Prednisone) 3 1 4 PA BvD PA BvD PA BvD (Triamcinolone Acetonide) 1 (Desmopressin Acetate) (DDAVP) (Desmopressin Acetate) (DDAVP) 2 2 2 2 5 4 QL (15 per 30 days) QL (15 per 30 days) PA PA You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 72 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name GENOTROPIN MINIQUICK SUBCUTANEOUS SYRINGE 0.4 MG/0.25 ML, 0.6 MG/0.25 ML, 0.8 MG/0.25 ML, 1 MG/0.25 ML, 1.2 MG/0.25 ML, 1.4 MG/0.25 ML, 1.6 MG/0.25 ML, 1.8 MG/0.25 ML, 2 MG/0.25 ML HUMATROPE INCRELEX NORDITROPIN FLEXPRO NUTROPIN NUTROPIN AQ NUSPIN NUTROPIN AQ SUBCUTANEOUS octreotide acetate injection solution 1,000 mcg/ml octreotide acetate injection solution 100 mcg/ml, 200 mcg/ml, 500 mcg/ml octreotide acetate injection solution 50 mcg/ml octreotide acetate injection syringe OMNITROPE SUBCUTANEOUS CARTRIDGE 10 MG/1.5 ML (6.7 MG/ML) OMNITROPE SUBCUTANEOUS CARTRIDGE 5 MG/1.5 ML (3.3 MG/ML) OMNITROPE SUBCUTANEOUS RECON SOLN PREGNYL SAIZEN SAIZEN CLICK.EASY SANDOSTATIN LAR DEPOT INTRAMUSCULAR KIT SEROSTIM SUBCUTANEOUS RECON SOLN 4 MG, 5 MG, 6 MG SOMATULINE DEPOT SOMAVERT STIMATE SUPPRELIN LA Drug Tier Requirements/Limits 5 PA PA (Sandostatin) 5 5 5 5 5 5 5 (Sandostatin) 2 (Octreotide Acetate) 2 (Octreotide Acetate) 2 4 PA 5 PA 5 PA 4 5 5 5 PA PA 5 PA 5 5 4 5 QL (1 per 28 days) PA PA PA PA QL (1 per 360 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 73 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name TEV-TROPIN vasopressin ZOMACTON Progestins DEPO-PROVERA INTRAMUSCULAR SOLUTION medroxyprogesterone intramuscular suspension medroxyprogesterone intramuscular syringe medroxyprogesterone oral norethindrone acetate progesterone progesterone micronized capsules Thyroid And Antithyroid Agents levothyroxine intravenous levothyroxine oral liothyronine intravenous liothyronine oral methimazole oral tablet 10 mg, 5 mg propylthiouracil Drug Tier Requirements/Limits 4 1 5 PA 4 QL (10 per 28 days) (Depo-Provera) 1 QL (1 per 84 days) (Medroxyprogesterone Acetate) (Provera) (Aygestin) (Progesterone) (Prometrium) 1 QL (1 per 84 days) (Levothyroxine Sodium) (Levoxyl) (Triostat) (Cytomel) (Tapazole) (Propylthiouracil) 2 1 2 2 1 1 (Pitressin) PA 1 1 1 2 Immunological Agents Immunological Agents ARCALYST ASTAGRAF XL AUBAGIO azathioprine azathioprine sodium CARIMUNE NF NANOFILTERED INTRAVENOUS RECON SOLN CELLCEPT INTRAVENOUS cyclosporine intravenous cyclosporine modified cyclosporine oral capsule cyclosporine, modified ENBREL ENBREL SURECLICK (Imuran) (Azathioprine Sodium) (Sandimmune) (Neoral) (Sandimmune) (Neoral) 5 4 5 1 1 5 PA BvD PA; QL (28 per 28 days) PA BvD PA BvD PA BvD 4 2 2 2 2 5 5 PA BvD PA BvD PA BvD PA BvD PA BvD PA PA You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 74 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier FLEBOGAMMA DIF GAMASTAN S/D GAMMAGARD LIQUID GAMMAPLEX GAMUNEX-C INJECTION SOLUTION HUMIRA HUMIRA PEN HUMIRA PEN CROHN'S-UC-HS START HYPERRAB S/D (PF) HYQVIA ILARIS (PF) IMOGAM RABIES-HT (PF) KINERET leflunomide mycophenolate mofetil oral capsule mycophenolate mofetil oral suspension for reconstitution mycophenolate mofetil oral tablet mycophenolate sodium NULOJIX OCTAGAM ORENCIA ORENCIA (WITH MALTOSE) PRIVIGEN PROGRAF INTRAVENOUS RAPAMUNE ORAL SOLUTION RAPAMUNE ORAL TABLET 1 MG, 2 MG RIDAURA sirolimus oral tablet 0.5 mg, 1 mg sirolimus oral tablet 2 mg tacrolimus oral TYSABRI ZORTRESS ORAL TABLET 0.25 MG 5 3 5 5 5 5 5 5 4 5 5 4 5 Requirements/Limits PA BvD PA BvD PA BvD PA BvD PA BvD PA PA PA PA BvD PA PA; QL (18.76 per 28 days) (Arava) (Cellcept) (Cellcept) 1 2 5 PA BvD PA BvD (Cellcept) (Myfortic) 2 2 5 5 5 5 5 4 5 5 PA BvD PA BvD PA BvD PA BvD PA; QL (4 per 28 days) PA PA BvD PA BvD PA BvD PA BvD (Rapamune) (Rapamune) (Hecoria) 5 2 5 2 5 4 PA BvD PA BvD PA BvD PA; LA; QL (15 per 28 days) PA BvD; QL (120 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 75 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name ZORTRESS ORAL TABLET 0.5 MG, 0.75 MG Vaccines ACTHIB (PF) ADACEL(TDAP ADOLESN/ADULT)(PF) BCG VACCINE, LIVE (PF) BEXSERO (PF) BOOSTRIX TDAP CERVARIX VACCINE (PF) COMVAX (PF) DAPTACEL (DTAP PEDIATRIC) (PF) ENGERIX-B (PF) ENGERIX-B PEDIATRIC (PF) GARDASIL (PF) GARDASIL 9 (PF) HAVRIX (PF) INTRAMUSCULAR SUSPENSION HAVRIX (PF) INTRAMUSCULAR SYRINGE IMOVAX RABIES VACCINE (PF) INFANRIX (DTAP) (PF) INTRAMUSCULAR IPOL INJECTION SUSPENSION IXIARO (PF) KINRIX (PF) MENACTRA (PF) INTRAMUSCULAR SOLUTION MENHIBRIX (PF) MENOMUNE - A/C/Y/W-135 (PF) MENVEO A-C-Y-W-135-DIP (PF) MENVEO MENA COMPONENT (PF) MENVEO MENCYW-135 COMPNT (PF) M-M-R II (PF) PEDIARIX (PF) PEDVAX HIB (PF) PENTACEL (PF) Drug Tier Requirements/Limits 5 PA BvD; QL (120 per 30 days) 3 3 3 3 3 3 3 3 3 3 3 3 3 PA BvD PA BvD PA BvD 3 3 3 PA BvD 3 3 3 3 3 3 3 3 3 3 3 3 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 76 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier PENTACEL ACTHIB COMPONENT (PF) PROQUAD (PF) QUADRACEL (PF) RABAVERT (PF) RECOMBIVAX HB (PF) ROTARIX ROTATEQ VACCINE TENIVAC (PF) INTRAMUSCULAR TETANUS TOXOID,ADSORBED (PF) TETANUS,DIPHTHERIA TOX PED(PF) TETANUS-DIPHTHERIA TOXOIDS-TD TICE BCG TRUMENBA TWINRIX (PF) TYPHIM VI VAQTA (PF) VARIVAX (PF) YF-VAX (PF) ZOSTAVAX (PF) Requirements/Limits 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 PA BvD PA BvD PA BvD PA BvD QL (1 per 365 days) Inflammatory Bowel Disease Agents Inflammatory Bowel Disease Agents alosetron (Alosetron HCl) APRISO ASACOL HD balsalazide (Colazal) budesonide oral (Entocort EC) DELZICOL DIPENTUM 5 3 3 2 5 3 4 ST Irrigating Solutions Irrigating Solutions acetic acid irrigation GLYCINE IRRIGATION LACTATED RINGERS IRRIGATION ringers irrigation sodium chloride irrigation (Acetic Acid) (Tis-U-Sol) (Sodium Chloride Irrig Solution) 1 1 3 1 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 77 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name sorbitol irrigation sorbitol-mannitol water for irrigation, sterile Drug Tier (Sorbitol Solution) (Mannitol/Sorbitol Solution) (Water For Irrigation,Sterile) Requirements/Limits 1 1 1 Metabolic Bone Disease Agents Metabolic Bone Disease Agents ACTONEL ORAL TABLET 35 MG alendronate oral solution alendronate oral tablet 10 mg, 40 mg, 5 mg alendronate oral tablet 35 mg, 70 mg calcitonin (salmon) calcitriol intravenous solution 1 mcg/ml (Alendronate Sodium) (Fosamax) 3 2 1 QL (4 per 28 days) QL (300 per 28 days) (Fosamax) (Miacalcin) (Calcitriol) 1 2 1 calcitriol oral capsule (Rocaltrol) 1 calcitriol oral solution (Rocaltrol) 2 doxercalciferol intravenous (Doxercalciferol) 1 doxercalciferol oral (Hectorol) 2 QL (4 per 28 days) QL (3.7 per 28 days) PA BvD; (PA for ESRD Only) PA BvD; (PA for ESRD Only) PA BvD; (PA for ESRD Only) PA BvD; (PA for ESRD Only) PA BvD; (PA for ESRD Only) etidronate disodium FORTEO FORTICAL ibandronate intravenous solution (Etidronate Disodium) (Ibandronate Sodium) 2 4 4 2 ibandronate intravenous syringe (Boniva) 2 ibandronate oral MIACALCIN INJECTION (Boniva) 2 3 NATPARA pamidronate intravenous (Pamidronate Disodium) 5 1 QL (2.4 per 28 days) QL (3.7 per 28 days) PA BvD; (PA for ESRD Only); QL (3 per 84 days) PA BvD; QL (3 per 84 days) QL (1 per 28 days) PA BvD; (PA for ESRD Only) PA; QL (2 per 28 days) PA BvD; (PA for ESRD Only) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 78 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name paricalcitol oral PROLIA risedronate oral tablet 150 mg risedronate oral tablet 30 mg, 5 mg risedronate oral tablet 35 mg, 35 mg (12 pack) XGEVA ZEMPLAR INTRAVENOUS zoledronic acid intravenous zoledronic acid-mannitol-water intravenous piggyback zoledronic acid-mannitol-water intravenous solution ZOMETA INTRAVENOUS SOLUTION 4 MG/100 ML Drug Tier Requirements/Limits (Zemplar) 2 (Actonel) (Actonel) (Actonel) 3 2 2 2 PA BvD; (PA for ESRD Only) QL (1 per 180 days) QL (1 per 28 days) QL (30 per 30 days) QL (4 per 28 days) 5 3 (Zometa) (Zoledronic Acid/Mannitol and Water) (Reclast) PA; QL (1.7 per 28 days) PA BvD; (PA for ESRD Only) 2 2 2 QL (100 per 300 days) 5 Miscellaneous Therapeutic Agents Miscellaneous Therapeutic Agents ACTEMRA INTRAVENOUS ACTEMRA SUBCUTANEOUS ACTIMMUNE allopurinol (Zyloprim) allopurinol sodium (Allopurinol Sodium) amifostine crystalline (Amifostine Crystalline) ammonium chloride (Ammonium Chloride) anticoag citrate phos dextrose (Citrate Phosphate Dextros Soln) AVODART AVONEX (WITH ALBUMIN) AVONEX INTRAMUSCULAR AVONEX INTRAMUSCULAR BENLYSTA INTRAVENOUS RECON SOLN BETASERON SUBCUTANEOUS bethanechol chloride (Urecholine) 5 5 5 1 2 1 1 1 3 5 5 5 5 5 2 PA; QL (40 per 30 days) PA; QL (3.6 per 28 days) ST ST ST PA ST You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 79 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name BOTOX INJECTION RECON SOLN 100 UNIT BOTOX INJECTION RECON SOLN 200 UNIT buspirone CERDELGA colchicine oral tablet colchicine-probenecid COLCRYS COPAXONE SUBCUTANEOUS SYRINGE CURITY GAUZE TOPICAL BANDAGE 2X2" CYSTADANE dexrazoxane hcl intravenous recon soln droperidol injection solution DYSPORT ELMIRON ergoloid EXTAVIA SUBCUTANEOUS finasteride oral tablet 5 mg fomepizole FUSILEV GILENYA GLUCAGEN HYPOKIT GLUCAGON EMERGENCY KIT (HUMAN) guanidine hydroxyzine hcl intramuscular hydroxyzine hcl oral solution 10 mg/5 ml hydroxyzine hcl oral tablet hydroxyzine pamoate JALYN LEMTRADA leucovorin calcium injection recon soln 100 mg, 200 mg, 350 mg leucovorin calcium oral Drug Tier (Buspirone HCl) (Colcrys) (Colchicine/Probenecid) Requirements/Limits 4 PA; QL (4 per 90 days) 4 PA; QL (1 per 90 days) 1 5 2 1 3 5 PA 1 (Totect) (Droperidol) (Ergoloid Mesylates) (Proscar) (Fomepizole) 5 1 1 3 4 2 5 1 5 5 5 3 4 (Guanidine HCl) (Hydroxyzine HCl) (Hydroxyzine HCl) (Hydroxyzine HCl) (Vistaril) 1 1 1 1 1 3 5 (Leucovorin Calcium) 1 (Leucovorin Calcium) 1 PA ST PA; QL (28 per 28 days) PA-HRM PA-HRM PA-HRM PA-HRM QL (30 per 30 days) PA; QL (9.6 per 365 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 80 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits 2 levocarnitine intravenous (Levocarnitine (With Sugar)) (Carnitor) levocarnitine oral (Carnitor) 2 PA BvD; (PA for ESRD Only) PA BvD; (PA for ESRD Only) PA BvD; (PA for ESRD Only) levoleucovorin calcium (Levoleucovorin Calcium) (Mesnex) 5 levocarnitine (with sugar) mesna MESNEX ORAL MESTINON ORAL SYRUP methylergonovine injection methylergonovine oral morrhuate sodium MYOBLOC INTRAMUSCULAR SOLUTION NPLATE SUBCUTANEOUS RECON SOLN OTEZLA OTEZLA STARTER PLEGRIDY probenecid PROCYSBI pyridostigmine bromide REBIF (WITH ALBUMIN) REBIF REBIDOSE REBIF TITRATION PACK REMICADE SENSIPAR ORAL TABLET 30 MG SENSIPAR ORAL TABLET 60 MG, 90 MG SIMPONI ARIA SIMPONI SUBCUTANEOUS PEN INJECTOR 100 MG/ML SIMPONI SUBCUTANEOUS PEN INJECTOR 50 MG/0.5 ML (Methylergonovine Maleate) (Methylergonovine Maleate) (Sodium Morrhuate) (Probenecid) (Mestinon) 2 1 5 4 1 2 1 4 QL (1 per 90 days) 5 PA; QL (8 per 28 days) 5 5 5 1 5 2 5 5 5 5 3 5 PA; QL (60 per 30 days) PA; QL (60 per 30 days) ST 5 5 PA; QL (12 per 28 days) PA; QL (3 per 28 days) 5 PA; QL (0.5 per 28 days) PA You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 81 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits SIMPONI SUBCUTANEOUS SYRINGE 100 MG/ML SIMPONI SUBCUTANEOUS SYRINGE 50 MG/0.5 ML SOLIRIS STELARA SUBCUTANEOUS SYRINGE STERILE PADS TOPICAL BANDAGE 2 X2" SYNAREL TECFIDERA ORAL CAPSULE,DELAYED RELEASE(DR/EC) 120 MG TECFIDERA ORAL CAPSULE,DELAYED RELEASE(DR/EC) 120 MG (14)- 240 MG (46), 240 MG THALOMID 5 PA; QL (3 per 28 days) 5 PA; QL (0.5 per 28 days) 5 5 PA TYBOST ULORIC XELJANZ 4 3 5 1 5 5 PA; QL (14 per 30 days) 5 PA; QL (60 per 30 days) 5 PA NSO; QL (60 per 30 days) QL (30 per 30 days) ST; QL (30 per 30 days) PA; QL (60 per 30 days) Ophthalmic Agents Antiglaucoma Agents acetazolamide oral capsule, extended release acetazolamide oral tablet acetazolamide sodium ALPHAGAN P OPHTHALMIC DROPS 0.1 % AZOPT betaxolol ophthalmic BETOPTIC S bimatoprost brimonidine COMBIGAN dorzolamide dorzolamide-timolol (Diamox Sequels) 2 (Acetazolamide) (Acetazolamide Sodium) 1 1 3 (Betaxolol HCl) (Bimatoprost) (Alphagan P) (Trusopt) (Cosopt) 3 2 4 2 2 3 1 1 (drops: 0.15%, 0.20%) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 82 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name latanoprost levobunolol LUMIGAN OPHTHALMIC DROPS 0.01 % methazolamide oral metipranolol PHOSPHOLINE IODIDE pilocarpine hcl ophthalmic drops 1 %, 2 %, 4 % SIMBRINZA timolol maleate ophthalmic drops timolol maleate ophthalmic gel forming solution TRAVATAN Z travoprost (benzalkonium) Drug Tier (Xalatan) (Betagan) (Neptazane) (Metipranolol) 1 1 3 (Isopto Carpine) 2 1 3 1 (Timoptic) (Timoptic-Xe) 3 1 1 (Travoprost (Benzalkonium)) ZIOPTAN (PF) Requirements/Limits QL (2.5 per 25 days) 3 2 QL (2.5 per 25 days) QL (2.5 per 25 days) 4 QL (30 per 30 days) Replacement Preparations Replacement Preparations calcium chloride intravenous calcium gluconate intravenous citric acid-sodium citrate electrolyte-48 in d5w HYPERLYTE CR IONOSOL-B IN D5W IONOSOL-MB IN D5W ISOLYTE M IN 5 % DEXTROSE ISOLYTE-H IN 5 % DEXTROSE ISOLYTE-P IN 5 % DEXTROSE ISOLYTE-S KLOR-CON klor-con 10 KLOR-CON 8 klor-con m10 klor-con m15 (Calcium Chloride) (Calcium Gluconate) 1 1 (Citric Acid/Sodium Citrate) (Electrolyte-48 Solution/D5W) 1 (Potassium Chloride) (Potassium Chloride) (Potassium Chloride) PA BvD; (PA for ESRD Only) 1 4 4 4 4 4 4 4 1 1 1 1 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 83 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name klor-con m20 klor-con sprinkle KLOR-CON/EF magnesium chloride injection magnesium sulf in 0.45% nacl magnesium sulfate in d5w intravenous piggyback 1 gram/100 ml, 4 gram/100 ml magnesium sulfate in water intravenous piggyback 4 gram/100 ml (4 %), 4 gram/50 ml (8 %) magnesium sulfate injection NORMOSOL-M IN 5 % DEXTROSE NORMOSOL-R NORMOSOL-R PH 7.4 NUTRILYTE NUTRILYTE II phosphorus #1 PLASMA-LYTE 148 PLASMA-LYTE A PLASMA-LYTE-56 IN 5 % DEXTROSE potassium acetate intravenous potassium bicarb and chloride potassium bicarb-citric acid potassium bicarbonate-cit ac oral tablet, effervescent 25 meq potassium chlorid-d5-0.45%nacl potassium chloride in 0.9%nacl intravenous parenteral solution 20 meq/l, 40 meq/l potassium chloride in 5 % dex intravenous parenteral solution 20 meq/l, 30 meq/l, 40 meq/l potassium chloride intravenous potassium chloride oral capsule, extended release Drug Tier (Potassium Chloride) (Micro-K) (Magnesium Chloride) (Magnesium Sulf In 0.45% NaCl) (Magnesium Sulfate/D5W) (Magnesium Sulfate in Water) (Magnesium Sulfate) (K-Phos Neutral) (Potassium Acetate) (Pot Chloride/Pot Bicarb/Cit Ac) (Klor-Con-Ef) (Klor-Con-Ef) Requirements/Limits 1 2 1 1 1 1 1 1 4 4 4 4 4 1 4 4 4 1 1 1 1 (Potassium Chloride/D50.45nacl) (Potassium Chloride In 0.9%NaCl) 1 (Potassium Chloride In D5w) 1 (Potassium Chloride) (Micro-K) 1 2 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 84 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name potassium chloride oral liquid potassium chloride oral packet potassium chloride oral tablet extended release potassium chloride oral tablet,er particles/crystals 10 meq potassium chloride oral tablet,er particles/crystals 20 meq potassium chloride-0.45 % nacl potassium chloride-d5-0.2%nacl potassium chloride-d5-0.3%nacl intravenous parenteral solution 20 meq/l potassium chloride-d5-0.9%nacl potassium citrate-citric acid oral packet 3,300-1,002 mg potassium citrate-citric acid oral solution 1,100-334 mg/5 ml potassium phosphate m-/d-basic ringers intravenous sodium acetate intravenous sodium bicarbonate intravenous sodium chloride 0.45 % intravenous sodium chloride 0.9 % injection solution sodium chloride 0.9 % intravenous sodium chloride 3 % sodium chloride 5 % sodium chloride intravenous sodium citrate-citric acid sodium lactate intravenous sodium phosphate Drug Tier (Kaochlor) (Klor-Con) (Klor-Con 8) 1 1 1 (Klor-Con 8) 1 (Potassium Chloride) 1 (Potassium Chloride0.45% NaCl) (Potassium Chloride/D50.2%NaCl) (Potassium Chloride/D50.3%NaCl) (Potassium Chloride/D50.9%NaCl) (Potassium Citrate/Citric Acid) (Potassium Citrate/Citric Acid) (Potassium Phos,MBasic-D-Basic) (Ringers Solution) (Sodium Acetate) (Sodium Bicarbonate) (Sodium Chloride 0.45 %) (0.9 % Sodium Chloride) (0.9 % Sodium Chloride) (Sodium Chloride 3 %) (Sodium Chloride 5 %) (Sodium Chloride) (Citric Acid/Sodium Citrate) (Sodium Lactate) (Sodium Phos,M-BasicD-Basic) 1 Requirements/Limits 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 85 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name sod-pot-k cit-sod cit-cit acid Drug Tier (Sod/Pot/K Cit/Sod Cit/Cit Acid) TPN ELECTROLYTES TPN ELECTROLYTES II Requirements/Limits 1 4 4 Respiratory Tract Agents Anti-Inflammatories, Inhaled Corticosteroids ADVAIR DISKUS ADVAIR HFA BREO ELLIPTA DULERA FLOVENT DISKUS INHALATION BLISTER WITH DEVICE 100 MCG/ACTUATION, 50 MCG/ACTUATION FLOVENT DISKUS INHALATION BLISTER WITH DEVICE 250 MCG/ACTUATION FLOVENT HFA INHALATION HFA AEROSOL INHALER 110 MCG/ACTUATION FLOVENT HFA INHALATION HFA AEROSOL INHALER 220 MCG/ACTUATION FLOVENT HFA INHALATION HFA AEROSOL INHALER 44 MCG/ACTUATION QVAR Antileukotrienes montelukast (Singulair) zafirlukast (Accolate) Bronchodilators albuterol sulfate inhalation solution for (Albuterol Sulfate) nebulization albuterol sulfate oral syrup (Albuterol Sulfate) albuterol sulfate oral tablet (Albuterol Sulfate) albuterol sulfate oral tablet extended (Vospire ER) release 12 hr ANORO ELLIPTA 3 3 3 3 3 QL (60 per 30 days) QL (12 per 28 days) QL (60 per 30 days) QL (13 per 28 days) QL (60 per 30 days) 3 QL (120 per 30 days) 3 QL (12 per 28 days) 3 QL (24 per 28 days) 3 QL (21.2 per 28 days) 3 QL (17.4 per 25 days) 1 2 1 PA BvD 1 1 2 3 QL (60 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 86 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name ATROVENT HFA COMBIVENT RESPIMAT FORADIL AEROLIZER metaproterenol oral PROAIR HFA PROAIR RESPICLICK SEREVENT DISKUS SPIRIVA RESPIMAT INHALATION MIST 2.5 MCG/ACTUATION SPIRIVA WITH HANDIHALER STIOLTO RESPIMAT STRIVERDI RESPIMAT terbutaline oral terbutaline subcutaneous theophylline anhydrous oral elixir 80 mg/15 ml theophylline anhydrous oral tablet extended release 12 hr 100 mg, 200 mg, 300 mg theophylline in dextrose 5 % intravenous parenteral solution 200 mg/100 ml, 200 mg/50 ml, 400 mg/250 ml, 400 mg/500 ml, 800 mg/250 ml theophylline oral theophylline oral theophylline oral Drug Tier (Metaproterenol Sulfate) (Terbutaline Sulfate) (Terbutaline Sulfate) (Theophylline Anhydrous) (Theophylline Anhydrous) 3 3 3 1 3 3 3 3 QL (25.8 per 28 days) QL (8 per 30 days) QL (62 per 30 days) 3 3 3 1 1 1 QL (30 per 30 days) QL (4 per 28 days) QL (4 per 28 days) QL (17 per 25 days) QL (2 per 25 days) QL (60 per 30 days) QL (4 per 30 days) 1 (Theophylline/D5W) 1 (Theophylline Anhydrous) (Theophylline Anhydrous) (Theophylline Anhydrous) 1 TUDORZA PRESSAIR VENTOLIN HFA Respiratory Tract Agents, Other acetylcysteine (Acetadote) acetylcysteine (Acetadote) ARALAST NP cromolyn inhalation (Cromolyn Sodium) DALIRESP Requirements/Limits 1 1 3 3 QL (1 per 28 days) QL (36 per 25 days) 1 1 5 1 3 PA BvD PA BvD PA BvD QL (30 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 87 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name Drug Tier Requirements/Limits ESBRIET 5 KALYDECO OFEV ORKAMBI 5 5 5 XOLAIR ZEMAIRA 5 5 PA; QL (270 per 30 days) PA; QL (60 per 30 days) PA; QL (60 per 30 days) PA; QL (120 per 30 days) PA; QL (6 per 28 days) Skeletal Muscle Relaxants Skeletal Muscle Relaxants baclofen carisoprodol chlorzoxazone COMFORT PAC-CYCLOBENZAPRINE COMFORT PAC-TIZANIDINE cyclobenzaprine oral tablet 10 mg, 5 mg cyclobenzaprine oral tablet 7.5 mg dantrolene dantrolene sodium metaxalone methocarbamol oral tizanidine oral capsule tizanidine oral tablet (Baclofen) (Soma) 1 1 (Parafon Forte DSC) (Fexmid) (Fexmid) (Dantrium) (Dantrium) (Skelaxin) (Robaxin) (Zanaflex) (Zanaflex) 1 1 1 1 2 2 1 2 1 2 1 (Sonata) 3 3 5 1 PA-HRM; QL (120 per 30 days) PA-HRM PA-HRM PA-HRM PA-HRM PA-HRM PA-HRM Sleep Disorder Agents Sleep Disorder Agents NUVIGIL ROZEREM XYREM zaleplon PA LA PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use with any non-benzodiazepine hypnotic drug); QL (60 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 88 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name zolpidem oral tablet (Ambien) zolpidem oral tablet,ext release multiphase (Ambien CR) Drug Tier Requirements/Limits 1 PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use with any non-benzodiazepine hypnotic drug); QL (30 per 30 days) PA-HRM; (High Risk Med. QL applies to all members; PA required for 65 years and older with over 90 days cumulative use with any non-benzodiazepine hypnotic drug); QL (30 per 30 days) 2 Sympatholytic Adrenergic Blocking Agents Alpha-Adrenergic Blocking Agents phentolamine injection (Phentolamine Mesylate) 2 PA 5 5 3 2 PA; QL (60 per 30 days) PA; QL (90 per 30 days) PA; QL (30 per 30 days) PA BvD 5 PA BvD 5 5 3 PA; QL (30 per 30 days) PA; QL (30 per 30 days) PA 5 PA 5 5 PA BvD PA; QL (37.5 per 1 day) Vasodilating Agents Vasodilating Agents ADCIRCA ADEMPAS CIALIS ORAL TABLET 2.5 MG, 5 MG epoprostenol (glycine) intravenous recon (Flolan) soln 0.5 mg epoprostenol (glycine) intravenous recon (Flolan) soln 1.5 mg LETAIRIS OPSUMIT ORENITRAM ORAL TABLET EXTENDED RELEASE 0.125 MG ORENITRAM ORAL TABLET EXTENDED RELEASE 0.25 MG, 1 MG, 2.5 MG REMODULIN sildenafil intravenous (Revatio) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 89 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 Drug Name sildenafil oral TRACLEER (Revatio) TYVASO TYVASO REFILL KIT TYVASO STARTER KIT VENTAVIS Drug Tier Requirements/Limits 2 5 PA; QL (90 per 30 days) PA; LA; QL (60 per 30 days) PA BvD PA BvD PA BvD PA BvD 5 5 5 5 Vitamins And Minerals Vitamins And Minerals multivit-fluor 0.25 mg/ml drop 0.25 mg/ml (Pedi Mvi No.82 with Fluoride) prenatal vitamins oral tablet 27 mg iron- 1 (Pnv with mg Ca,No.72/Iron/Fa) PRENATAL VITAMINS ORAL TABLET 29 MG IRON- 1 MG-25 MG sodium fluoride 1 mg (2.2 mg) (Sodium Fluoride) sodium fluoride oral tablet 1 mg fluoride (Pedi Mvi No.82 with (2.2 mg) Fluoride) 1 3 (All Rx Prenatal Vitamins Covered) 3 1 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document 90 Access Medicare 2015 Part D Formulary Effective: December 01, 2015 Formulary ID: 15483.000, Version: 17 INDEX 8 8-MOP .................................... 59 A abacavir .................................. 39 abacavir-lamivudine-zidovudine ............................................ 39 ABELCET .............................. 31 ABILIFY ................................ 36 ABILIFY DISCMELT ........... 36 ABILIFY MAINTENA .......... 36 ABRAXANE .................... 16, 17 acamprosate .............................. 6 acarbose .................................. 28 acebutolol ............................... 50 acetaminophen-codeine ............ 1 acetazolamide ......................... 82 acetazolamide sodium ............ 82 acetic acid ......................... 65, 77 acetic acid-hydrocortisone...... 65 acetylcysteine ......................... 87 acitretin ................................... 59 ACTEMRA ............................ 79 ACTHIB (PF) ......................... 76 ACTIMMUNE ....................... 79 ACTONEL ............................. 78 ACTOPLUS MET XR ........... 28 acyclovir ..................... 41, 42, 59 acyclovir sodium .................... 42 ADACEL(TDAP ADOLESN/ADULT)(PF) .. 76 ADAGEN ............................... 63 adapalene ................................ 63 ADCETRIS ............................ 17 ADCIRCA .............................. 89 adefovir................................... 42 ADEMPAS ............................. 89 adrenalin ................................. 51 ADRENALIN......................... 51 ADVAIR DISKUS ................ 86 ADVAIR HFA ....................... 86 AFINITOR............................. 17 AFINITOR DISPERZ ........... 17 AGGRENOX ......................... 45 AKTEN (PF).......................... 64 ALBENZA............................. 35 ALBUKED-25 ....................... 45 ALBUKED-5 ......................... 45 ALBUMIN, HUMAN 25 % .. 45 ALBUMIN, HUMAN 5 % .... 45 ALBUMINAR 25 % .............. 45 ALBUMINAR 5 % ................ 45 ALBURX (HUMAN) 5 % ..... 45 ALBUTEIN 25 % .................. 45 ALBUTEIN 5 % .................... 45 albuterol sulfate ..................... 86 alclometasone .................. 60, 61 ALCOHOL PADS ................. 59 ALCOHOL PREP PADS ...... 59 ALCOH-WIPE ...................... 59 ALDURAZYME ................... 63 alendronate............................. 78 alfuzosin................................. 70 ALIMTA ................................ 17 ALINIA ................................. 35 allopurinol .............................. 79 allopurinol sodium ................. 79 alosetron................................. 77 ALPHAGAN P ...................... 82 alprazolam ............................... 7 ALREX .................................. 66 altacaine ................................. 64 ALTOPREV .......................... 54 aluminum chloride ................. 59 amantadine hcl ....................... 36 AMBISOME .......................... 31 amifostine crystalline ............. 79 amiloride ................................ 53 amiloride-hydrochlorothiazide ............................................ 53 AMINO ACIDS 15 % ............ 45 aminocaproic acid .................. 44 AMINOSYN 10 % ................. 45 AMINOSYN 3.5 % ................ 45 AMINOSYN 7 % ................... 45 AMINOSYN 7 % WITH ELECTROLYTES ............. 45 AMINOSYN 8.5 % ................ 46 AMINOSYN 8.5 %ELECTROLYTES ............. 46 AMINOSYN II 10 % ............. 46 AMINOSYN II 15 % ............. 46 AMINOSYN II 7 % ............... 46 AMINOSYN II 8.5 % ............ 46 AMINOSYN II 8.5 %ELECTROLYTES ............. 46 AMINOSYN M 3.5 % ........... 46 AMINOSYN-HBC 7% .......... 46 AMINOSYN-PF 10 % ........... 46 AMINOSYN-PF 7 % (SULFITE-FREE) .............. 46 AMINOSYN-RF 5.2 % ......... 46 amiodarone ....................... 49, 50 amiodarone hcl ....................... 49 AMITIZA ............................... 68 amitriptyline ........................... 26 amlodipine.............................. 53 amlodipine-atorvastatin.......... 54 amlodipine-benazepril............ 53 amlodipine-valsartan .............. 53 amlodipine-valsartan-hcthiazid ............................................ 53 ammonium chloride ............... 79 ammonium lactate .................. 59 amoxapine .............................. 27 I-1 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 amoxicil-clarithromy-lansopraz ............................................ 67 amoxicillin.............................. 14 amoxicillin-pot clavulanate .... 14 amphetamine salt combo .. 55, 56 amphotericin b ........................ 32 ampicillin................................ 14 ampicillin sodium ................... 14 ampicillin-sulbactam ........ 14, 15 AMPYRA ............................... 56 ANACAINE ........................... 59 ANADROL-50 ....................... 70 anagrelide ............................... 44 anastrozole .............................. 17 ANDRODERM ...................... 70 ANDROGEL .......................... 70 ANORO ELLIPTA ................ 86 anticoag citrate phos dextrose 79 APOKYN ............................... 36 apraclonidine .......................... 64 APRISO .................................. 77 APTIOM................................. 24 APTIVUS ............................... 39 ARALAST NP ....................... 87 ARCALYST ........................... 74 aripiprazole ............................. 37 ARRANON ............................ 17 ARZERRA ............................. 17 ASACOL HD ......................... 77 ashlyna .................................... 57 aspirin-dipyridamole .............. 45 ASSURE ID INSULIN SAFETY ............................. 63 ASTAGRAF XL .................... 74 atenolol ................................... 50 atenolol-chlorthalidone........... 50 atorvastatin ............................. 54 atovaquone ............................. 35 atovaquone-proguanil ............. 35 ATRIPLA ............................... 39 atropine ............................. 23, 64 ATROVENT HFA ................. 87 AUBAGIO ............................. 74 AURYXIA ............................. 69 AVASTIN .............................. 17 AVC VAGINAL.................... 33 AVODART ............................ 79 AVONEX .............................. 79 AVONEX (WITH ALBUMIN) ........................................... 79 AXIRON ................................ 71 azacitidine .............................. 17 azathioprine ........................... 74 azathioprine sodium ............... 74 azelastine ............................... 64 AZILECT............................... 36 azithromycin .......................... 13 AZOPT .................................. 82 AZOR .................................... 53 aztreonam............................... 14 B bacitracin ......................... 10, 65 bacitracin-polymyxin b .......... 65 baclofen ................................. 88 balsalazide ............................. 77 BANZEL ............................... 24 BARACLUDE ....................... 42 BCG VACCINE, LIVE (PF) . 76 BD INSULIN PEN NEEDLE UF SHORT ........................ 63 BD INSULIN SYRINGE ULTRA-FINE .................... 63 BD LUER-LOK SYRINGE .. 63 BELEODAQ .......................... 17 benazepril............................... 49 benazepril-hydrochlorothiazide ........................................... 49 BENICAR .............................. 48 BENICAR HCT ..................... 48 BENLYSTA .......................... 79 benztropine ............................ 36 BEPREVE ............................. 64 betamethasone acet,sod phos 71, 72 betamethasone dipropionate... 61 betamethasone valerate .......... 61 betamethasone, augmented .... 61 BETASERON ........................ 79 betaxolol........................... 50, 82 bethanechol chloride .............. 79 BETHKIS ................................. 9 BETOPTIC S ......................... 82 bexarotene .............................. 17 BEXSERO (PF) ..................... 76 bicalutamide ........................... 17 BICILLIN C-R ....................... 15 BICILLIN L-A ....................... 15 BIDIL ..................................... 55 BILTRICIDE ......................... 35 bimatoprost ............................ 82 bisoprolol fumarate ................ 50 bisoprolol-hydrochlorothiazide ............................................ 50 bleomycin ............................... 17 BLEPHAMIDE ...................... 65 BLEPHAMIDE S.O.P. .......... 65 BLINCYTO ........................... 17 BOOSTRIX TDAP ................ 76 BOSULIF ............................... 17 BOTOX .................................. 80 BREO ELLIPTA .................... 86 BRILINTA ............................. 45 brimonidine ............................ 82 BRINTELLIX ........................ 27 bromfenac .............................. 66 bromocriptine ......................... 36 budesonide ............................. 77 bumetanide ............................. 53 BUMINATE 25 % ................. 45 BUMINATE 5 % ................... 45 BUPHENYL .......................... 68 buprenorphine hcl ................ 1, 6 buprenorphine-naloxone .......... 6 bupropion hcl ..................... 6, 27 buspirone ................................ 80 butalb-acetaminophen-caffeine 1 I-2 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 butalbital-acetaminop-caf-cod .. 1 butalbital-acetaminophen ......... 1 butalbital-acetaminophen-caff .. 1 butalbital-aspirin-caffeine ........ 1 butorphanol tartrate .................. 1 BUTRANS ............................... 1 BYDUREON .......................... 28 BYETTA .......................... 28, 29 BYSTOLIC ............................ 50 C cabergoline ............................. 36 caffeine citrated ...................... 56 caffeine-sodium benzoate....... 56 calcipotriene ........................... 59 calcitonin (salmon) ................. 78 calcitriol ............................ 59, 78 calcium acetate ....................... 69 calcium carbonate-mag carb-fa ............................................ 69 calcium chloride ..................... 83 calcium gluconate ................... 83 CALDOLOR ............................ 4 CANCIDAS ........................... 32 candesartan ............................. 48 candesartan-hydrochlorothiazid ............................................ 48 CAPASTAT ........................... 34 CAPRELSA ........................... 17 captopril .................................. 49 captopril-hydrochlorothiazide 49 CARAFATE ........................... 67 carbamazepine ........................ 24 carbidopa ................................ 36 carbidopa-levodopa ................ 36 carbidopa-levodopa-entacapone ............................................ 36 carbinoxamine maleate ........... 33 carboplatin .............................. 17 CARIMUNE NF NANOFILTERED ............. 74 carisoprodol ............................ 88 carteolol .................................. 64 cartia xt .................................. 51 carvedilol ............................... 50 CAYSTON ............................ 14 CEDAX ........................... 11, 12 cefaclor .................................. 12 cefadroxil ............................... 12 cefazolin................................. 12 cefazolin in dextrose (iso-os) . 12 cefdinir ................................... 12 cefditoren pivoxil ................... 12 cefepime................................. 12 CEFEPIME IN DEXTROSE 5 % ........................................ 12 CEFEPIME IN DEXTROSE,ISO-OSM ..... 12 cefixime ................................. 12 cefotaxime ............................. 12 cefoxitin ................................. 12 cefoxitin in dextrose, iso-osm 12 cefpodoxime .......................... 12 cefprozil ................................. 12 ceftazidime............................. 12 ceftibuten ............................... 13 ceftriaxone ............................. 13 CEFTRIAXONE ................... 13 ceftriaxone in dextrose,iso-os 13 CEFTRIAXONE IN DEXTROSE,ISO-OS ........ 13 cefuroxime axetil ................... 13 cefuroxime sodium ................ 13 cefuroxime-dextrose (iso-osm) ........................................... 13 celecoxib .................................. 4 CELLCEPT INTRAVENOUS ........................................... 74 CELONTIN ........................... 24 cephalexin .............................. 13 CEPROTIN (BLUE BAR) .... 42 CERDELGA .......................... 80 CEREZYME .......................... 63 CERVARIX VACCINE (PF) 76 cevimeline .............................. 58 CHANTIX................................ 6 CHANTIX CONTINUING MONTH BOX ..................... 6 CHANTIX CONTINUING MONTH PAK ...................... 6 CHANTIX STARTING MONTH BOX ..................... 6 chloramphenicol sod succinate ............................................ 10 chlordiazepoxide hcl ................ 7 chlorhexidine gluconate ......... 58 chloroquine phosphate ........... 35 chlorothiazide ......................... 53 chlorothiazide sodium ............ 53 chlorpromazine ...................... 37 chlorthalidone ........................ 53 chlorzoxazone ........................ 88 CHOLBAM............................ 68 cholestyramine (with sugar) ... 54 cholestyramine-aspartame...... 54 choline,magnesium salicylate .. 4 CIALIS ................................... 89 ciclopirox ............................... 32 ciclopirox-ure-camph-mentheuc ...................................... 32 cidofovir ................................. 42 cilostazol ................................ 45 CILOXAN.............................. 65 cimetidine ............................... 67 cimetidine hcl ......................... 67 CIMZIA ................................. 63 CIMZIA POWDER FOR RECONST ......................... 64 CIPRODEX............................ 65 ciprofloxacin .......................... 15 ciprofloxacin (mixture) .......... 15 ciprofloxacin hcl .............. 15, 65 ciprofloxacin in 5 % dextrose 15 ciprofloxacin lactate ............... 15 cisplatin .................................. 17 citalopram .............................. 27 citric acid-sodium citrate........ 83 I-3 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 cladribine ................................ 17 clarithromycin ........................ 13 clemastine ............................... 33 CLEVIPREX .......................... 53 clindamycin hcl ...................... 10 clindamycin in 5 % dextrose .. 10 clindamycin palmitate hcl ...... 10 clindamycin phos-benzoyl perox ............................................ 60 clindamycin phosphate .... 10, 33, 60 clindamycin-benzoyl peroxide ............................................ 60 CLINIMIX 5%/D15W SULFITE FREE ................. 46 CLINIMIX 5%/D25W SULFITE-FREE ................. 46 CLINIMIX 2.75%/D5W SULFIT FREE.................... 46 CLINIMIX 4.25%/D10W SULF FREE .................................. 46 CLINIMIX 4.25%/D5W SULFIT FREE.................... 46 CLINIMIX 4.25%-D20W SULF-FREE ....................... 46 CLINIMIX 4.25%-D25W SULF-FREE ....................... 46 CLINIMIX 5%D20W(SULFITE-FREE) ... 46 CLINIMIX E 2.75%/D10W SUL FREE.......................... 46 CLINIMIX E 2.75%/D5W SULF FREE ....................... 46 CLINIMIX E 4.25%/D10W SUL FREE.......................... 46 CLINIMIX E 4.25%/D25W SUL FREE.......................... 46 CLINIMIX E 4.25%/D5W SULF FREE ....................... 46 CLINIMIX E 5%/D15W SULFIT FREE.................... 46 CLINIMIX E 5%/D20W SULFIT FREE ................... 46 CLINIMIX E 5%/D25W SULFIT FREE ................... 46 CLINISOL SF 15 % .............. 46 clobetasol ............................... 61 clobetasol propionate ............. 61 clobetasol-emollient............... 61 clocortolone pivalate.............. 61 clomipramine ......................... 27 clonazepam .............................. 7 clonidine ................................ 48 clonidine hcl .................... 48, 56 clonidine hcl-chlorthalidone .. 48 clopidogrel ............................. 45 clorazepate dipotassium ........... 7 clotrimazole ........................... 32 clotrimazole-betamethasone .. 32 clozapine ................................ 37 COARTEM ............................ 35 codeine sulfate ......................... 1 codeine-butalbital-asa-caffein . 1 colchicine ............................... 80 colchicine-probenecid ............ 80 COLCRYS ............................. 80 colestipol ................................ 54 colistin (colistimethate na)..... 10 COLY-MYCIN S .................. 65 COMBIGAN ......................... 82 COMBIPATCH ..................... 71 COMBIVENT RESPIMAT ... 87 COMETRIQ .......................... 17 COMFORT PACCYCLOBENZAPRINE ..... 88 COMFORT PAC-IBUPROFEN ............................................. 4 COMFORT PACMELOXICAM..................... 4 COMFORT PAC-NAPROXEN ............................................. 4 COMFORT PAC-TIZANIDINE ........................................... 88 COMPLERA .......................... 39 COMVAX (PF) ...................... 76 CONDYLOX ......................... 59 COPAXONE .......................... 80 CORDRAN ............................ 61 CORDRAN TAPE LARGE ROLL ................................. 61 COREG CR............................ 50 CORLANOR.......................... 51 cortisone ................................. 72 CORTISPORIN-TC ............... 65 COSENTYX (2 SYRINGES) 59 COSENTYX PEN .................. 59 COSENTYX PEN (2 PENS) . 59 CREON .................................. 64 CRESTOR.............................. 54 CRIXIVAN ............................ 39 cromolyn .................... 64, 68, 87 CUBICIN ............................... 10 CURITY GAUZE .................. 80 cyclobenzaprine ..................... 88 CYCLOGYL .......................... 64 cyclopentolate ........................ 64 cyclophosphamide............ 17, 18 CYCLOPHOSPHAMIDE...... 18 CYCLOSET ........................... 29 cyclosporine ........................... 74 cyclosporine modified ............ 74 cyclosporine, modified ........... 74 cyproheptadine ....................... 33 CYRAMZA............................ 18 cyred ....................................... 57 CYSTADANE ....................... 80 CYSTARAN .......................... 65 cysteine (l-cysteine) ............... 46 cytarabine ............................... 18 cytarabine (pf) ........................ 18 D d10 % & 0.45 % sodium chloride .............................. 46 d10 %-0.9 % sodium chloride 46 I-4 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 d2.5 %-0.45 % sodium chloride ............................................ 46 d5 % and 0.9 % sodium chloride ............................................ 47 d5 %-0.45 % sodium chloride 47 dacarbazine ............................. 18 dactinomycin .......................... 18 DAKLINZA ........................... 41 DALIRESP ............................. 87 danazol ................................... 71 dantrolene ............................... 88 dantrolene sodium .................. 88 dapsone ................................... 34 DAPTACEL (DTAP PEDIATRIC) (PF).............. 76 DARAPRIM ........................... 35 daunorubicin ........................... 18 DAUNOXOME ...................... 18 deblitane ................................. 57 decitabine ............................... 18 deferoxamine .......................... 70 DELZICOL ............................ 77 demeclocycline ....................... 16 DEMSER................................ 52 DENAVIR .............................. 59 DEPEN TITRATABS ............ 70 DEPO-PROVERA ................. 74 desipramine ............................ 27 desmopressin .......................... 72 desog-e.estradiol/e.estradiol ... 57 desogestrel-ethinyl estradiol... 57 desonide.................................. 61 desoximetasone ...................... 62 DESVENLAFAXINE ............ 27 DESVENLAFAXINE FUMARATE ...................... 27 dexamethasone ....................... 72 dexamethasone sodium phosphate...................... 66, 72 DEXILANT ............................ 67 dexmethylphenidate ............... 56 dexrazoxane hcl ...................... 80 dextroamphetamine ............... 56 dextroamphetamineamphetamine ...................... 56 dextrose 10 % and 0.2 % nacl 47 dextrose 10 % in water (d10w) ........................................... 47 dextrose 2.5 % in water(d2.5w) ........................................... 47 dextrose 20 % in water (d20w) ........................................... 47 dextrose 25 % in water (d25w) ........................................... 47 dextrose 40 % in water (d40w) ........................................... 47 dextrose 5 % in ringers .......... 47 dextrose 5 % in water (d5w) .. 47 dextrose 5 %-lactated ringers 47 dextrose 5%-0.2 % sod chloride ........................................... 47 dextrose 5%-0.3 % sod.chloride ........................................... 47 dextrose 50 % in water (d50w) ........................................... 47 dextrose 70 % in water (d70w) ........................................... 47 dextrose with sodium chloride47 DIASTAT ACUDIAL ............. 7 diazepam .................................. 7 diazepam intensol .................... 7 diclofenac potassium ............... 4 diclofenac sodium .............. 4, 66 diclofenac-misoprostol ............ 4 dicloxacillin ........................... 15 dicyclomine ........................... 68 didanosine .............................. 39 DIFICID................................. 13 diflorasone ............................. 62 diflunisal .................................. 4 digitek .................................... 52 digoxin ................................... 52 DIGOXIN .............................. 52 dihydroergotamine ................. 33 DILANTIN ............................ 24 diltiazem hcl ........................... 51 dilt-xr...................................... 51 dimenhydrinate ...................... 34 DIPENTUM ........................... 77 diphenhydramine hcl .............. 33 diphenoxylate-atropine .......... 68 disopyramide phosphate......... 50 disulfiram ................................. 6 divalproex .............................. 24 dobutamine ............................. 52 dobutamine in d5w ................. 52 docetaxel ................................ 18 donepezil ................................ 26 dopamine ................................ 52 dopamine in 5 % dextrose ...... 52 dorzolamide............................ 82 dorzolamide-timolol............... 82 doxazosin ............................... 48 doxepin................................... 27 doxercalciferol ....................... 78 doxorubicin hcl ...................... 18 doxorubicin hcl peg-liposomal ............................................ 18 doxorubicin, peg-liposomal ... 18 doxycycline hyclate ............... 16 doxycycline monohydrate ...... 16 dronabinol .............................. 34 droperidol ............................... 80 drospirenone-ethinyl estradiol 57 DROXIA ................................ 18 DRYSOL DAB-O-MATIC .... 59 DUAVEE ............................... 71 DULERA ............................... 86 duloxetine............................... 27 DURAMORPH (PF) ................ 1 DUREZOL ............................. 66 DYRENIUM .......................... 53 DYSPORT ............................. 80 E econazole................................ 32 EDARBI................................. 48 I-5 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 EDARBYCLOR ..................... 48 EDURANT ............................. 39 EFFIENT ................................ 45 ELAPRASE ............................ 64 electrolyte-48 in d5w .............. 83 ELIDEL .................................. 62 ELIGARD .............................. 18 ELIQUIS ................................ 42 ELITEK .................................. 64 ELLA ...................................... 57 ELMIRON .............................. 80 EMBEDA ................................. 1 EMCYT .................................. 18 EMEND.................................. 34 EMSAM ................................. 27 EMTRIVA .............................. 39 enalapril maleate .................... 49 enalaprilat ............................... 49 enalapril-hydrochlorothiazide 49 ENBREL ................................ 74 ENBREL SURECLICK ......... 74 ENGERIX-B (PF) .................. 76 ENGERIX-B PEDIATRIC (PF) ............................................ 76 enoxaparin ........................ 42, 43 entacapone .............................. 36 entecavir ................................. 42 ENTRESTO ........................... 49 ephedrine sulfate .................... 52 epinastine................................ 65 epinephrine ............................. 52 epinephrine hcl (pf) ................ 52 EPIPEN 2-PAK ...................... 52 EPIPEN JR 2-PAK ................. 52 epirubicin ................................ 18 EPIVIR HBV.......................... 39 eplerenone .............................. 55 EPOGEN ................................ 44 epoprostenol (glycine) ............ 89 eprosartan ............................... 49 EPZICOM .............................. 39 ERBITUX............................... 18 ergoloid .................................. 80 ERGOMAR ........................... 33 ERIVEDGE ........................... 18 ERYTHROCIN ..................... 13 erythromycin .................... 14, 65 erythromycin base.................. 13 ERYTHROMYCIN BASE .... 14 erythromycin base-ethanol .... 60 erythromycin ethylsuccinate .. 14 erythromycin stearate ............ 14 erythromycin with ethanol ..... 60 erythromycin-benzoyl peroxide ........................................... 60 ESBRIET ............................... 88 escitalopram oxalate .............. 27 esmolol................................... 50 esomeprazole sodium ............ 67 estazolam ............................. 7, 8 ESTRACE ............................. 71 estradiol ................................. 71 estradiol valerate .................... 71 estradiol/norethindrone acet .. 71 estradiol-norethindrone acet .. 71 ESTRASORB ........................ 71 ESTRING .............................. 71 estropipate .............................. 71 ethambutol ............................. 34 ethamolin ............................... 52 ethinyl estradiol/drospirenone 57 ethosuximide .......................... 24 ethynodiol d-ethinyl estradiol 57 etidronate disodium ............... 78 etodolac .................................... 4 ETOPOPHOS ........................ 18 etoposide ................................ 18 EURAX ................................. 63 EVOTAZ ............................... 39 EXELDERM ......................... 32 EXELON ............................... 26 exemestane............................. 18 EXJADE ................................ 70 EXTAVIA ............................. 80 F FABRAZYME ....................... 64 famciclovir ............................. 42 famotidine .............................. 67 famotidine (pf) ....................... 67 famotidine (pf)-nacl (iso-os) . 67 FANAPT ................................ 37 FARESTON ........................... 18 FARYDAK ............................ 19 FASLODEX ........................... 19 felbamate ................................ 24 felodipine ............................... 53 FEMRING.............................. 71 fenofibrate .............................. 54 fenofibrate micronized ........... 54 fenofibrate nanocrystallized ... 54 fenofibric acid ........................ 54 fenofibric acid (choline) ......... 54 fenoprofen ................................ 4 fentanyl ................................ 1, 2 fentanyl citrate ......................... 1 FERRIPROX.......................... 70 FETZIMA .............................. 27 finasteride ............................... 80 FIRAZYR .............................. 52 FIRMAGON KIT W DILUENT SYRINGE .......................... 19 flavoxate................................. 69 FLEBOGAMMA DIF ............ 75 flecainide ................................ 50 FLECTOR ................................ 4 FLEXBUMIN 25 % ............... 45 FLEXBUMIN 5 % ................. 45 FLOVENT DISKUS .............. 86 FLOVENT HFA .................... 86 floxuridine .............................. 19 fluconazole ............................. 32 fluconazole in dextrose(iso-o) 32 fluconazole in nacl (iso-osm) . 32 flucytosine .............................. 32 fludarabine ............................. 19 fludrocortisone ....................... 72 I-6 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 flumazenil ............................... 56 fluocinonide............................ 62 fluocinonide-emollient base ... 62 fluorometholone ..................... 67 FLUOROPLEX ...................... 59 fluorouracil ....................... 19, 59 fluoxetine................................ 27 FLUOXETINE ....................... 27 fluoxymesterone ..................... 71 fluphenazine decanoate .......... 37 fluphenazine hcl ..................... 37 flurazepam ................................ 8 flurbiprofen............................... 4 flurbiprofen sodium ................ 67 flutamide................................. 19 fluticasone ........................ 62, 67 fluvastatin ............................... 54 fluvoxamine............................ 27 fomepizole .............................. 80 fondaparinux........................... 43 FORADIL AEROLIZER ....... 87 FORTEO ................................ 78 FORTICAL ............................ 78 foscarnet ................................. 41 fosinopril ................................ 49 fosinopril-hydrochlorothiazide ............................................ 49 fosphenytoin ........................... 24 FOSRENOL ........................... 69 FREAMINE HBC 6.9 % ........ 47 FREAMINE III 10 % ............. 47 furosemide .............................. 54 FUSILEV ............................... 80 FUZEON ................................ 40 FYCOMPA ............................ 24 G gabapentin .............................. 24 GABITRIL ............................. 24 galantamine ............................ 26 GAMASTAN S/D .................. 75 GAMMAGARD LIQUID ...... 75 GAMMAPLEX ...................... 75 GAMUNEX-C ....................... 75 ganciclovir sodium ................ 42 GARDASIL (PF) ................... 76 GARDASIL 9 (PF) ................ 76 gatifloxacin ............................ 65 GAZYVA .............................. 19 gemcitabine ............................ 19 gemfibrozil............................. 54 GENOTROPIN ...................... 72 GENOTROPIN MINIQUICK ..................................... 72, 73 gentamicin ................. 10, 60, 65 gentamicin in nacl (iso-osm) . 10 gentamicin sulfate .................. 66 gentamicin sulfate (ped) (pf) . 10 gentamicin sulfate (pf) ........... 10 GEODON .............................. 37 gildess 24 fe ........................... 57 GILENYA ............................. 80 GILOTRIF ............................. 19 GLEEVEC ............................. 19 glimepiride ............................. 31 glipizide ................................. 31 glipizide-metformin ............... 31 GLUCAGEN HYPOKIT ....... 80 GLUCAGON EMERGENCY KIT (HUMAN) .................. 80 glucose ................................... 47 glyburide ................................ 31 glyburide micronized ............. 31 glyburide-metformin .............. 31 GLYCINE .............................. 77 glycopyrrolate ........................ 68 glydo ........................................ 5 GLYSET ................................ 29 GLYXAMBI .......................... 29 GRALISE .............................. 24 GRALISE 30-DAY STARTER PACK................................. 24 granisetron (pf) ...................... 34 granisetron hcl ....................... 35 GRANIX ................................ 44 griseofulvin microsize ............ 32 griseofulvin ultramicrosize .... 32 guanfacine ........................ 48, 56 guanidine ................................ 80 H HALAVEN ............................ 19 halobetasol propionate ........... 62 haloperidol ............................. 37 haloperidol decanoate ............ 37 haloperidol lactate .................. 37 HARVONI ............................. 41 HAVRIX (PF) ........................ 76 heparin (porcine) .................... 43 heparin (porcine) in 5 % dex . 43, 44 HEPARIN (PORCINE) IN 5 % DEX ................................... 43 heparin (porcine) in nacl (pf) . 43 HEPARIN(PORCINE) IN 0.45% NACL ..................... 43 heparin, porcine (pf)............... 43 HEPATAMINE 8% ............... 47 HEPATASOL 8 % ................. 47 HERCEPTIN.......................... 19 HEXALEN ............................. 19 homatropine hbr ..................... 65 HUMALOG ........................... 30 HUMALOG KWIKPEN ........ 30 HUMALOG MIX 50-50 ........ 30 HUMALOG MIX 50-50 KWIKPEN ......................... 30 HUMALOG MIX 75-25 ........ 30 HUMALOG MIX 75-25 KWIKPEN ......................... 30 HUMATROPE ....................... 73 HUMIRA ............................... 75 HUMIRA PEN ....................... 75 HUMIRA PEN CROHN'S-UCHS START ......................... 75 HUMULIN 70/30................... 30 HUMULIN 70/30 KWIKPEN30 HUMULIN N ......................... 30 I-7 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 HUMULIN N KWIKPEN ...... 30 HUMULIN R ......................... 30 HUMULIN R U-500 (CONCENTRATED) ......... 30 hydralazine ............................. 53 hydrochlorothiazide ................ 54 hydrocodone-acetaminophen ... 2 hydrocodone-ibuprofen ............ 2 hydrocortisone .................. 62, 72 hydrocortisone acet-aloe vera. 62 hydrocortisone acetate-urea.... 62 hydrocortisone butyrate .......... 62 hydrocortisone butyr-emollient ............................................ 62 hydrocortisone sod succinate . 72 hydrocortisone valerate .......... 62 hydrocortisone-acetic acid...... 66 hydromorphone ........................ 2 hydromorphone (pf) ................. 2 hydroxychloroquine ............... 35 hydroxyurea ............................ 19 hydroxyzine hcl ...................... 80 hydroxyzine pamoate ............. 80 HYPERLYTE CR .................. 83 HYPERRAB S/D (PF) ........... 75 HYQVIA ................................ 75 I ibandronate ............................. 78 IBRANCE .............................. 19 ibuprofen .................................. 4 ICLUSIG ................................ 19 idarubicin ................................ 19 ifosfamide ............................... 19 ifosfamide-mesna ................... 19 ILARIS (PF) ........................... 75 ILEVRO ................................. 67 IMBRUVICA ......................... 19 imipenem-cilastatin ................ 14 imipramine hcl........................ 27 imipramine pamoate ............... 27 imiquimod .............................. 59 IMOGAM RABIES-HT (PF) . 75 IMOVAX RABIES VACCINE (PF) .................................... 76 INCRELEX ........................... 73 indapamide............................. 54 indomethacin ........................... 4 indomethacin sodium ............... 5 INFANRIX (DTAP) (PF) ...... 76 INLYTA ................................ 20 INSULIN SYRINGE ............. 63 INSULIN SYRINGE NEEDLELESS .................. 63 INSULIN SYRINGE-NEEDLE U-100 ................................. 63 INTELENCE ......................... 40 INTRALIPID ......................... 47 INTRON A ............................ 41 INVANZ ................................ 14 INVEGA ................................ 37 INVEGA SUSTENNA .... 37, 38 INVEGA TRINZA ................ 38 INVIRASE............................. 40 INVOKAMET ....................... 29 INVOKANA .......................... 29 IONOSOL-B IN D5W ........... 83 IONOSOL-MB IN D5W ....... 83 IPOL ...................................... 76 ipratropium bromide .............. 65 IPRIVASK ............................. 44 irbesartan ............................... 49 irbesartan-hydrochlorothiazide ........................................... 49 IRENKA ................................ 27 IRESSA ................................. 20 irinotecan ............................... 20 ISENTRESS .......................... 40 ISOLYTE M IN 5 % DEXTROSE ...................... 83 ISOLYTE-H IN 5 % DEXTROSE ...................... 83 ISOLYTE-P IN 5 % DEXTROSE ...................... 83 ISOLYTE-S ........................... 83 isoniazid ................................. 34 isosorbide dinitrate ................. 55 isosorbide mononitrate ........... 55 isotretinoin ............................. 59 isradipine ................................ 53 ISTODAX .............................. 20 itraconazole ............................ 32 ivermectin .............................. 35 IXEMPRA.............................. 20 IXIARO (PF) ......................... 76 J JADENU ................................ 70 JAKAFI .................................. 20 JALYN ................................... 80 jantoven .................................. 44 JANUMET ............................. 29 JANUMET XR ...................... 29 JANUVIA .............................. 29 JARDIANCE ......................... 29 JENTADUETO ...................... 29 JEVTANA.............................. 20 junel fe 24 .............................. 57 K KABIVEN.............................. 47 KADCYLA ............................ 20 KALETRA ............................. 40 KALYDECO.......................... 88 KAZANO ............................... 29 KEDBUMIN .......................... 45 ketoconazole .......................... 32 ketoprofen ................................ 5 ketorolac ............................. 5, 67 KEYTRUDA.......................... 20 KHEDEZLA .......................... 27 kimidess (28) .......................... 57 KINERET .............................. 75 KINRIX (PF) ......................... 76 KLOR-CON ........................... 83 klor-con 10 ............................. 83 KLOR-CON 8 ........................ 83 klor-con m10 .......................... 83 klor-con m15 .......................... 83 I-8 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 klor-con m20 .......................... 84 klor-con sprinkle .................... 84 KLOR-CON/EF ..................... 84 KORLYM............................... 29 KRYSTEXXA........................ 64 KUVAN ................................. 64 KYPROLIS ............................ 20 L l norgest/e.estradiol-e.estrad ... 57 labetalol .................................. 50 LACRISERT .......................... 65 LACTATED RINGERS ......... 77 lactulose.................................. 68 LAMICTAL ........................... 24 LAMICTAL ODT STARTER (BLUE) ............................... 24 LAMICTAL ODT STARTER (GREEN) ............................ 24 LAMICTAL ODT STARTER (ORANGE)......................... 24 lamivudine .............................. 40 lamivudine-zidovudine ........... 40 lamotrigine ....................... 24, 25 LANOXIN .............................. 53 lansoprazole ............................ 67 LANTUS ................................ 30 LANTUS SOLOSTAR .......... 30 larin 24 fe ............................... 57 latanoprost .............................. 83 LATUDA ............................... 38 LAZANDA............................... 2 leflunomide............................. 75 LEMTRADA .......................... 80 LENVIMA ............................. 20 LETAIRIS .............................. 89 letrozole .................................. 20 leucovorin calcium ................. 80 LEUKERAN .......................... 20 LEUKINE............................... 44 leuprolide................................ 20 levetiracetam .......................... 25 levetiracetam in nacl (iso-os) . 25 levobunolol ............................ 83 levocarnitine .......................... 81 levocarnitine (with sugar) ...... 81 levocetirizine ......................... 33 levofloxacin ..................... 15, 66 levofloxacin in d5w ............... 15 levoleucovorin calcium.......... 81 levonorgestrel ........................ 57 levonorgestrel-ethin estradiol 58 levonorgestrel-ethinyl estrad . 58 levorphanol tartrate .................. 2 levothyroxine ......................... 74 LEXIVA ................................ 40 lidocaine................................... 6 lidocaine (pf)...................... 5, 50 lidocaine hcl ......................... 5, 6 lidocaine in 5 % dextrose (pf) 50 lidocaine-prilocaine ................. 6 linezolid ................................. 10 LINZESS ............................... 64 liothyronine ............................ 74 lipase-protease-amylase ......... 64 LIPOSYN II........................... 48 LIPOSYN III ......................... 48 lisinopril ................................. 49 lisinopril-hydrochlorothiazide 49 lithium carbonate ................... 56 lithium citrate ......................... 56 l-norgest-eth estr/ethin estra .. 58 lomustine ............................... 20 loperamide ............................. 68 lorazepam oral solution ........... 8 losartan................................... 49 losartan-hydrochlorothiazide . 49 LOTEMAX ............................ 67 LOTRONEX .......................... 64 lovastatin ................................ 54 loxapine succinate.................. 38 LUMIGAN ............................ 83 LUMIZYME .......................... 64 LUPRON DEPOT ................. 20 LUPRON DEPOT (3 MONTH) ............................................ 20 LUPRON DEPOT (4 MONTH) ............................................ 20 LUPRON DEPOT (6 MONTH) ............................................ 20 LUPRON DEPOT-PED ......... 20 LUPRON DEPOT-PED (3 MONTH)............................ 20 LYNPARZA .......................... 20 LYRICA ................................. 25 LYSODREN .......................... 20 M mafenide acetate..................... 59 magnesium chloride ............... 84 magnesium sulf in 0.45% nacl84 magnesium sulfate ................. 84 magnesium sulfate in d5w ..... 84 magnesium sulfate in water ... 84 malathion................................ 63 maprotiline ............................. 27 MARPLAN ............................ 28 MARQIBO ............................. 20 MATULANE ......................... 20 matzim la................................ 51 meclizine ................................ 35 medroxyprogesterone ............. 74 mefenamic acid ........................ 5 mefloquine ............................. 35 MEFOXIN IN DEXTROSE (ISO-OSM) ........................ 13 MEGACE ES ......................... 20 megestrol ................................ 20 MEKINIST ............................ 21 meloxicam ................................ 5 melphalan hcl intravenous ..... 21 memantine .............................. 26 MENACTRA (PF) ................. 76 MENEST................................ 71 MENHIBRIX (PF) ................. 76 MENOMUNE - A/C/Y/W-135 (PF) .................................... 76 I-9 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 MENVEO A-C-Y-W-135-DIP (PF) ..................................... 76 MENVEO MENA COMPONENT (PF) ........... 76 MENVEO MENCYW-135 COMPNT (PF) ................... 76 mercaptopurine ....................... 21 meropenem ............................. 14 mesna...................................... 81 MESNEX ............................... 81 MESTINON ........................... 81 metaproterenol ........................ 87 metaxalone ............................. 88 metformin ............................... 29 methadone ................................ 2 methadone hcl .......................... 2 methazolamide ....................... 83 methenamine hippurate .......... 10 methenamine mandelate ......... 10 methimazole ........................... 74 methocarbamol ....................... 88 methotrexate sodium .............. 21 methotrexate sodium (pf) ....... 21 methoxsalen rapid .................. 59 methscopolamine.................... 68 methyclothiazide .................... 54 methylergonovine ................... 81 methylphenidate ............... 56, 57 methylprednisolone ................ 72 methylprednisolone acetate .... 72 methylprednisolone sodium succ ............................................ 72 metipranolol ........................... 83 metoclopramide hcl ................ 68 metolazone ............................. 54 metoprolol succinate .............. 50 metoprolol ta-hydrochlorothiaz ............................................ 50 metoprolol tartrate .................. 50 metronidazole ............. 33, 35, 60 metronidazole in nacl (iso-os) 35 mexiletine ............................... 50 MIACALCIN......................... 78 miconazole nitrate.................. 32 midazolam ............................... 8 midazolam (pf) ........................ 8 midodrine ............................... 48 milrinone................................ 53 milrinone in 5 % dextrose ...... 53 minitran .................................. 55 MINOCIN .............................. 16 minocycline ........................... 16 minoxidil................................ 55 MIRCERA ............................. 44 mirtazapine ............................ 28 misoprostol ............................ 67 mitomycin .............................. 21 mitoxantrone .......................... 21 M-M-R II (PF) ....................... 76 moexipril................................ 49 moexipril-hydrochlorothiazide ........................................... 49 mometasone ........................... 62 montelukast ............................ 86 morphine .............................. 2, 3 MORPHINE ............................ 3 morphine concentrate .............. 2 morrhuate sodium .................. 81 MOVANTIK ......................... 68 MOVIPREP ........................... 68 MOXEZA .............................. 66 moxifloxacin .......................... 15 MOZOBIL ............................. 44 MULTAQ .............................. 50 mupirocin ............................... 60 mupirocin calcium ................. 60 MUSTARGEN ...................... 21 mycophenolate mofetil .......... 75 mycophenolate sodium .......... 75 MYOBLOC ........................... 81 MYOZYME........................... 64 MYRBETRIQ ........................ 69 N nabumetone .............................. 5 nadolol.................................... 50 nafcillin .................................. 15 nafcillin in dextrose iso-osm .. 15 NAGLAZYME ...................... 64 naloxone ................................... 6 naltrexone................................. 6 naltrexone hcl ........................... 6 NAMENDA ........................... 26 NAMENDA TITRATION PAK ............................................ 26 NAMENDA XR..................... 26 NAMZARIC .......................... 26 naphazoline ............................ 65 naproxen ................................... 5 naproxen sodium ...................... 5 naratriptan .............................. 33 NASONEX ............................ 67 NATACYN ............................ 66 nateglinide .............................. 29 NATPARA ............................. 78 NEBUPENT ........................... 35 nefazodone ............................. 28 neomy sulf-bacitrac zn-poly-hc ............................................ 66 neomycin ................................ 10 neomycin-bacitracin-poly-hc . 66 neomycin-bacitracin-polymyxin ............................................ 66 neomycin-polymyxin b gu ..... 60 neomycin-polymyxin bdexameth ............................ 66 neomycin-polymyxingramicidin .......................... 66 neomycin-polymyxin-hc ........ 66 NEPHRAMINE 5.4 % ........... 48 NESINA ................................. 29 NEULASTA .......................... 44 NEUMEGA............................ 44 NEUPOGEN .......................... 44 NEUPRO................................ 36 NEVANAC ............................ 67 nevirapine ............................... 40 I-10 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 NEXAVAR ............................ 21 niacin ...................................... 54 nicardipine .............................. 53 NICOTROL.............................. 6 nifedipine................................ 53 NILANDRON ........................ 21 NITRO-BID ........................... 55 nitrofurantoin .......................... 11 nitrofurantoin macrocrystal ... 10, 11 nitrofurantoin monohyd/m-cryst ............................................ 11 nitroglycerin ........................... 55 nitroglycerin in 5 % dextrose . 55 NITROSTAT.......................... 55 nizatidine ................................ 67 NORDITROPIN FLEXPRO .. 73 norelgestromin/ethin.estradiol 58 norepinephrine bitartrate ........ 53 noreth-ethinyl estradiol/iron ... 58 norethindrone ......................... 58 norethindrone (contraceptive) 58 norethindrone acetate ............. 74 norethindrone ac-eth estradiol ...................................... 58, 71 norethindrone-e.estradiol-iron 58 norethindrone-ethinyl estrad .. 58 norethindrone-mestranol ........ 58 norgestimate-ethinyl estradiol 58 norgestrel-ethinyl estradiol..... 58 NORMOSOL-M IN 5 % DEXTROSE ....................... 84 NORMOSOL-R ..................... 84 NORMOSOL-R PH 7.4 ......... 84 NORTHERA .......................... 48 nortriptyline ............................ 28 NORVIR................................. 40 NOVOLIN 70/30.................... 30 NOVOLIN N .......................... 30 NOVOLIN R .......................... 30 NOVOLOG ............................ 30 NOVOLOG FLEXPEN.......... 30 NOVOLOG MIX 70-30 ........ 30 NOVOLOG MIX 70-30 FLEXPEN .......................... 30 NOVOLOG PENFILL .......... 31 NOXAFIL.............................. 32 NPLATE ................................ 81 NUCYNTA .............................. 3 NUCYNTA ER........................ 3 NUEDEXTA ......................... 57 NULOJIX .............................. 75 NUTRESTORE ..................... 68 NUTRILIPID ......................... 48 NUTRILYTE ......................... 84 NUTRILYTE II ..................... 84 NUTROPIN ........................... 73 NUTROPIN AQ .................... 73 NUTROPIN AQ NUSPIN ..... 73 NUVARING .......................... 58 NUVIGIL............................... 88 nystatin................................... 32 NYSTATIN (BULK) ............. 32 nystatin-triamcinolone ........... 33 O OCTAGAM ........................... 75 octreotide acetate ................... 73 OFEV ..................................... 88 ofloxacin .......................... 15, 66 olanzapine .............................. 38 olanzapine-fluoxetine ............ 28 olopatadine............................. 65 OLYSIO................................. 41 omega-3 acid ethyl esters ...... 54 omeprazole............................. 68 OMNITROPE ........................ 73 ONCASPAR .......................... 21 ondansetron ............................ 35 ondansetron hcl ...................... 35 ondansetron hcl (pf) ............... 35 ONFI ........................................ 8 OPDIVO ................................ 21 OPSUMIT .............................. 89 ORAP..................................... 38 ORENCIA .............................. 75 ORENCIA (WITH MALTOSE) ............................................ 75 ORENITRAM ........................ 89 ORFADIN .............................. 64 ORKAMBI ............................. 88 OSENI .................................... 29 OTEZLA ................................ 81 OTEZLA STARTER ............. 81 oxacillin.................................. 15 oxacillin in dextrose(iso-osm) 15 oxaliplatin .............................. 21 oxandrolone............................ 71 oxcarbazepine ........................ 25 OXTELLAR XR .................... 25 oxybutynin chloride ............... 69 oxycodone ................................ 3 oxycodone hcl-acetaminophen. 3 oxycodone hcl-aspirin .............. 3 oxycodone-acetaminophen ...... 3 oxycodone-aspirin .................... 3 OXYCONTIN .......................... 3 oxymorphone ....................... 3, 4 P paclitaxel ................................ 21 paliperidone............................ 38 pamidronate............................ 78 PANRETIN ............................ 59 pantoprazole ........................... 68 papaverine .............................. 53 paricalcitol.............................. 79 paromomycin ......................... 35 paroxetine hcl ......................... 28 PASER ................................... 34 PATADAY ............................ 65 PATANOL ............................. 65 PAXIL .................................... 28 pedi m.vit no.17 with fluoride 90 PEDIARIX (PF) ..................... 76 PEDVAX HIB (PF) ............... 76 peg 3350-electrolytes ............. 69 PEG 3350-GRX ..................... 69 I-11 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 peg 3350-na sulf,bicarb,cl-kcl 69 PEGANONE .......................... 25 PEGASYS .............................. 41 PEGASYS PROCLICK ......... 41 peg-electrolyte soln ................ 69 PEGINTRON ......................... 41 PEGINTRON REDIPEN ....... 41 PEN NEEDLE, DIABETIC ... 63 penicillin g pot in dextrose ..... 15 penicillin g potassium............. 15 penicillin g procaine ............... 15 penicillin v potassium............. 15 PENTACEL (PF) ................... 76 PENTACEL ACTHIB COMPONENT (PF) ........... 77 PENTAM ............................... 35 pentoxifylline ......................... 45 PERIKABIVEN ..................... 48 perindopril erbumine .............. 49 PERJETA ............................... 21 permethrin .............................. 63 perphenazine........................... 38 perphenazine-amitriptyline..... 28 PERTZYE .............................. 64 phenelzine............................... 28 phenobarbital .......................... 25 phenobarbital sodium ............. 25 phentolamine .......................... 89 phenylephrine hcl ............. 48, 65 PHENYTEK ........................... 25 phenytoin ................................ 25 phenytoin sodium ................... 25 phenytoin sodium extended .... 25 PHOSLYRA ........................... 69 PHOSPHOLINE IODIDE ...... 83 phosphorus #1 ........................ 84 PICATO ................................. 59 pilocarpine hcl .................. 58, 83 pindolol................................... 50 pioglitazone ............................ 29 pioglitazone-glimepiride ........ 29 pioglitazone-metformin .......... 30 piperacillin-tazobactam ......... 15 piroxicam ................................. 5 PLASBUMIN 25 % ............... 45 PLASBUMIN 5 % ................. 45 PLASMA-LYTE 148 ............ 84 PLASMA-LYTE A................ 84 PLASMA-LYTE-56 IN 5 % DEXTROSE ...................... 84 PLEGRIDY ........................... 81 podofilox ................................ 59 podophyllum resin ................. 59 polyethylene glycol 3350....... 69 polymyxin b sulfate ............... 11 polymyxin b sulf-trimethoprim ........................................... 66 POMALYST .......................... 21 potassium acetate ................... 84 potassium bicarb and chloride 84 potassium bicarb-citric acid ... 84 potassium bicarbonate-cit ac . 84 potassium chlorid-d5-0.45%nacl ........................................... 84 potassium chloride ........... 84, 85 potassium chloride in 0.9%nacl ........................................... 84 potassium chloride in 5 % dex84 potassium chloride in lr-d5 .... 48 potassium chloride-0.45 % nacl ........................................... 85 potassium chloride-d5-0.2%nacl ........................................... 85 potassium chloride-d5-0.3%nacl ........................................... 85 potassium chloride-d5-0.9%nacl ........................................... 85 potassium citrate-citric acid ... 85 potassium hydroxide .............. 60 potassium phosphate m-/d-basic ........................................... 85 POTIGA................................. 25 PRADAXA ............................ 44 PRALUENT PEN .................. 54 PRALUENT SYRINGE ........ 54 pramipexole............................ 36 PRANDIMET ........................ 30 pravastatin .............................. 54 prazosin .................................. 48 prednicarbate .......................... 62 prednisolone acetate ............... 67 prednisolone sodium phosphate ...................................... 67, 72 prednisone .............................. 72 PREDNISONE INTENSOL .. 72 PREGNYL ............................. 73 PREMARIN ........................... 71 PREMASOL 10 % ................. 48 PREMASOL 6 % ................... 48 PREMPHASE ........................ 71 PREMPRO ............................. 71 prenatal vitamins .................... 90 PRENATAL VITAMINS ...... 90 PREPOPIK ............................. 69 PREZCOBIX ......................... 40 PREZISTA ............................. 40 PRIFTIN ................................ 34 PRIMAQUINE ...................... 36 primidone ............................... 25 PRISTIQ ................................ 28 PRIVIGEN ............................. 75 PROAIR HFA ........................ 87 PROAIR RESPICLICK ......... 87 probenecid .............................. 81 procainamide .......................... 50 PROCALAMINE 3% ............ 48 prochlorperazine .................... 35 prochlorperazine edisylate ..... 35 prochlorperazine maleate ....... 35 PROCRIT ............................... 44 PROCYSBI ............................ 81 progesterone ........................... 74 progesterone micronized capsules .............................. 74 PROGLYCEM ....................... 55 PROGRAF ............................. 75 I-12 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 PROLENSA ........................... 67 PROLEUKIN ......................... 21 PROLIA ................................. 79 PROMACTA.......................... 44 promethazine .................... 33, 35 promethazine hcl .................... 35 propafenone ............................ 50 propantheline .......................... 23 proparacaine ........................... 65 proparacaine hcl ..................... 65 proparacaine-fluorescein sod.. 65 propranolol ....................... 50, 51 propranolol-hydrochlorothiazid ............................................ 51 propylthiouracil ...................... 74 PROQUAD (PF) .................... 77 PROSOL 20 % ....................... 48 protamine................................ 45 protriptyline ............................ 28 PULMOZYME....................... 64 PURIXAN .............................. 21 pyrazinamide .......................... 34 pyridostigmine bromide ......... 81 Q QNASL................................... 67 QUADRACEL (PF) ............... 77 QUDEXY XR ........................ 25 quetiapine ............................... 38 QUILLIVANT XR ................. 57 quinapril ................................. 49 quinapril-hydrochlorothiazide 49 quinidine gluconate ................ 50 quinidine sulfate ..................... 50 quinine sulfate ........................ 36 QVAR..................................... 86 R RABAVERT (PF) .................. 77 raloxifene................................ 71 ramipril ................................... 49 RANEXA ............................... 53 ranitidine hcl ........................... 68 RAPAMUNE ......................... 75 REBIF (WITH ALBUMIN) .. 81 REBIF REBIDOSE ............... 81 REBIF TITRATION PACK .. 81 RECOMBIVAX HB (PF) ...... 77 REGRANEX ......................... 60 RELADOR PAK ..................... 6 RELENZA DISKHALER ..... 41 RELISTOR ............................ 68 REMICADE .......................... 81 REMODULIN ....................... 89 RENAGEL............................. 69 RENVELA............................. 69 repaglinide ............................. 30 REPATHA SURECLICK...... 55 REPATHA SYRINGE .......... 55 RESCRIPTOR ....................... 40 RESTASIS ............................. 67 RETROVIR ........................... 40 REVLIMID ............................ 21 REXULTI .............................. 38 REYATAZ............................. 40 ribavirin ................................. 42 RIDAURA ............................. 75 rifabutin ................................. 34 rifampin ................................. 34 RIFATER............................... 34 riluzole ................................... 57 rimantadine ............................ 41 ringers .............................. 77, 85 risedronate ............................. 79 RISPERDAL CONSTA ........ 39 risperidone ............................. 39 RITUXAN ............................. 21 rivastigmine tartrate ............... 26 rizatriptan ............................... 33 ropinirole ............................... 36 ROTARIX ............................. 77 ROTATEQ VACCINE .......... 77 ROZEREM ............................ 88 S SABRIL ................................. 25 SAIZEN ................................. 73 SAIZEN CLICK.EASY ......... 73 salsalate .................................... 5 SANDOSTATIN LAR DEPOT ............................................ 73 SANTYL ................................ 60 SAPHRIS (BLACK CHERRY) ............................................ 39 SAVAYSA ............................. 44 SAVELLA ............................. 57 selegiline hcl .......................... 36 selenium sulfide ..................... 60 SELZENTRY ......................... 40 SENSIPAR ............................. 81 SEREVENT DISKUS ............ 87 SEROQUEL XR .................... 39 SEROSTIM ............................ 73 sertraline ................................. 28 setlakin ................................... 58 sildenafil oral tablet 20 mg ... 89, 90 SILENOR ............................... 28 silver nitrate ........................... 60 silver nitrate applicators ......... 60 silver sulfadiazine .................. 60 SIMBRINZA.......................... 83 SIMPONI ......................... 81, 82 SIMPONI ARIA .................... 81 simvastatin ............................. 55 sirolimus................................. 75 SIRTURO .............................. 34 sodium acetate ........................ 85 sodium bicarbonate ................ 85 sodium chloride ................ 77, 85 sodium chloride 0.45 % ......... 85 sodium chloride 0.9 % ........... 85 sodium chloride 3 % .............. 85 sodium chloride 5 % .............. 85 sodium chloride-nahco3-kcl-peg ............................................ 69 sodium citrate-citric acid........ 85 sodium fluoride ...................... 90 sodium lactate ........................ 85 I-13 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 sodium phosphate ................... 85 sodium polystyrene sulfonate . 69 sodium thiosulfate .................. 70 sod-pot-k cit-sod cit-cit acid ... 86 SOLIRIS ................................. 82 SOLTAMOX .......................... 21 SOLU-CORTEF (PF) ............. 72 SOMATULINE DEPOT ........ 73 SOMAVERT .......................... 73 sorbitol.................................... 78 sorbitol-mannitol .................... 78 sotalol ..................................... 51 sotalol hcl ............................... 51 SOVALDI .............................. 41 spinosad .................................. 63 SPIRIVA RESPIMAT ........... 87 SPIRIVA WITH HANDIHALER .................. 87 spironolactone ........................ 55 spironolacton-hydrochlorothiaz ............................................ 55 SPORANOX .......................... 33 SPRYCEL .............................. 21 stavudine................................. 40 STELARA .............................. 82 STERILE PADS ..................... 82 STIMATE............................... 73 STIOLTO RESPIMAT .......... 87 STIVARGA ............................ 22 STRATTERA ......................... 57 streptomycin ........................... 10 STRIBILD .............................. 40 STRIVERDI RESPIMAT ...... 87 sucralfate ................................ 68 sulfacetamide sodium ............. 66 sulfacetamide sodium (acne) .. 60 sulfacetamide-prednisolone.... 66 sulfadiazine............................. 15 sulfamethoxazole-trimethoprim ...................................... 15, 16 sulfasalazine ........................... 16 sulfatrim ................................. 16 sulfazine ................................. 16 sulfazine ec ............................ 16 sulindac .................................... 5 sumatriptan nasal spray ......... 33 sumatriptan succinate ...... 33, 34 SUPPRELIN LA.................... 73 SUPRAX ............................... 13 SURE COMFORT INS. SYR. U-100 ................................. 63 SURMONTIL ........................ 28 SUSTIVA .............................. 40 SUTENT ................................ 22 SYLATRON .......................... 41 SYLVANT............................. 22 SYMLINPEN 120 ................. 30 SYMLINPEN 60 ................... 30 SYNAGIS .............................. 41 SYNAREL ............................. 82 SYNERCID ........................... 11 SYNRIBO .............................. 22 SYPRINE............................... 70 T TABLOID .............................. 22 tacrolimus ........................ 62, 75 TAFINLAR ........................... 22 TAMIFLU ............................. 41 tamoxifen ............................... 22 tamsulosin .............................. 70 TARCEVA ............................ 22 TARGRETIN......................... 22 tarina fe .................................. 58 TASIGNA .............................. 22 TAZORAC ............................ 63 taztia xt .................................. 51 TECFIDERA ......................... 82 TECHNIVIE .......................... 41 TEFLARO ............................. 13 TEGRETOL XR .................... 25 telmisartan ............................. 49 telmisartan-hydrochlorothiazid ........................................... 49 temazepam ............................... 9 TEMODAR ............................ 22 teniposide ............................... 22 TENIVAC (PF) ...................... 77 terazosin ................................. 70 terbinafine hcl ........................ 33 terbutaline .............................. 87 terconazole ............................. 33 testosterone ............................ 71 testosterone cypionate ............ 71 testosterone enanthate ............ 71 TETANUS TOXOID,ADSORBED (PF) ............................................ 77 TETANUS,DIPHTHERIA TOX PED(PF) ............................. 77 TETANUS-DIPHTHERIA TOXOIDS-TD ................... 77 tetrabenazine .......................... 57 tetracaine hcl .......................... 65 tetracycline ............................. 16 TEVETEN HCT..................... 49 TEV-TROPIN ........................ 74 THALOMID .......................... 82 theophylline............................ 87 theophylline anhydrous .......... 87 theophylline in dextrose 5 %.. 87 thioridazine ............................ 39 thiothixene.............................. 39 tiagabine ................................. 25 TICE BCG ............................. 77 TIKOSYN .............................. 50 timolol maleate................. 51, 83 tinidazole ................................ 36 TIVICAY ............................... 41 tizanidine ................................ 88 TOBI PODHALER ................ 10 TOBRADEX .......................... 66 TOBRADEX ST .................... 66 tobramycin ............................. 66 tobramycin in 0.225 % nacl ... 10 tobramycin in 0.9 % nacl ....... 10 tobramycin sulfate .................. 10 I-14 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 tolazamide .............................. 31 tolbutamide ............................. 31 tolmetin..................................... 5 tolterodine............................... 69 topiramate ............................... 26 toposar intravenous ................ 22 topotecan ................................ 22 TORISEL ............................... 22 torsemide ................................ 54 TOUJEO SOLOSTAR ........... 31 TOVIAZ ................................. 69 TPN ELECTROLYTES ......... 86 TPN ELECTROLYTES II ..... 86 TRACLEER ........................... 90 TRADJENTA ......................... 30 tramadol .................................... 4 tramadol-acetaminophen .......... 4 trandolapril ............................. 49 tranexamic acid ...................... 45 TRANSDERM-SCOP ............ 35 tranylcypromine ..................... 28 TRAVASOL 10 % ................. 48 TRAVATAN Z ...................... 83 travoprost (benzalkonium) ..... 83 trazodone ................................ 28 TREANDA ............................. 22 TRECATOR ........................... 34 TRELSTAR ............................ 22 tretinoin .................................. 63 tretinoin (chemotherapy) ........ 22 tretinoin microspheres ............ 63 TREXALL.............................. 22 triamcinolone acetonide .. 59, 62, 67, 72 triamterene-hydrochlorothiazid ............................................ 54 triazolam ................................... 9 TRIBENZOR ......................... 49 triderm .................................... 63 trifluoperazine ........................ 39 trifluridine............................... 66 trihexyphenidyl....................... 36 TRILEPTAL .......................... 26 trimethoprim .......................... 11 TRIUMEQ ............................. 41 TROKENDI XR .................... 26 TROPHAMINE 10 % ............ 48 TROPHAMINE 6% ............... 48 trospium ................................. 70 TRULICITY .......................... 30 TRUMENBA ......................... 77 TRUVADA ............................ 41 TUDORZA PRESSAIR ........ 87 TWINRIX (PF) ...................... 77 TYBOST ................................ 82 TYGACIL.............................. 16 TYKERB ............................... 23 TYPHIM VI ........................... 77 TYSABRI .............................. 75 TYVASO ............................... 90 TYVASO REFILL KIT ......... 90 TYVASO STARTER KIT..... 90 TYZEKA ............................... 42 TYZINE ................................. 65 U ULORIC ................................ 82 UNITUXIN ............................ 23 ursodiol .................................. 68 V VAGIFEM ............................. 71 valacyclovir ........................... 42 VALCHLOR ......................... 60 VALCYTE............................. 42 valganciclovir ........................ 42 valproate sodium.................... 26 valproic acid .......................... 26 valproic acid (as sodium salt) 26 valsartan ................................. 49 valsartan-hydrochlorothiazide 49 VALSTAR ............................. 23 vancomycin ............................ 11 vancomycin in d5w ................ 11 VAQTA (PF) ......................... 77 VARIVAX (PF) ..................... 77 VASCEPA ............................. 55 vasopressin ............................. 74 VECTIBIX ............................. 23 VELCADE ............................. 23 VELPHORO .......................... 69 venlafaxine ............................. 28 VENTAVIS............................ 90 VENTOLIN HFA .................. 87 verapamil................................ 51 VEREGEN ............................. 60 VERSACLOZ ........................ 39 VESICARE ............................ 70 VICTOZA .............................. 30 VIDEX 2 GRAM PEDIATRIC ............................................ 41 VIDEX 4 GRAM PEDIATRIC ............................................ 41 VIEKIRA PAK ...................... 41 VIGAMOX ............................ 66 VIIBRYD ............................... 28 VIMIZIM ............................... 64 VIMPAT ................................ 26 vinblastine .............................. 23 vincristine............................... 23 vincristine sulfate ................... 23 vinorelbine ............................. 23 VIRACEPT ............................ 41 VIRAMUNE XR ................... 41 VIRAZOLE............................ 42 VIREAD ................................ 41 VITEKTA .............................. 41 VOLTAREN ............................ 5 voriconazole ........................... 33 VOTRIENT............................ 23 VPRIV.................................... 64 VYTORIN 10-10 ................... 55 VYTORIN 10-20 ................... 55 VYTORIN 10-40 ................... 55 VYTORIN 10-80 ................... 55 W warfarin .................................. 44 water for irrigation, sterile ..... 78 I-15 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015 WELCHOL ............................ 55 X XALKORI .............................. 23 XARELTO ............................. 44 XARTEMIS XR ....................... 4 XELJANZ .............................. 82 XENAZINE ............................ 57 XGEVA .................................. 79 XIFAXAN .............................. 11 XOLAIR ................................. 88 XTANDI................................. 23 xylon 10 .................................... 4 XYREM ................................. 88 Y YERVOY ............................... 23 YF-VAX (PF) ......................... 77 Z zafirlukast ............................... 86 zaleplon .................................. 88 ZALTRAP ............................. 23 ZARXIO ................................ 44 ZAVESCA ............................. 64 ZELBORAF........................... 23 ZEMAIRA ............................. 88 ZEMPLAR............................. 79 ZENPEP................................. 64 ZETIA .................................... 55 ZIAGEN ................................ 41 zidovudine ............................. 41 ZIOPTAN (PF) ...................... 83 ziprasidone hcl ....................... 39 ZIRGAN ................................ 66 ZOLADEX ............................ 23 zoledronic acid ....................... 79 zoledronic acid-mannitol-water ........................................... 79 ZOLINZA .............................. 23 zolmitriptan ............................ 34 zolpidem................................. 89 ZOMACTON ......................... 74 ZOMETA ............................... 79 zonisamide ............................. 26 ZORTRESS...................... 75, 76 ZOSTAVAX (PF) .................. 77 ZOVIRAX.............................. 60 ZUBSOLV ........................... 6, 7 ZYDELIG .............................. 23 ZYKADIA ............................. 23 ZYLET ................................... 66 ZYPREXA RELPREVV ....... 39 ZYTIGA ................................. 23 ZYVOX.................................. 11 I-16 Access Medicare 2015 Part D Formulary Formulary ID: 15483.000, Version: 17 Effective: December 01, 2015